Upcoming Issue Highlights

Monograph: Vitamin D

Monograph Vitamin D Monograph Vitamin D

Based on a systemic review of scientific literature edited and peer-reviewed by contributors to the Natural Medicines Research Collaboration.

Vitamin D is found in many dietary sources, such as fish, eggs, fortified milk and cod liver oil. The sun also contributes significantly to the daily production of vitamin D, and as little as 10 minutes of exposure is thought to be enough to prevent deficiencies. The term “vitamin D” refers to several different forms of this vitamin. Two forms are important in humans: ergocalciferol (vitamin D2) and cholecalciferol (vitamin D3). Vitamin D2 is synthesized by plants. Vitamin D3 is synthesized by humans in the skin when it is exposed to ultraviolet B (UVB) rays from sunlight. Foods may be fortified with vitamin D2 or D3.

History

Orally, vitamin D is used for preventing osteoporosis, muscle weakness, enhancing immune function, preventing autoimmune diseases, multiple sclerosis, rheumatoid arthritis, chronic obstructive pulmonary disease (COPD), asthma, bronchitis and cancer. It is also used orally for rickets, premenstrual syndrome (PMS), influenza, preventing falls and fractures in people at risk for osteoporosis, corticosteroid-induced osteoporosis, osteomalacia, anticonvulsant-induced osteomalacia, renal osteodystrophy, osteitis fibrosa in people on dialysis, hepatic osteodystrophy and osteogenesis imperfecta. Vitamin D is also used for preventing and treating hypocalcemia and tetany in premature infants’ bone disorders in people with familial hypophosphatemia, hypophosphatemia associated with Fanconi syndrome, and hypocalcemia associated with postoperative or idiopathic hypoparathyroidism or pseudohypoparathyroidism. Other uses include, plaque-type psoriasis, actinic keratosis, lupus vulgaris, squamous cell carcinomas, vitiligo, scleroderma, myelodysplastic syndrome, periodontal disease, hypertension, hyperlipidemia, cardiovascular disease, obesity and diabetes. Vitamin D is also used orally to treat severe proximal myopathy associated with vitamin D deficiency or myopathy associated with the use of HMG-CoA reductase inhibitors (statin-induced myopathy), and to maintain bone density in prostatic cancer patients at risk for osteoporosis when treated with luteinizing hormone-releasing hormone analogue (LHRH-a).

Topically, vitamin D is used as calcitriol or calcipotriene for plaque-type psoriasis.

Intravenously, vitamin D, administered as calcitriol, is used for hypocalcemic tetany in premature infants, hypocalcemia and hyperparathyroidism in renal dialysis patients and osteitis fibrosa.

Intramuscularly, vitamin D is administered as ergocalciferol for hepatic osteodystrophy, as an injectable source of vitamin D, and to treat severe proximal myopathy associated with vitamin D deficiency.

Safety

Vitamin D is likely safe when used orally or intramuscularly and appropriately. Vitamin D has been safely used in a wide range of doses. When used orally long-term, doses should not exceed the tolerable upper intake level of 4,000 IU per day for adults; however, much higher doses such as 50,000 IU/week orally for six to 12 weeks are often needed for the short-term treatment of vitamin D deficiency. Optimal blood levels of 25-hydroxyvitamin D for maintaining bone density is 30-100 ng/mL. Toxicity usually does not occur until levels exceed 150 ng/mL.

Vitamin D is possibly unsafe when used orally in excessive doses, long-term. Taking doses greater than the tolerable upper intake level of 4,000 IU per day for long periods can increase the risk of hypercalcemia; however, much higher doses are often needed for short-term treatment of vitamin D deficiency. Optimal blood levels of 25-hydroxyvitamin D for maintaining bone density is 30-100 ng/mL. Toxicity usually does not occur until levels exceed 150 ng/mL.

Children

Vitamin D is likely safe when used orally and appropriately. When used long-term, doses should not exceed the tolerable upper intake level. Infants from 0-6 months should not exceed the UL (upper level) of 1,000 IU daily. Infants aged 6-12 months should not exceed the UL of 1,500 IU daily. Children aged 1-3 years should not exceed the UL of 2,500 IU daily. Children aged 4-8 years should not exceed the UL of 3,000 IU daily. Children aged 9 years and older should not exceed the UL of 4,000 IU daily; however, much higher doses are often needed for the short-term treatment of vitamin D deficiency. Some research shows that giving vitamin D 14,000 IU/week for a year in children aged 10-17 is safe. It is possibly unsafe when used orally in excessive doses, long-term. Taking doses greater than the tolerable upper intake level long-term can increase the risk of hypercalcemia. Infants from 0-6 months should not exceed the UL of 1,000 IU daily. Infants aged 6-12 months should not exceed the UL of 1500 IU daily. Children aged 1-3 years should not exceed the UL of 2,500 IU daily. Children aged 4-8 years should not exceed the UL of 3,000 IU daily. Children aged 9 years and older should not exceed the UL of 4,000 IU daily; however, much higher doses are often needed for the short-term treatment of vitamin D deficiency. Some research shows that giving vitamin D 14,000 IU/week for a year in children aged 10-17 is safe.

Pregnancy

Vitamin D is likely safe when used orally and appropriately. Vitamin D is safe when used in doses below the tolerable upper intake level of 4,000 IU per day. It is possibly unsafe when used orally in excessive amounts. Tell patients not to use doses above the tolerable upper intake level of 4,000 IU per day. Hypercalcemia during pregnancy due to excessive vitamin D intake can lead to several adverse effects in the fetus including suppression of parathyroid hormone, hypocalcemia, tetany, seizures, aortic valve stenosis, retinopathy, and mental and/or physical retardation in the infant.

Lactation

Vitamin D is likely safe when used orally and appropriately. Vitamin D is safe when used in doses below the tolerable upper intake level of 4,000 IU per day. It is possibly unsafe when used orally in excessive amounts. Tell patients not to use doses above the tolerable upper intake level of 4,000 IU per day.

Effectiveness

Effective

Familial hypophosphatemia. Taking calcitriol or dihydrotachysterol orally in combination with phosphate supplements is effective for treating bone disorders in people with familial hypophosphatemia.

Fanconi syndrome. Taking ergocalciferol orally is effective for treating hypophosphatemia associated with Fanconi syndrome.

Hypoparathyroidism. Taking dihydrotachysterol or calcitriol orally is effective for increasing serum calcium concentrations in people with hypoparathyroidism or pseudohypoparathyroidism. Ergocalciferol is effective in high doses for increasing serum calcium concentrations in people with hypoparathyroidism or pseudohypoparathyroidism. Taking vitamin D or calcitriol postoperatively is also effective for preventing hypocalcemia in people with hypoparathyroidism due to thyroidectomy.

Osteomalacia. Taking cholecalciferol is effective for treating osteomalacia. Oral calcifediol is effective for treating osteomalacia secondary to liver disease and anticonvulsant-induced osteomalacia. Ergocalciferol is effective for osteomalacia due to malabsorption syndromes and corticosteroid-induced osteomalacia.

Psoriasis. Applying vitamin D or calcipotriene topically effectively treats plaque-type psoriasis in some patients, including those with chronic plaque psoriasis. Applying topical vitamin D or its analogues in combination with topical corticosteroids seems to be more effective for treating psoriasis than either agent used alone. Also, applying a specific combination product containing calcipotriene and betamethasone can reduce psoriasis severity compared to pretreatment, and the combination seems to be more effective than topical vitamin D analogues alone.

Renal osteodystrophy. Taking calcifediol orally manages hypocalcemia and prevents renal osteodystrophy in patients with chronic renal failure undergoing dialysis. However, vitamin D and vitamin D analogues do not appear to reduce the risk of death, bone pain, or parathyroidectomy in patients with chronic renal failure undergoing dialysis.

Rickets. Vitamin D is effective for preventing and treating rickets. Calcitriol should be used in patients with renal failure. Vitamin D deficiency. Vitamin D is effective for preventing and treating vitamin D deficiency using a wide range of doses. Optimal blood levels of 25-hydroxyvitamin D for maintaining bone density is 30-100 ng/mL. Toxicity usually does not occur until levels exceed 150 ng/mL.

Dosing & Administration

• Adult Oral:

General: Vitamin D is included in most multivitamins, usually in strengths from 50 IU to 1,000 IU, as soft gels, capsules, tablets and liquids. According to research, ergocalciferol and cholecalciferol are considered equivalent; however, some evidence indicates that ergocalciferol is less potent than cholecalciferol. Since 2000, discrepancies have arisen regarding the benefits of vitamin D and how much is sufficient. A clinical review has suggested an upper limit of a dose of vitamin D to be more than or equal to 250 mcg daily, based on the lack of observed toxicity in adult trials. The Institute of Medicine (IOM) has reviewed and updated the Dietary Reference Intakes (DRIs). The IOM found that there is strong evidence to support the use of vitamin D with calcium for bone health but that it was lacking for other health conditions. The new recommended daily allowance, as set in 2010, is based on age, as follows: for those 1-70 years of age, 600 IU daily; for those 71 years and older, 800 IU daily; and for pregnant and lactating women, 600 IU daily. The IOM further recommended that serum 25D levels of 20 ng/mL is adequate, and levels >50 ng/mL could have potential adverse effects. This level can be achieved through substantial daily skin exposure to sunlight.

Anticonvulsant-induced osteomalacia: In human research, vitamin D2 2,000 IU daily plus calcium lactate 390 mg daily for three months improved well-being and increased bone mineral content when used in combination with antiepileptic agents. Atopic eczema: 1,600 IU of cholecalciferol, either with or without 600 IU synthetic all-rac-alpha-tocopherol, has been taken daily for 60 days.

Autoimmune diseases: 0.25-2 mcg of alfacalcidol has been taken once or twice daily, and 0.5 mcg of 1-alfa-OH D3 has been taken daily for up to 12 months.

Cancer prevention: According to observational studies, individuals with 1,000 IU of oral vitamin D daily had a lower incidence of colon cancer. 100,000 IU of vitamin D3 has been taken every four months, 1,100 IU of vitamin D has been taken daily, and 400 IU of vitamin D3 or 1,100 mg of vitamin D plus 1,400-1,500 mg of calcium daily has been taken for 4-7 years. 400-1,100 IU of vitamin D has been taken daily for four years.

Cancer treatment: 10 mcg of doxercalciferol has been taken daily for 28 days or 45 mcg calcitriol has been taken weekly for three weeks out of every four weeks. 400 IU and 1,100 IU of vitamin D has been taken daily for 4-7 years.

Cardiovascular disease: According to a review, moderate or high doses of vitamin D of approximately 1,000 IU daily reduced cardiovascular disease (CVD) risk. According to another review, supplementation of vitamin D2 or D3 of approximately 528 IU daily raised serum 25D levels and found an association with decreased systolic blood pressure and risk for CVD-related deaths; however, no beneficial effect was found on blood pressure, myocardial infarction, or mortality for postmenopausal women. In most studies in a review, 320-2,000 IU of vitamin D3 has been taken daily for 1.4-84 months or 200-800 IU of vitamin D2 has been taken daily for five months; 100,000 IU of vitamin D2 or D3 three times yearly for up to three years has also been used, and in one study, participants received a single injection of 300,000 IU of vitamin D2 followed by 1 g of vitamin D2, 800 IU of vitamin D3, plus 1 g of calcium daily for 12 months. 400 IU of vitamin D with calcium has been taken at an unspecified frequency for seven years. In a systematic review, participants in some of the included studies received 800 IU of vitamin D daily for eight weeks. In a systematic review, dosing included 2.5 mg of vitamin D every four months for five years, 10-25 mcg of vitamin D daily for 1-7 years, with or without 1,000 mg of calcium.

Cognition: According to a review, supplementation of vitamin D2 or D3 of approximately 528 IU daily raised serum 25D levels and found an association with improved cognition. 9,000 IU of vitamin D2 has been taken daily for eight-40 weeks.

Cystic fibrosis: According to published guidelines, if individuals with cystic fibrosis had a minimal 25-hydroxyvitamin D concentration of <30 ng/mL, vitamin D supplementation was recommended. A recommendation regarding whether oil- or powder-based formulas were more effective was lacking. Calcitriol, doxercalciferol or paricalcitol, under the guidance of an expert in vitamin D therapy, was recommended. For adults, the committee recommended that CF patients be treated with 800-2,000 IU of vitamin D3 daily, which could be increased to a maximum of 10,000 IU daily if serum levels of 25-hydroxyvitamin D were persistently <30 ng/mL.

Dental caries: Vi-delta Liquid emulsion and Ostelin were both reported as having been taken; a vitamin D mixture in milk was also used.

Fall prevention: According to a systematic review, high doses of vitamin D were found to have a greater benefit than lower doses at preventing nonvertebral and hip fractures. In systematic reviews and meta-analyses, 200-2,000 IU daily of vitamin D2 or vitamin D3 has been taken, often in combination with calcium for up to 62 months. 100,000 IU of vitamin D2 has been taken up to every three months for up to five years. Single doses of 300,000 IU and 500,000 IU of vitamin D have been taken. In a systematic review, dose information was limited and was 700 IU, 0.50 mcg, or 600,000 IU, administered daily or weekly for a treatment duration of eight weeks to three years; some trials administered vitamin D in combination with calcium. 1,100-15,000 IU has been taken weekly for 3-24 months. According to a review, for optimal blood levels of 75-100 nmol/L for improving lower muscular strength and bone density, important in fall prevention, 800-1000 IU of vitamin D daily is suggested. Vitamin D 100 IU has been taken daily in combination with calcium, or 300,000 IU and 500,000 IU of vitamin D have been taken yearly without calcium for one-four years. 1 mcg of 1-alpha hydroxycholecalciferol have been taken daily for 36 weeks, and 0.25 mcg of calcitriol has been taken daily for three years. According to a review, 800-5,000 IU daily improved musculoskeletal health and reduced the risk of falls and fractures in the elderly.

Fertility: 400-50,000 IU of vitamin D has been taken weekly or every two weeks, alone or with calcium. Elocalcitol has been used for three months.

Fibromyalgia: 50,000 IU of vitamin D has been taken once weekly for three months.

Fracture prevention: 800 IU of vitamin D3 has been taken daily. 400-1,100 IU has also been taken daily. 100,000 IU of oral vitamin D2 has been taken every four months for 36 months, or 10-20 mcg of oral vitamin D3 has been taken daily for 24 months. 400-1,000 IU has been taken daily. 400-1,370 IU has been taken daily with a follow-up of 7-60 months, or 300-1,000 IU of vitamin D plus 500-1,200 mg of calcium have been taken daily for a follow-up of one to seven years. According to a systematic review, doses of 400 IU daily to 5,000 IU have been taken twice weekly in combination with calcium, and alpha-calcidiol has been taken. 1-alpha-hydroxyvitamin D 0.25 mcg has been taken daily for six months, and calcitriol 0.25 mcg has been taken twice daily for two years. 200-800 IU of vitamin D has been taken daily for an average of 3.5 years in combination with calcium. According to a systematic review, calcitriol 0.25-1 mcg daily or vitamin D 800 IU daily in combination with 1.2 g calcium has been used for an unknown duration; however, some studies were conducted for up to three years.

400-800 IU has been taken in combination with calcium at an unspecified frequency, or 400-500,000 IU has been taken at an unspecified frequency, once every four months, or once a year without calcium, for two to seven years. According to a review, for optimal blood levels of 75-100 nmol/L for improving lower muscular strength and bone density, important in fracture prevention, 800-1,000 IU of vitamin D daily is suggested. According to a review, 800-5,000 IU daily improved musculoskeletal health and reduced the risk of falls and fractures in the elderly. According to a review, 10-20 mcg of vitamin D3 has been taken daily; other doses have included vitamin D2 2,500 mcg by mouth every four months or 12,500 mcg of vitamin D3 once annually for three to five years.

Hyperlipidemia: 300-3,332 IU has been taken daily for 42 days to three years, and single doses have ranged from 100,000 to 200,000 IU; D3 cholecalciferol, calcitriol, ergocalciferol, and alpha-calcidiol were used, and calcium was given in some studies. In a systematic review, the following doses were used: 7.5-1,250 mcg of vitamin D daily for 15 weeks to five years, calcitriol 0.5 mcg daily or 1.5-2.25 mcg twice weekly for two to three months, or 1 mg of alphacalcidol daily for four to six months.

Hypertension: According to a clinical review, vitamin D 400-8,571 IU daily for various durations showed no effect on hypertension. 0.75-1 mcg of 25D, 200-2,900 IU of D3 or 1,800 IU of D2 daily have been taken.

Hypocalcemia: According to secondary sources, calcitriol has been used in an initial oral dose of 0.25 mcg daily; dosing may be increased by 0.25 mcg daily at four to eight-week intervals in patients with hypocalcemia from chronic dialysis.

Hypocalcemia due to hyperparathyroidism: In a systematic review, 0.5 or 1.0 mcg of calcitriol, 0.5 g of vitamin D and 400 IU of vitamin D have been taken once to twice daily with oral calcium carbonate in some studies and up to postoperative day 14 in some studies.

Hypoparathyroidism: According to secondary sources, dihydrotachysterol has been used in an oral initial dose of 750 mcg to 2.5 mg daily for several days for the treatment of hypoparathyroidism. A maintenance dose is typically 200 mcg to 1 mg daily. Ergocalciferol has also been used in an oral dose of 50,000 to 200,000 IU daily concomitantly with calcium lactate 4 g, six times daily.

Immunomodulation: The following doses have been taken: 40 IU of vitamin D3 given daily for 20 years to 100,000 IU of vitamin D3 given bimonthly for 12 months; and 10,000 IU daily.

Inflammatory bowel disease: 0.5 mcg of alfacalcidol has been taken daily and compared with cholecalciferol 1,000 IU daily, or cholecalciferol 1,200 IU has been taken daily with 1,200 mg of calcium and compared with 1,200 mg of calcium alone for 12 months.

Kidney disease: 1-9 mcg of vitamin D has been taken once daily or weekly over a four to 24-week period. 400-100,000 IU has been taken daily to monthly over a follow up period of six months to two years.

Mood disorders: In human research, 400-800 IU daily or 100,000 IU weekly of vitamin D for up to one month improved symptoms of depression associated with seasonal affective disorder. In obese patients, 20,000-40,000 IU of vitamin D per week for one year was found to improve symptoms of depression.

Mortality reduction: 10 mcg to 500,000 IU has been taken with frequencies varying from daily, to every third or fourth month, to once yearly. In a systematic review, the following doses were reported: cholecalciferol 300-1,8000,000 IU; ergocalciferol 200-300,000 IU; alfacalcidol 1 mcg; calcitriol, 0.5 mcg and 2 mcg; and if in combination with calcium, a calcium dose of 300-1,600 mg was taken, and the frequency of vitamin D supplementation varied from daily to yearly with a duration of treatment of one day to seven years. 400 IU and 100,000 IU of vitamin D have been taken daily with or without calcium for two to seven years.

Multiple sclerosis (MS): In human research, high-dose vitamin D was found to be safe and showed evidence of immunomodulatory effects. In clinical research, 5,000 IU of vitamin D3 daily reduced the number of relapses in patients with MS. In a safety study, progressive weekly increases of vitamin D3 per week plus 1,200 mg of calcium were found to be safe in individuals with multiple sclerosis.

Muscle strength: In a systematic review, ergocalciferol has been taken at doses of 1,000-600,000 IU, calciferol has been taken at doses of 20-300,000 IU, and cholecalciferol has been taken at doses of 400-150,000 IU; if in combination with calcium, 800-1,100 mg was taken. The treatment was daily in some studies and the duration was two to 36 months. In a systematic review, doses of vitamin D were 400-150,000 IU of D3, 1,000-600,000 IU of D2, and 0.25 mcg of calcitriol. In a systematic review, participants in some of the included studies received 700-1,000 IU of vitamin D daily for two months to two years.

Muscle weakness/pain: 100,000 IU of calciferol has been taken daily for 12 months in patients with rheumatoid arthritis. Osteoporosis: In postmenopausal African American women, 2,000 IU daily of oral vitamin D3 was sufficient to raise 25-hydroxyvitamin D concentrations to more than 50 nmol/L, but higher doses may also be required. In women residing in sunny areas, 400 IU daily was not sufficient enough to achieve optimal 25-hydroxyvitamin D concentrations for bone health. For chronic supplementation to protect against bone loss, a daily dosage of at least 800 IU seems required. Higher dosages may be needed to correct established vitamin D deficiency; a repeat 25D assay after four to six months may help to assess the treatment response and to adjust the subsequent vitamin D dosage. According to a clinical review, vitamin D 400-1,200 IU daily with calcium or intermittently 100,000 IU every four months with or without calcium may reduce the risk of falls and fall-related fractures in the elderly. 300-7,000 IU daily and 400-5,714 IU of vitamin D3 and 5,000-10,000 IU of vitamin D2 daily have been taken. 100 IU daily to 1000,000 IU weekly and 50,000 IU of vitamin D weekly along with 1,500 mg of calcium daily and 800 IU of vitamin D have been used. Vitamin D supplementation of 400-2,000 IU daily, as vitamin D alone, combined with calcium, or within a multivitamin, has been used.

Osteoporosis: Weight-based calcitriol has been taken for two years, or 800 IU of vitamin D has been taken, or 1,600 IU has been taken, with or without 1 g of calcium for six months.

Osteoporosis: 200-800 IU has been taken daily, occasionally in combination with calcium for up to 24 months. Calcitriol and alfacalcidol daily were the recommendations in the individual trials.

Parasitic infections: In patients with Schistosoma haematobium infection, 40 IU of vitamin D daily for five days resulted in some positive effects on levels of activated eosinophils and Schistosoma-specific antibodies.

Physical performance: In elderly subjects, vitamin D 400 IU plus 800 mg of calcium daily improved gait speed, body sway and muscle strength. According to post hoc analysis, in older adults, 8,400 IU of vitamin D3 weekly for 16 weeks reduced mediolateral sway and was well tolerated.

Pregnancy nutritional supplement: 400-600,000 IU has been taken as a daily dose from week 12, week 27, or during the third trimester or a single dose at either the seventh or eighth month of gestation. 400-4,000 IU of vitamin D has been taken daily for the third trimester or starting the 12th week of pregnancy; other doses were 120,000-600,000 IU of vitamin D monthly at the fifth, seventh and/or eighth months, or the 27th week of gestation. 400-4,000 IU daily, a single dose of 200,000 IU, or two doses of 600,000 IU has been taken with supplementation starting anywhere between 12 and 27 weeks of gestation. 800-1,200 IU has been taken daily starting at weeks 20-32 of pregnancy and continued until the end of pregnancy; other doses have included a single dose of 200,000 IU at 27-28 weeks of pregnancy or 600,000 IU given once in the seventh month and once in the eighth month of pregnancy. A single dose of 1,500-6,000 IU has been taken in both the second and third trimester.

Prevention of respiratory tract infections: 400-2,000 IU of vitamin D has been taken daily for up to three years. 4,000 IU has been taken daily for one year. An initial dose of 200,000 IU of vitamin D3 has been taken followed by 200,000 IU one month later, and 100,000 IU monthly.

Respiratory infections: According to a clinical review, doses of 2,000 IU/kg of body weight for three days may be beneficial in treating viral respiratory infections.

Rheumatoid arthritis: In human research, patients with active rheumatoid arthritis stabilized on methotrexate and receiving vitamin D 50,000 IU weekly for 12 weeks showed a moderate improvement in efficacy outcomes.

Tuberculosis (TB): A single dose of 10,000 IU daily of vitamin D2 to purified protein derivative-positive contacts of active TB cases improved immunologic control of bacille Calmette-Guérin in the peripheral blood. Four daily doses of 2.5 mg of vitamin D has been taken on day seven of usual tuberculosis treatment, followed by supplementation on days 14, 28 and 42. In a second study in this review, 1,000 IU of vitamin D was taken daily for eight weeks in addition to usual tuberculosis therapy, and a third study administered vitamin D at 0.25 mg daily for six weeks.

Type 2 diabetes: Calcitriol, 1-alpha-calcidiol, cholecalciferol, doxecalciferol, and ergocalciferol have been used at doses of 400-200,000 IU for cholecalciferol, 0.25 mcg and 0.75 mcg for 1-alphacalcidiol, 1 mcg and 1.5 mg for calcitriol, 1 and 2 mcg for paricalcitol, and 100,000 IU for ergocalciferol for seven days to seven years. 0.75-2 mcg of alpha-calcidol, 1-1.5 mcg of 1,25-dihydroxyvitamin D3, 0.75 mcg daily of 1-hydroxyvitamin D3, and 400-100,000 IU of vitamin D3 have been taken daily or weekly as a single dose for up to seven years. 400-8,751 IU has been taken daily for six weeks to nine years. According to a clinical review, vitamin D 400-5,714 IU daily for two months to seven years showed no effect on glycemia.

Viral infection: In human research, 800 IU of vitamin D daily for two years, followed by 2,000 IU of vitamin D daily for 12 months, produced a lower rate of self-reported upper respiratory tract infection.

Vitamin D deficiency: According to a clinical review, treatment of vitamin D deficiency in healthy individuals or those with serious illness should be individualized to maintain 25-hydroxyvitamin D levels in the normal range. To achieve an optimal vitamin D status of 75 nmol/L, research suggests an intake for all adults of 1,000 IU or more daily. Weekly doses of 8,400 IU of vitamin D3 have also been shown to raise 25D levels. According to a clinical review, 50,000 IU daily for six weeks lacked evidence of toxicity. Doses of 300,000 IU of oral vitamin D3 three times per year have also been shown to be effective for vitamin D insufficiency and well tolerated.

According to clinical research in the United States, Canada and Japan, elderly patients living in long-term care facilities at risk for vitamin D deficiency should receive a minimum of 800 IU daily in combination with calcium. Doses of 400 IU daily have not been found sufficient enough to improve bone health in sunny areas.

In women with secondary hyperparathyroidism and hypovitaminosis D, cholecalciferol 300,000 IU every three months was more effective than 1,000 IU daily in correcting vitamin D deficiency. In rheumatology patients with severe vitamin D deficiency, a single oral dose of 300,000 IU of vitamin D3 has been used.

In a separate guideline, supplementation at suggested daily intake and tolerable upper limit levels was recommended; however, age and clinical circumstance were to play a role in the level. The guideline recommended measuring serum 25-hydroxyvitamin D levels and both vitamin D2 and vitamin D3 were recommended. The authors suggested that screening of individuals not at risk for deficiency lacks supportive evidence, as does the need for prescription of vitamin D for cardiovascular protection. According to a review, a cumulative dose of 600,000 IU or more over several weeks is needed for treatment of vitamin D deficiency.

Topical:

Psoriasis: Calcipotriene is a synthetic form of vitamin D3 and is used for psoriasis. Experts recommend applying the ointment twice daily to control the excess production of skin cells in psoriasis. In clinical trials, topical vitamin D analogs have been used alone or with topical steroids for three to 52 weeks. Topical calcipotriol 50 mg/g, tacalcitol 4 mg/g, calcitriol 3 mg/g, or the two compound formulation ointment containing calcipotriol with betamethasone dipropionate have been applied once or twice daily for four to 12 weeks.

Senile warts: In human research in the elderly, topical vitamin D3 ointments for three to 12 months reduced senile warts. Vitiligo: In human research, calcipotriol ointment alone twice daily showed marked improvement in repigmentation in patients with vitiligo; betamethasone dipropionate in the morning and calcipotriol in the evening also showed marked repigmentation. Vitamin D analogs such as calcipotriol or tacalcitol have been used alone or combined with phototherapy or topical steroids and applied topically twice per week to twice daily for six weeks to 18 months.

Intravenous/Intramuscular:

Cardiovascular disease: A single injection of 300,000 IU of vitamin D2 has been followed by 1g of vitamin D2, 800 IU of vitamin D3, plus 1g of calcium daily for 12 months.

Fall prevention: 300,000-600,000 IU of vitamin D2 has been given intramuscularly once annually for up to 62 months. In a systematic review, the following doses were reported: a single intramuscular injection containing 300,000-600,000 IU of vitamin D or 300,000 IU of vitamin D annually for three years.

Fracture prevention: 300,000 IU of intramuscular vitamin D2 has been given every 12 months for 36 months. According to a review, vitamin D2 7,500 mcg has been given intramuscularly every 12 months.

Hyperlipidemia: Calcitriol has been administered intravenously at a dose of 1 mcg twice weekly for eight weeks. Kidney disease: 0.04 mcg/kg to 4 mcg of vitamin D has been administered intravenously once or three times weekly over a four to 12-week period.

Muscle strength: In a systematic review, doses of vitamin D were 400-150,000 IU of D3, 1,000-600,000 IU of D2, or 0.25 mcg of calcitriol.

Vitamin D deficiency: In human research, 300,000 IU of an intramuscular bolus dose of vitamin D2 or D3, administered three times per year, was well tolerated and effective for vitamin D insufficiency. According to a clinical review, higher doses of single injections of 600,000 IU of vitamin D were sufficient to raise levels with no evidence of toxicity and may also be beneficial for the prevention of vitamin D deficiency during the winter season. A single intramuscular injection of 600,000 IU of cholecalciferol vitamin D3 has been given.

• Children Oral:

General: Since 2000, discrepancies have arisen regarding the benefits of vitamin D and how much to take. IOM has reviewed and updated the DRIs. In 2008, the American Academy of Pediatrics (AAP) increased its recommended daily intake of vitamin D in infants, children and adolescents to 400 IU. Exclusively breastfed infants who do not consume less than 1 L of vitamin D-fortified milk daily will likely need supplementation to reach 400 IU of vitamin D daily. Although the AAP advises against keeping children in direct sunlight exposure, this may increase the risk of vitamin D deficiency. However, the IOM found that there is strong evidence to support the use of vitamin D with calcium for bone health but that it was lacking for other health conditions. The new recommended daily allowance, as set in 2010, is based on age, as follows: for those 1-70 years of age, 600 IU daily; for infants aged 0-12 months, the upper level intake is 1,000 IU daily. Other research confirms these recommendations. According to a review, for their first 12 months, infants at low risk of vitamin D deficiency should be supplemented with 400 IU daily.

Anticonvulsant-induced osteomalacia: In human research, vitamin D2 2,000 IU daily plus calcium Sandoz 500 mg for three months improved well-being and increased bone mineral content in children aged 7-14 years when used in combination with phenytoin. Atopic eczema: 1,600 IU of cholecalciferol, either with or without 600 IU of synthetic all-rac-alpha-tocopherol, has been taken daily for 60 days, or 1,000 IU of ergocalciferol has been taken daily for one month.

Cystic fibrosis (CF): According to published guidelines, if individuals with cystic fibrosis had a minimal 25-hydroxyvitamin D concentration of <30 ng/mL, vitamin D supplementation was recommended. A recommendation regarding whether oil- or powder-based formulas were more effective was lacking. Calcitriol, doxercalciferol or paricalcitol, under the guidance of an expert in vitamin D therapy, was recommended. For infants with CF, the committee recommended treatment consisting of 400-500 IU of vitamin D daily from birth to 12 months. If serum 25-hydroxyvitamin D levels in infants became <10 ng/mL, it was suggested that the infants be assessed for rickets by an expert in vitamin D therapy. If serum levels of 25-hydroxyvitamin D became <20 ng/mL or if they were persistently <30 ng/mL, it was recommended that the dose be increased to 2,000 IU daily. If this dosing lacked an appropriate effect, the committee recommended that the infant consult an expert in vitamin D therapy. Children with CF who were aged 1-10 years were advised to be treated with 800-1,000 IU of vitamin D daily, which could be increased to a maximum of 4,000 IU daily if the serum levels of 25-hydroxyvitamin D were persistently <30 ng/mL. For children aged >10 years, the committee recommended that CF patients be treated with 800-2,000 IU of vitamin D3 daily, which could be increased to a maximum of 10,000 IU daily if serum levels of 25-hydroxyvitamin D were persistently <30 ng/mL.

Immunomodulation: In a systematic review, participants in some of the included studies received 2,000 IU of vitamin D daily during the first year of life.

Osteoporosis: Weight-based calcitriol has been taken for two years, or 800 IU of vitamin D has been taken, or 1,600 IU has been taken, with or without 1 g of calcium for six months.

Osteoporosis: 0.25 mcg of calcitriol has been taken in combination with 500 mg of elemental calcium daily for nine months, and alfacalcidol has been taken daily for six months.

Prevention of respiratory tract infections: 1,200 IU of vitamin D has been taken daily for three months to three years. 300 IU of vitamin D3 has been given in milk over a three-month period in winter. 1,200 IU of vitamin D3 has been taken.

Respiratory tract infections: A single dose of 100,000 IU of vitamin D3 has been taken.

Rickets: According to secondary sources, rickets may be treated gradually over several months or in a single day’s dose. In one clinical trial, a single dose of 600,000 IU of oral vitamin D3 was comparable to a dose of 20,000 IU of oral vitamin D3 daily for 30 days. Gradual dosing may be 125-250 mcg taken daily for two to three months, until recovery is well established and alkaline phosphatase blood concentration is close to normal limits. Single-day dosing may be 15,000 mcg of vitamin D, taken by mouth, divided into four to six doses. Intramuscular injection is also an alternative for single-day dosing. For resistant rickets, some authors suggest a higher dose of 12,000-500,000 IU daily.

Tuberculosis (TB): 1,000 IU of vitamin D daily in combination with standard TB therapy improved symptom resolution in children. Type 1 diabetes: In observational research, 2,000 IU daily for a year produced a reduced risk of type 1 diabetes; it may be more beneficial to begin supplementation between the age of seven and 12 months vs. birth to six months of age.

Viral infection: In children, 60,000 IU weekly for six weeks prevented the recurrence of viral infection.

Vitamin D deficiency: In human research, oral doses of 2.5 mg of vitamin D every three months as prophylaxis during infancy maintained protection against vitamin D deficiency in high-risk infant populations. In children with chronic kidney disease and vitamin D deficiency, 600,000 IU of cholecalciferol was taken.

• Intravenous/Intramuscular: Prevention of respiratory tract infections: A single parenteral dose of 100,000 IU of vitamin D has been administered.

• Standardization & Formulation

There is no well-known standardization for vitamin D. In a clinical trial, Calcichew D3 Forte was used.

Adverse Effects

General: Vitamin D orally and parenterally is generally well tolerated in recommended doses, with the most common adverse effect being gastrointestinal complaints. Vitamin D analogs used for psoriasis are also generally well tolerated. When administered with calcium, the combination was well tolerated for up to one year. Adverse effects are lacking in some clinical trials. A review of the potential adverse effects of vitamin D has been published. According to secondary sources, one study found a greater likelihood of daytime sleepiness for patients given vitamin D analogs. Vitamin D supplementation may also cause hypercalcemia and hypercalciuria, particularly at high doses, according to human research.

Toxicology

According to the European Food Safety Authority (EFSA), safe upper intake levels (ULs) of vitamin D have been established as 25 mg daily up to age 10 years and 50 mg daily for those =11-years-old.

IOM released a report on November 30, 2010, recommending vitamin D UL of 3,000 IU for those less than nine years old and 4,000 IU for those over nine years old. According to the IOM, recommended ULs of vitamin D are 1,000 IU for ages 0-6 months, 1,500 IU for ages 7-12 months, 2,500 IU for ages 1-3 years, 3,000 IU for ages 4-8 years and 4,000 IU for those over age nine. A clinical review has suggested the use of 250 mcg (10,000 IU) of vitamin D3 daily as the UL, based on the lack of observed toxicity in adult trials.

Vitamin D toxicity can result from regular excess intake of this vitamin and may lead to hypercalcemia and excess bone loss. Individuals at particular risk include those with hyperparathyroidism, kidney disease, sarcoidosis, tuberculosis or histoplasmosis. Chronic hypercalcemia may lead to serious or even life-threatening complications and should be managed by a physician. Early symptoms of hypercalcemia may include, nausea, vomiting and anorexia, followed by polyuria , polydipsia, weakness, fatigue, somnolence, headache, dry mouth, metallic taste, vertigo, tinnitus and ataxia. Kidney function may become impaired, and metastatic calcifications may occur, particularly affecting the kidneys. Treatment involves stopping the intake of vitamin D or calcium and lowering the calcium levels under strict medical supervision, with frequent monitoring of calcium levels. Acidification of urine and corticosteroids may be necessary. To return vitamin D levels to normal, the supplement is discontinued.

Human reports: In a human case report of an 84-year-old man with vitamin D deficiency, the prescription was incorrectly filled, and he received ergocalciferol 50,000 units daily, rather than weekly, as it was written. The patient’s vitamin D levels rose from <7.0 ng/mL to 100 ng/mL over a six-month span. He complained of decreased appetite and weight loss, and he experienced an elevated international normalized ratio. Vitamin D therapy was discontinued. In human research, vitamin D supplementation resulted in hypervitaminosis D in some subjects.

In a case report, a 42-year-old man who had been taking a vitamin D3 containing supplement for two years was admitted to the hospital. The patient had hypercalcemia and increased serum levels of 25-hydroxyvitamin D and creatinine, as well as decreased hemoglobin. The patient was advised to wear sunscreen outdoors and to discontinue the vitamin D3. Blood tests were normal after 30 months. The product used by the patient was found to contain 26-430 times the vitamin D that was listed on the label, resulting in the consumption of 156,000-2,604,000 IU of vitamin D3 daily. Although glucocorticoids were not used in this situation, the authors indicated that they are useful for short-term management of vitamin D toxicity. The authors also suggest that renal and hematological abnormalities are possible.

When examined in a safety study, 14,000 IU weekly for eight weeks and 1,400 IU or 14,000 IU weekly for one year lacked toxic effects.

According to review, long-term daily intakes of 4,000 to 10,000 IU of vitamin D daily lack toxicity and are safe for the healthy adult population. According to a review, single large doses of 300,000-500,000 IU of vitamin D should be avoided, but the authors suggested that doses of 2,000 IU or lower daily are unlikely to cause harm in young, otherwise healthy adults.

Interactions

Interactions with Drugs

Vitamin D may interact with certain drugs, and caution is advised when used in combination with these agents. These include aluminum, Atorvastatin (Lipitor), Calcipotriene (Dovonex), Cimetidine (Tagamet), Cytochrome P450 3A4 Substrates, Digoxin (Lanoxin), Diltiazem, Heparin, Low-molecular weight heparins, Thiazide Diuretics and Verapamil.

Interactions With Herbs & Supplements

Magnesium: The protein that transports calcium across the intestinal wall can also bind and transport magnesium. This protein is stimulated by vitamin D, which may, therefore, increase magnesium absorption. In people with low vitamin D and magnesium levels, taking vitamin D may improve magnesium status. In people with normal magnesium levels, this effect does not seem to be significant, possibly because urinary magnesium excretion also increases.

Nutrient Depletion

Some drugs can affect vitamin D levels, including: Carbamazepine (Tegretol), Cholestyramine, Colestipol (Colestid), Corticosteroids, mineral oil, Orlistat (Xenical, Alli), Phenobarbital, Phenytoin (Dilantin), Fosphenytoin (Cerebyx), Rifampin, Stimulant laxatives and sunscreens.

Interactions with Foods
None knows.

Interactions with Lab Tests
None known.

References:

 

2

Blumenthal M, ed. The Complete German Commission E Monographs: Therapeutic Guide to Herbal Medicines. Trans. S. Klein. Boston, MA: American Botanical Council, 1998.

3

Tyler VE. Herbs of Choice. Binghamton, NY: Pharmaceutical Products Press, 1994.

15

McEvoy GK, ed. AHFS Drug Information. Bethesda, MD: American Society of Health-System Pharmacists, 1998.

366

Nityanand S, Srivastava JS, Asthana OP. Clinical trials with gugulipid. A new hypolipidaemic agent. J Assoc Phys India 1989;37:323-8. View abstract.

970

Baron JA, Beach M, Mandel JS, et al. Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prev Study Group. N Engl J Med 1999;340:101-7. View abstract.

977

Storm D, Eslin R, Porter ES, et al. Calcium supplementation prevents seasonal bone loss and changes in biochemical markers of bone turnover in elderly New England women: a randomized, placebo-controlled trial. J Clin Endocrinol Metab 1998;83:3817-25. View abstract.

978

Baeksgaard L, Andersen KP, Hyldstrup L. Calcium and vitamin D supplementation increases spinal BMD in healthy, postmenopausal women. Osteoporos Int 1998;8:255-60. View abstract.

979

Riggs BL, O’Fallon WM, Muhs J, et al. Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 1998;13:168-74. View abstract.

980

Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-6. View abstract.

982

Bernstein CN, Seeger LL, Anton PA, et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther 1996;10:777-86. View abstract.

994

Baron JA, Tosteson TD, Wargovich MJ, et al. Calcium supplementation and rectal mucosal proliferation: a randomized controlled trial. J Natl Cancer Inst 1995;87:1303-7. View abstract.

1046

Buckley LM, Leib ES, Cartularo KS, et al. Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized double-blind, placebo-controlled trial. Ann Intern Med 1996;125:961-8. View abstract.

1047

White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev 1997;6:769-74. View abstract.

1530

De Stefani E, Correa P, Fierro L, et al. Black tobacco, mate, and bladder cancer. A case-control study from Uruguay. Cancer 1991;67:536-40. View abstract.

1730

Roche, Inc. Xenical package insert. Nutley, NJ. May 1999.

1831

Adachi JD, Bensen WG, Bianchi F, et al. Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year followup. J Rheumatol 1996;23:995-1000. View abstract.

1832

Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. American College of Rheumatology Task Force on Osteoporosis Guidelines. Arthritis Rheum 1996;39:1791-801. View abstract.

1835

Dawson-Hughes B, Harris SS, Krall EA, Dallal GE. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older. N Engl J Med 1997;337:670-6. View abstract.

1836

Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637-42. View abstract.

1845

Saunders D, Sillery J, Chapman R. Effect of calcium carbonate and aluminum hydroxide on human intestinal function. Dig Dis Sci 1988;33:409-13. View abstract.

1846

Krall EA, Dawson-Hughes B. Smoking increases bone loss and decreases intestinal calcium absorption. J Bone Miner Res 1999;14:215-20. View abstract.

1994

Strause L, Saltman P, Smith KT, et al. Spinal bone loss in postmenopausal women supplemented with calcium and trace minerals. J Nutr 1994;124:1060-4. View abstract.

2174

Ushiroyama T, Okamura S, Ikeda A, et al. Efficacy of ipriflavone and 1 alpha vitamin D therapy for the cessation of vertebral bone loss. Int J Gynaecol Obstet 1995;48:283-8. View abstract.

2672

Hoogwerf BJ, Hibbard DM, Hunninghake DB. Effects of long-term cholestyramine administration on vitamin D and parathormone levels in middle-aged men with hypercholesterolaemia. J Lab Clin Med 1992;119:407-11. View abstract.

2675

Gough H, Goggin T, Bissessar A, et al. A comparative study of the relative influence of different anticonvulsant drugs, UV exposure and diet on vitamin D and calcium metabolism in out-patients with epilepsy. Quart J Med 1986;59:569-77. View abstract.

3072

Tatro DS, ed. Drug Interactions Facts. Facts and Comparisons Inc., St. Louis, MO. 1999.

3463

Kyriakidou-Himonas M, Aloia JF, Yeh JK. Vitamin D supplementation in postmenopausal black women. J Clin Endocrinol Metab 1999;84:3988-90. View abstract.

3464

Zamora SA, Rizzoli R, Belli DC, et al. Vitamin D supplementation during infancy is associated with higher bone mineral mass in prepubertal girls. J Clin Endocrinol Metab 1999;84:4541-4. View abstract.

4430

Hoikka V, Alhava EM, Karjalainen P, et al. Carbamazepine and bone mineral metabolism. Acta Neurol Scand 1984;70:77-80. View abstract.

4431

Rajantie J, Lamberg-Allardt C, Wilska M. Does carbamazepine treatment lead to a need of extra vitamin D in some mentally retarded children? Acta Paediatr Scand 1984;73:325-8. View abstract.

4458

Knodel LC, Talbert RL. Adverse effects of hypolipidaemic drugs. Med Toxicol 1987;2:10-32. View abstract.

4460

Schwarz KB, Goldstein PD, Witztum JL, et al. Fat-soluble vitamin concentrations in hypercholestrolemic children treated with colestipol. Pediatrics 1980;65:243-50. View abstract.

4461

Tonstad S, Silverstein M, Aksnes L, Ose L. Low dose colestipol in adolescents with familial hypercholesterolemia. Arch Dis Child 1996;74:157-60. View abstract.

4475

Bell RD, Pak CY, Zerwekh J, et al. Effect of phenytoin on bone and mineral density in ambulatory epileptic children. Brain Dev 1994;16:382-5.

4495

Becker GL. The case against mineral oil. Am J Digestive Dis 1952;19:344-8. View abstract.

4823

Cueto-Manzano AM, Konel S, Freemont AJ, et al. Effect of 1,25-dihydroxyvitamin D3 and calcium carbonate on bone loss associated with long-term renal transplantation. Am J Kidney Dis 2000;35:227-36. View abstract.

5655

Compston JE, Horton LW. Oral 25-hydroxyvitamin D3 in treatment of osteomalacia associated with ileal resection and cholestyramine therapy. Gastroenterology 1978;74:900-2. View abstract.

5809

Compston JE, Thompson RP. Intestinal absorption of 25-hydroxyvitamin D and osteomalacia in primary biliary cirrhosis. Lancet 1977;1:721-4. View abstract.

5838

Heaton KW, Lever JV, Barnard RE. Osteomalacia associated with cholestyramine therapy for post-ileectomy diarrhea. Gastroenterology 1972;62:642-6. View abstract.

6360

Suzuki Y, Oishi Y, Yamazaki H, et al. How to avoid bone loss in patients with prostatic carcinoma receiving long-term LHRH-analogue. 2000 Abstract Info-Am Urol Assn, Inc.

6362

Minne HW, Pfeifer M, Begerow B, et al. Vitamin D and calcium supplementation reduces falls in elderly women via improvement of body sway and normalization of blood pressure: a prospective, randomized, and double-blind study. Abstracts World Congress on Osteoporosis 2000.

6852

Jorde R, Bonaa KH. Calcium from dairy products, vitamin D intake, and blood pressure: the Tromso study. Am J Clin Nutr 2000;71:1530-5. View abstract.

6854

Need AG, Horowitz M, Morris HA, Nordin BEC. Vitamin D status: effects on parathyroid hormone and 1,25-dihydroxyvitamin D in postmenopausal women. Am J Clin Nutr 2000;71:1577-81. View abstract.

6855

Gesensway D. Vitamin D. Ann Int Med 2000;133:318. View abstract.

6856

Wortsman J, Matsuoka LY, Chen TC, et al. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690-3. View abstract.

6857

Shah M, Salhab N, Patterson D, Seikaly MG. Nutritional rickets still afflict children in north Texas. Tex Med 2000;96:64-8. View abstract.

7132

Tamatani M, Morimoto S, Nakajima M, et al. Decreased circulating levels of vitamin K and 25-hydroxyvitamin D in osteopenic elderly men. Metabolism 1998;47:195-9. View abstract.

7133

Shearer MJ. The roles of vitamins D and K in bone health and osteoporosis prevention. Proc Nutr Sci 1997;56:915-37. View abstract.

7555

Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. Washington, DC: National Academy Press, 1999. Available at: http://books.nap.edu/books/0309063507/html/index.html.

8816

Krall EA, Wehler C, Garcia RI, et al. Calcium and vitamin D supplements reduce tooth loss in the elderly. Am J Med 2001;111:452-6.. View abstract.

8818

Chapuy MC, Pamphile R, Paris E, et al. Combined calcium and vitamin D3 supplementation in elderly women: confirmation of reversal of secondary hyperparathyroidism and hip fracture risk: the Decalyos II study. Osteoporos Int 2002;13:257-64.. View abstract.

8820

Terry P, Baron JA, Bergkvist L, et al. Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in women. Nutr Cancer 2002;43:39-46.. View abstract.

8827

Ebeling PR, Wark JD, Yeung S, et al. Effects of calcitriol or calcium on bone mineral density, bone turnover, and fractures in men with primary osteoporosis: a two-year randomized, double blind, double placebo study. J Clin Endocrinol Metab 2001;86:4098-103.. View abstract.

9595

McDuffie JR, Calis KA, Booth SL, et al. Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy 2002;22:814-22.. View abstract.

10139

Hypponen E, Laara E, Reunanen A, et al. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet 2001;358:1500-3. View abstract.

10140

Meyer H, Smedshaug GB, Kvaavik E, et al. Can vitamin D supplementation reduce the risk fracture in the elderly? A randomized controlled trial. J Bone Miner Res 2002;17:709-15. View abstract.

10141

Devine A, Wilson SG, Dick IM, Prince RL. Effects of vitamin D metabolites on intestinal absorption and bone turnover in elderly women. Am J Clin Nutr 2002;75:283-8.. View abstract.

10142

Koutkia P, Chen TC, Holick MF. Vitamin D intoxication associated with an over-the-counter supplement. N Engl J Med 2001;345:66-7. View abstract.

10570

Davidson MH, Hauptman J, DiGirolamo M, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat. JAMA 1999;281:235-42. View abstract.

10574

Bar-Or D, Yoel G. Calcium and calciferol antagonize effect of verapamil in atrial fibrillation. Br Med J 1981;282:1585-6. View abstract.

10577

Tannirandorn P, Epstein S. Drug-induced bone loss. Osteoporos Int 2000;11:637-59. View abstract.

10578

Collins N, Maher J, Cole M, et al. A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. Q J Med 1991;78:113-22. View abstract.

10593

Martineau P, Tawil N. Low-molecular-weight heparins in the treatment of deep-vein thrombosis. Ann Pharmacother 1998;32:588-98,601. View abstract.

10594

Zimran A, Shilo S, Fisher D, Bab I. Histomorphometric evaluation of reversible heparin-induced osteoporosis in pregnancy. Arch Intern Med 1986;146:386-8. View abstract.

10595

Dahlman TC. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin. Am J Obstet Gynecol 1993;168:1265-70. View abstract.

10596

Barbour LA, Kick SD, Steiner JF, et al. A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol 1994;170:862-9. View abstract.

10597

Aarskog D, Aksnes L, Lehmann V. Low 1,25-dihydroxyvitamin D in heparin-induced osteopenia (letter). Lancet 1980;2:650-1. View abstract.

10598

Monreal M, Olive A, Lafoz E, del Rio L. Heparins, coumarin and bone density (letter). Lancet 1991;338:706. View abstract.

10599

Pettila V, Leinonen P, Markkola A, et al. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost 2002;87:182-6. View abstract.

10932

NIH Consensus Development Panel on Osteoporosis Prevention, Diagnosis, and Therapy. Osteoporosis prevention, diagnosis, and therapy. JAMA 2001;285:785-95. View abstract.

11356

Munger KL, Zhang SM, O’Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60-5. . View abstract.

11507

Matsuoka LY, Ide L, Wortsman J, et al. Suncreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987;64:1165-8. View abstract.

11508

Matsuoka LY, Wortsman J, Hanifan N, Holick MF. Chronic suncreen use decreases circulating concentrations of 25-hydroxyvitamin D. Arch Dermatol 1988;124:1802-4. View abstract.

11509

Prystowsky JH. Photoprotection and the vitamin D status of the elderly. Arch Dermatol 1988;124:1844-8. View abstract.

11529

Demontis R, Leflon A, Fournier A, et al. 1 alpha(OH) vitamin D3 increases plasma aluminum in hemodialyzed patients taking AI(OH)3. Clin Nephrol 1986;26:146-9. View abstract.

11530

Frier BM, Scott RD. Osteomalacia and arthropathy associated with prolonged abuse of purgatives. Br J Clin Pract 1977;31:17-9. View abstract.

11531

Odes HS, Fraser GM, Krugliak P, et al. Effect of cimetidine on hepatic vitamin D metabolism in humans. Digestion 1990;46:61-4. View abstract.

11532

Bengoa JM, Bolt MJ, Rosenberg IH. Hepatic vitamin D 25-hydroxylase inhibition by cimetidine and isoniazid. J Lab Clin Med 1984;104;546-52. View abstract.

11539

Crowe M, Wollner L, Griffiths RA. Hypercalcemia following vitamin D and thiazide therapy in the elderly. Practitioner 1984;228:312-3. View abstract.

11540

Parfitt AM. Thiazide-induced hypercalcemia in vitamin D-treated hypoparathyroidism. Ann Intern Med 1972;77:557-63. View abstract.

11541

Thiazide diuretics and the risk of osteoporosis. Pharmacist’s Letter/Prescriber’s Letter 2003;19(11):191105.

11555

Sivakumaran M, Ghosh K, Zaidi Y, Hutchinson RM. Osteoporosis and vertebral collapse following low-dose, low molecular weight heparin therapy in a young patient. Clin Lab Haematol 1996;18:55-7. View abstract.

11561

Williams SE, Wardman AG, Taylor GA, et al. Long term study of the effect of rifampicin and isoniazid on vitamin D metabolism. Tubercle 1985;66:49-54. View abstract.

11562

Kovacs CS, Jones G, Yendt ER. Primary hyperparathyroidism masked by antituberculous therapy-induced vitamin D deficiency. Clin Endocrinol (Oxf) 1994;41:831-8. View abstract.

11563

Perry W, Erooga MA, Brown J, Stamp TC. Calcium metabolism during rifampicin and isoniazid therapy for tuberculosis. J R Soc Med 1982;75:533-6. View abstract.

11564

Shah SC, Sharma RK, Hemangini, Chitle AR. Rifampicin induced osteomalacia. Tubercle 1981;62:207-9. View abstract.

11565

Brodie MJ, Boobis AR, Hillyard CJ, et al. Effect of rifampicin and isoniazid on vitamin D metabolism. Clin Pharmacol Ther 1982;32:525-30. View abstract.

11595

Moon J. The role of vitamin D in toxic metal absorption. J Am Coll Nutr 1994;13:559-64. View abstract.

11596

Demontis R, Reissi D, Noel C, et al. Indirect clinical evidence that 1alphaOH vitamin D3 increases the intestinal absorption of aluminum. Clin Nephrol 1989;31:123-7. View abstract.

11597

Adler AJ, Berlyne GM. Duodenal aluminum absorption in the rat: effect of vitamin D. Am J Physiol 1985;249:G209-13. View abstract.

11598

Hardwick LL, Jones MR, Brautbar N, Lee DBN. Magnesium absorption: mechanisms and the influence of vitamin D, calcium and phosphate. J Nutr 1991;121:13-23. View abstract.

11599

Fukumoto S, Matsumoto T, Tanaka Y, et al. Renal magnesium wasting in a paitient with short bowel syndrome and magnesium deficiency: effect of 1alpha-hydroxyvitamin D3 treatment. J Clin Endocrinol Metab 1987;65:1301-4. View abstract.

11814

Kenny AM, Biskup B, Robbins B, et al. Effects of vitamin D supplementation on strength, physical function, and health perception in older, community-dwelling men. J Am Geriatr Soc 2003;51:1762-7. View abstract.

11815

Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999;69:842-56. View abstract.

11816

Seyrek N, Balal M, Karayaylali I, et al. Which parameter is more influential on the development of arteriosclerosis in hemodialysis patients? Ren Fail 2003;25:1011-8. View abstract.

11818

DiMeglio LA, White KE, Econs MJ. Disorders of phosphate metabolism. Endocrinol Metab Clin North Am 2000;29:591-609. View abstract.

11819

Clarke BL, Wynne AG, Wilson DM, Fitzpatrick LA. Osteomalacia associated with adult Fanconi’s syndrome: clinical and diagnostic features. Clin Endocrinol (Oxf) 1995;43:479-90. View abstract.

11820

Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000;343:1863-75. View abstract.

11821

Rouillard S, Lane NE. Hepatic osteodystrophy. Hepatology 2001;33:301-7. View abstract.

11822

Linden KG, Weinstein GD. Psoriasis: current perspectives with an emphasis on treatment. Am J Med 1999;107:595-605. View abstract.

11823

Malluche HH, Monier-Faugere MC, Koszewski NJ. Use and indication of vitamin D and vitamin D analogues in patients with renal bone disease. Nephrol Dial Transplant 2002;17 Suppl 10:6-9. View abstract.

11824

Prince RL, Glendenning P. 8: Disorders of bone and mineral other than osteoporosis. Med J Aust 2004;180:354-9. View abstract.

11825

Mellibovsky L, Diez A, Perez-Vila E, et al. Vitamin D treatment in myelodysplastic syndromes. Br J Haematol 1998;100:516-20. View abstract.

11881

Sharma OP. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med 2000;6:442-7. View abstract.

11916

Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of Vitamin D on falls: a meta-analysis. JAMA 2004;291:1999-2006.. View abstract.

11917

Flicker L, Mead K, MacInnis RJ, et al. Serum vitamin D and falls in older women in residential care in Australia. J Am Geriatr Soc 2003;51:1533-8.. View abstract.

11918

Dhesi JK, Moniz C, Close JC, et al. A rationale for vitamin D prescribing in a falls clinic population. Age Ageing 2002;31:267-71.. View abstract.

11919

Janssen HC, Samson MM, Verhaar HJ. Vitamin D deficiency, muscle function, and falls in elderly people. Am J Clin Nutr 2002;75:611-5.. View abstract.

11921

Bischoff-Ferrari HA, Borchers M, Gudat F, et al. Vitamin D receptor expression in human muscle tissue decreases with age. J Bone Miner Res 2004;19:265-9. . View abstract.

11922

Pfeifer M, Begerow B, Minne HW. Vitamin D and muscle function. Osteoporos Int 2002;13:187-94. . View abstract.

11923

Prabhala A, Garg R, Dandona P. Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med 2000; 160:1199–203. . View abstract.

11924

Pfeifer M, Begerow B, Minne HW, et al. Effects of a short-term vitamin D and calcium supplementation on body sway and secondary hyperparathyroidism in elderly women. J Bone Miner Res 2000;15:1113-8.. View abstract.

11925

Dhesi JK, Bearne LM, Moniz C, et al. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner Res 2002;17:891-7. . View abstract.

11926

Graafmans WC, Ooms ME, Hofstee HM, et al. Falls in the elderly: a prospective study of risk factors and risk profiles. Am J Epidemiol 1996;143:1129-36. . View abstract.

11927

Meyer HE, Smedshaug GB, Kvaavik E, et al. Can vitamin D supplementation reduce the risk of fracture in the elderly? A randomized controlled trial. J Bone Miner Res 2002;17:709-15. . View abstract.

11928

Lips P, Graafmans WC, Ooms ME, et al. Vitamin D supplementation and fracture incidence in elderly persons. A randomized, placebo- controlled clinical trial. Ann Intern Med 1996;124:400-6. . View abstract.

11930

Chapuy MC, Arlot ME, Duboeuf F, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly women. N Engl J Med 1992;327:1637-42.. View abstract.

11931

Trivedi DP, Doll R, Khaw KT. Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial. BMJ 2003;326:469.. View abstract.

11932

Dukas L, Bischoff HA, Lindpaintner LS, et al. Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily. J Am Geriatr Soc 2004;52:230-6.. View abstract.

11933

Heaney RP, Dowell MS, Hale CA, Bendich A. Calcium absorption varies within the reference range for serum 25-hydroxyvitamin D. J Am Coll Nutr 2003;22:142-6.. View abstract.

11935

Holick MF. Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart disease, and osteoporosis. Am J Clin Nutr 2004;79:362-71.. View abstract.

11936

Holick MF. Sunlight and vitamin D: both good for cardiovascular health. J Gen Intern Med 2002;17:733-5. . View abstract.

11937

Arnas LAG, Heaney RP, Hollis BW. Vitamin D2 is much less effective than vitamin D3 in humans (abstract OR22-2). The Endocrine Society 86th Annual Meeting, June 16-19, New Orleans, LA.

11938

Trang HM, Cole DE, Rubin LA, et al. Evidence that vitamin D3 increases serum 25-hydroxyvitamin D more efficiently than does vitamin D2. Am J Clin Nutr 1998;68:854-8. . View abstract.

11939

Bischoff HA, Stahelin HB, Dick W, et al. Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial. J Bone Miner Res 2003;18:343-51.. View abstract.

11940

L’Abbe MR, Whiting SJ, Hanley DA. The Canadian health claim for calcium, vitamin D and osteoporosis. J Am Coll Nutr 2004;23:303-8. . View abstract.

12118

Grau MV, Baron JA, Sandler RS, et al. Vitamin D, calcium supplementation, and colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 2003;95:1765-71. View abstract.

12120

Cho E, Smith-Warner SA, Spiegelman D, et al. Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst 2004;96:1015-22. View abstract.

12206

Merlino LA, Curtis J, Mikuls TR, et al. Vitamin D intake is inversely associated with rheumatoid arthritis. Arthritis Rheum 2004;50:72-7. View abstract.

12491

Baker K, Zhang YQ, Goggins J, et al. Hypovitaminosis D and its association with muscle strength, pain, and physical function in knee osteoarthritis (OA). American College of Rheumatology Meeting; San Antonio, Texas, October 16-21, 2004. Abstract 1755.

12926

National Osteoporosis Foundation. Physician’s Guide to Prevention and Treatment of Osteoporosis. Universal Recommendations for All Patients. Available at: http://www.nof.org/physguide/univeral_recommendations.htm#adequate. (Accessed 14 May 2005).

12929

Porthouse J, Cockayne S, King C, et al. Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care. BMJ 2005;330:1003. View abstract.

12930

Larsen ER, Mosekilde L, Foldspang A. Vitamin D and calcium supplementation prevents osteoporotic fractures in elderly community dwelling residents: a pragmatic population-based 3-year intervention study. J Bone Miner Res 2004;19:370-8. View abstract.

12931

Sambrook P. Vitamin D and fractures: quo vadis? Lancet 2005;365:1599-600. View abstract.

12933

Bischoff-Ferrari HA, Willett WC, Wong JB, et al. Fracture prevention with vitamin D supplementation: a meta-analysis of randomized controlled trials. JAMA 2005;293:2257-64. View abstract.

12934

Boonen S, Body JJ, Boutsen Y, et al. Evidence-based guidelines for the treatment of postmenopausal osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int 2005;16:239-54. View abstract.

12945

Homik J, Suarez-Almazor ME, Shea B, et al. Calcium and vitamin D for corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2000;(2):CD000952. View abstract.

12950

Weingarten MA, Zalmanovici A, Yaphe J. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database Syst Rev 2004;(1):CD003548. View abstract.

12952

Papadimitropoulos E, Wells G, Shea B, et al. Meta-analyses of therapies for postmenopausal osteoporosis. VIII: Meta-analysis of the efficacy of vitamin D treatment in preventing osteoporosis in postmenopausal women. Endocr Rev 2002;23:560-9. View abstract.

12992

Holick MF. Sunlight “D”ilemma: risk of skin cancer or bone disease and muscle weakness. Lancet 2001;357:4-6. View abstract.

12993

Reichrath J. Protecting against adverse effects of sun protection. J Am Acad Dermatol 2003;49:1204-6. View abstract.

12994

John EM, Schwartz GG, Koo J, et al. Sun exposure, vitamin D receptor gene polymorphisms, and risk of advanced prostate cancer. Cancer Res 2005; 65:5470-9. View abstract.

12995

Hanley DA, Davison KS. Vitamin D insufficiency in North America. J Nutr 2005;135:332-7. View abstract.

12996

Holick MF, Siris ES, Binkley N, et al. Prevalence of Vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. J Clin Endocrinol Metab 2005;90:3215-24. View abstract.

12997

Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135:317-22. View abstract.

12998

Duplessis CA, Harris EB, Watenpaugh DE, Horn WG. Vitamin D supplementation in underway submariners. Aviat Space Environ Med 2005;76:569-75. View abstract.

12999

Holick MF. Vitamin D: A millenium perspective. J Cell Biochem 2003;88:296-307. View abstract.

13000

Engelsen O, Brustad M, Aksnes L, Lund E. Daily duration of vitamin D synthesis in human skin with relation to latitude, total ozone, altitude, ground cover, aerosols and cloud thickness. Photochem Photobiol 2005;81:1287-90. View abstract.

13073

The RECORD Trial Group. Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial. Lancet 2005;365:1621-8. View abstract.

13094

Bertone-Johnson ER, Hankinson SE, Bendich A, et al. Calcium and vitamin D intake and risk of incident premenstrual syndrome. Arch Intern Med 2005;165:1246-52. View abstract.

13276

Dawson-Hughes B, Heaney RP, Holick MF, et al. Estimates of optimal vitamin D status. Osteoporos Int 2005;16:713-6. View abstract.

14252

Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin D and pulmonary function in the Third National Health and Nutrition Examination Survey. Chest 2005;128:3792-8. View abstract.

14253

Wright RJ. Make no bones about it: increasing epidemiologic evidence links vitamin D to pulmonary function and COPD. Chest 2005;128:3781-3. View abstract.

14265

Liu S, Song Y, Ford ES, et al. Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 2005;28:2926-32. View abstract.

14282

Jackson RD, LaCroix AZ, Gass M. Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med 2006;354:669-83. View abstract.

14290

Wactawski-Wende J, Kotchen JM, Anderson GL. Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med 2006;354:684-96. View abstract.

14291

Bischoff-Ferrari HA, Orav EJ, Dawson-Hughes B. Effect of Cholecalciferol plus calcium on falling in ambulatory older men and women: a 3-year randomized controlled trial. Arch Intern Med 2006;166:424-30. View abstract.

14320

Giovannucci E, Liu Y, Rimm EB, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98:451-9. View abstract.

14614

Linhartova K, Veselka J, Sterbakova G, et al. Parathyroid hormone and vitamin D levels are independently associated with calcific aortic stenosis. Circ J 2008;72:245-50. View abstract.

15159

Munger KL, Levin LI, Hollis BW, et al. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 2006;296:2832-8. View abstract.

15263

Armas LA, Hollis BW, Heaney RP. Vitamin D2 is much less effective than vitamin D3 in humans. J Clin Endocrinol Metab 2004;89:5387-91. View abstract.

15264

Houghton LA, Vieth R. The case against ergocalciferol (vitamin D2) as a vitamin supplement. Am J Clin Nutr 2006;84:694-7. View abstract.

15601

Major GC, Alarie F, Dore J, et al. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007;85:54-9. View abstract.

15604

Caan B, Neuhouser M, Aragaki A, et al. Calcium plus vitamin d supplementation and the risk of postmenopausal weight gain. Arch Intern Med 2007;167:893-902. View abstract.

15606

Broe KE, Chen TC, Weinberg J, et al. A higher dose of vitamin D reduces the risk of falls in nursing home residents: a randomized, multiple-dose study. J Am Geriatr Soc 2007;55:234-9. View abstract.

15629

Lappe JM, Travers-Gustafson D, Davies KM, et al. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. Am J Clin Nutr 2007;85:1586-91. View abstract.

15630

Martins D, Wolf M, Pan D, et al. Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States. Arch Intern Med 2007;167:1159-65.. View abstract.

15631

Lin J, Manson JE, Lee IM, et al. Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 2007;167:1050-9. View abstract.

15632

Canadian Cancer Society Announces Vitamin D Recommendation. Canadian Cancer Society Press Release, June 8, 2007. Available at: www.cancer.ca (Accessed 13 June 2007).

15633

Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab 2007;92:1415-23. View abstract.

15634

Dietrich T, Joshipura KJ, Dawson-Hughes B, Bischoff-Ferrari HA. Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. Am J Clin Nutr 2004;80:108-13. View abstract.

15635

Egawa K, Ono T. Topical vitamin D3 derivatives for recalcitrant warts in three immunocompromised patients. Br J Dermatol 2004;150:374-6. View abstract.

15636

Bischoff-Ferrari HA, Dietrich T, Orav EJ, et al. Higher 25-hydroxyvitamin D concentrations are associated with better lower-extremity function in both active and inactive persons aged >=60 y. Am J Clin Nutr 2004;80:752-8. View abstract.

15637

Levis S, Gomez A, Jimenez C, et al. Vitamin D deficiency and seasonal variation in an adult South Florida population. J Clin Endocrinol Metab 2005;90:1557-62. View abstract.

15638

Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80(6 Suppl):1678S-88S. View abstract.

16049

Garland CF, Gorham ED, Mohr SB, et al. Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 2007;103:708-11. View abstract.

16101

Gorham ED, Garland CF, Garland FC, et al. Optimal vitamin D status for colorectal cancer prevention. a quantitative meta analysis. Am J Prev Med 2007;32:210-6. View abstract.

16102

Autier P, Gandini S. Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730-7. View abstract.

16103

Freedman DM, Looker AC, Chang SC, Graubard BI. Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007;99:1594-602. View abstract.

16119

Prevention and treatment of vitamin D deficiency. Pharmacist’s Letter/Prescriber’s Letter 2008;24(3):240311.

16120

National Osteoporosis Foundation. Vitamin D and bone health. Available at: www.nof.org/aboutosteoporosis/prevention/vitamind. (Accessed 11 February 2008).

16121

North American Menopause Society. Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society. Menopause 2006;13:340-67. View abstract.

16122

Osteoporosis Society of Canada, Scientific Advisory Council. 2002 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ 2002;167(10 Suppl):S1-34. View abstract.

16275

Prince RL, Austin N, Devine A, et al. Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med 2008;168:103-8. View abstract.

16614

Wagner CL, Greer FR. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics 2008;122:1142-52. View abstract.

16615

Wang TJ, Pencina MJ, Booth SL, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008;117;503-11. View abstract.

16616

Hsia J, Heiss G, Ren H, et al. Calcium/vitamin D supplementation and cardiovascular events. Circulation 2007;115;846-54. View abstract.

16617

Giovannucci E, Liu Y, Hollis BW, Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med 2008;168:1174-80. View abstract.

16618

Dobnig H, Pilz S, Scharnagl H, et al. Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340-49. View abstract.

16619

Melamed ML, Michos ED, Post W, Astor B. 25-hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008;168:1629-37. View abstract.

16620

Schleithoff SS, Zittermann A, Tenderich G, et al. Vitamin D supplementation improves cytokine profiles in patients with congestive heart failure: a double-blind, randomized, placebo-controlled trial. Am J Clin Nutr 2006;83:754-9. View abstract.

16621

Symons C, Fortune F, Greenbaum RA, Dandona P. Cardiac hypertrophy, hypertrophic cardiomyopathy, and hyperparathyroidism-an association. Br Heart J 1985;54:539-42. View abstract.

16622

Saleh FN, Schirmer H, Sundsfjord J, Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J 2003;24:2054-60. View abstract.

16713

Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin d and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29. View abstract.

16714

Margolis KL, Ray RM, Van Horn L, et al. Effect of calcium and vitamin D supplementation on blood pressure: the Women’s Health Initiative Randomized Trial. Hypertension 2008;52:847-55. View abstract.

16715

Chlebowski RT, Johnson KC, Kooperberg C, et al. Calcium plus vitamin D supplementation and the risk of breast cancer. J Natl Cancer Inst 2007;100:1581-91. View abstract.

16828

Schwartz JB. Effects of vitamin D supplementation in atorvastatin-treated patients: A new drug interaction with an unexpected consequence. Clin Pharmacol Ther 2009;85:198-203. View abstract.

16829

Lee P, Greenfield JR, Campbell LV. Vitamin D insufficiency-a novel mechanism of statin-induced myalgia? Clin Endocrinol Published online October 16, 2008:doi:10.1111/j.1365-2265.2008.03448.x. View abstract.

16830

Ginde AA, Mansbach JM, Camargo CA Jr. Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med 2009;169:384-90. View abstract.

16831

Ahmed W, Khan N, Glueck CJ, et al. Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 2009;153:11-6. View abstract.

16869

Khajehei M, Abdali K, Parsanezhad ME, Tabatabaee HR. Effect of treatment with dydrogesterone or calcium plus vitamin D on the severity of premenstrual syndrome. Int J Gynaecol Obstet 2009;105:158-61. View abstract.

16872

Semba RD, Houston DK, Ferrucci L, et al. Low serum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women. Nutr Res 2009;29:525-30. View abstract.

16873

Oh J, Weng S, Felton SK, et al. 1,25 (OH)2 Vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009;120:687-98. View abstract.

16874

Passeri G, Pini G, Troiano L, et al. Low vitamin D status, high bone turnover, and bone fractures in centenarians. J Clin Endocrinol Metab 2003;88:5109-15. View abstract.

16875

Maalouf J, Nabulsi M, Vieth R, et al. Short term and long term safety of weekly high dose vitamin D3 supplementation in schoolchildren. J Clin Endocrinol Metab 2008;93:2693-701. View abstract.

16878

Aloia JF, Talwar SA, Pollack S, Yeh J. A randomized controlled trial of vitamin D3 supplementation in African American women. Arch Intern Med 2005;165:1618-23. View abstract.

16879

Yildirim B, Kaleli B, Düzcan E, Topuz O. The effects of postmenopausal Vitamin D treatment on vaginal atrophy. Maturitas 2004;49:334-7. View abstract.

16882

Gross MD. Vitamin D and calcium in the prevention of prostate and colon cancer: new approaches for the identification of needs. J Nutr 2005;135:326-31. View abstract.

16883

Coburn JW. An update on vitamin D as related to nephrology practice: 2003. Kidney Int Suppl 2003;64(87):S125-30. View abstract.

16886

Harris SS. Vitamin D in type I diabetes prevention. J Nutr 2005;135:323-5. View abstract.

16887

Looker AC. Body fat and vitamin D status in black versus white women. J Clin Endocrinol Metab 2005;90:635-40. View abstract.

16888

Diamond TH, Ho KW, Rohl PG, Meerkin M. Annual intramuscular injection of a megadose of cholecalciferol for treatment of vitamin D deficiency: efficacy and safety data. Med J Aust 2005;183:10-2. View abstract.

16890

Holick MF. Vitamin D deficiency. N Engl J Med 2007;357:266-81. View abstract.

16891

Cava RC, Javier AN. Vitamin D deficiency [editorial]. N Engl J Med 2007;357:1981. View abstract.

17475

New 2010 Vitamin D Recommendations. Osteoporosis Canada, July 2010. Available at: http://www.osteoporosis.ca/index.php/ci_id/5536/la_id/1.htm.

17476

Vitamin D dosing: an update. Pharmacist’s Letter/Prescriber’s Letter 2010;26(7):260707.

17485

Manson JE, Allison MA, Carr JJ, et al. Calcium/vitamin D supplementation and coronary artery calcification. Menopause 2010;17:683-91. View abstract.

17486

Urashima M, Segawa T, Okazaki M, et al. Randomized trial of vitamin D supplementation to prevent seasonal influenza A in schoolchildren. Am J Clin Nutr 2010;91:1255-60. View abstract.

17506

Dietary reference intakes for calcium and vitamin D. Institute of Medicine, November 30, 2010. Available at: http://www.iom.edu/~/media/Files/Report%20Files/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D/Vitamin%20D%20and%20Calcium%202010%20Report%20Brief.pdf.

17685

Herr C, Greulich T, Koczulla R, et al. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res 2011;12:31. View abstract.

17686

Bozzetto S, Carraro S, Giordano G, et al. Asthma, allergy, and respiratory infections: the vitamin D hypothesis. Allergy 2012;67:10-7. View abstract.

17687

Majak P, Olszowiec-Chlebna M, Smejda K, Stelmach I. Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J Allergy Clin Immunol 2011;127:1294-6. View abstract.

22283

van de Kerkhof PC, Wasel N, Kraqballe K, et al. A two-compound product containing calipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity. Dermatology 2005;210:294-9. View abstract.

22916

Cox KA, Dunn MA. Aluminum toxicity alters the regulation of calbindin-D28k protein and mRNA expression in chick intestine. J Nutr 2001;131:2007-13. View abstract.

22917

Cimetidine inhibits the hepatic hydroxylation of vitamin D. Nutr Rev 1985;43:184-5. View abstract.

32041

Abba, K., Sudarsanam, T. D., Grobler, L., and Volmink, J. Nutritional supplements for people being treated for active tuberculosis. Cochrane.Database.Syst.Rev. 2008;(4):CD006086. View abstract.

34559

Grieger, J. A., Nowson, C. A., Jarman, H. F., Malon, R., and Ackland, L. M. Multivitamin supplementation improves nutritional status and bone quality in aged care residents. Eur.J.Clin.Nutr. 2009;63(4):558-565. View abstract.

34596

Cooper, K., Squires, H., Carroll, C., Papaioannou, D., Booth, A., Logan, R. F., Maguire, C., Hind, D., and Tappenden, P. Chemoprevention of colorectal cancer: systematic review and economic evaluation. Health Technol.Assess. 2010;14(32):1-206. View abstract.

34604

Irlam, J. H., Visser, M. M., Rollins, N. N., and Siegfried, N. Micronutrient supplementation in children and adults with HIV infection. Cochrane.Database.Syst.Rev. 2010;(12):CD003650. View abstract.

34606

Nurmatov, U., Devereux, G., and Sheikh, A. Nutrients and foods for the primary prevention of asthma and allergy: systematic review and meta-analysis. J.Allergy Clin.Immunol. 2011;127(3):724-733. View abstract.

38477

Komulainen, M., Kroger, H., Tuppurainen, M. T., Heikkinen, A. M., Alhava, E., Honkanen, R., Jurvelin, J., and Saarikoski, S. Prevention of femoral and lumbar bone loss with hormone replacement therapy and vitamin D3 in early postmenopausal women: a population-based 5-year randomized trial. J Clin Endocrinol Metab 1999;84(2):546-552. View abstract.

38479

Komulainen, M. H., Kroger, H., Tuppurainen, M. T., Heikkinen, A. M., Alhava, E., Honkanen, R., and Saarikoski, S. HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trial. Maturitas 11-30-1998;31(1):45-54. View abstract.

38487

Reginster, J. Y., Kuntz, D., Verdickt, W., Wouters, M., Guillevin, L., Menkes, C. J., and Nielsen, K. Prophylactic use of alfacalcidol in corticosteroid-induced osteoporosis. Osteoporos.Int 1999;9(1):75-81. View abstract.

38488

Gorai, I., Chaki, O., Taguchi, Y., Nakayama, M., Osada, H., Suzuki, N., Katagiri, N., Misu, Y., and Minaguchi, H. Early postmenopausal bone loss is prevented by estrogen and partially by 1alpha-OH-vitamin D3: therapeutic effects of estrogen and/or 1alpha-OH-vitamin D3. Calcif Tissue Int 1999;65(1):16-22. View abstract.

38493

Amin, S., LaValley, M. P., Simms, R. W., and Felson, D. T. The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach. Arthritis Rheum 1999;42(8):1740-1751. View abstract.

38504

Krieg, M. A., Jacquet, A. F., Bremgartner, M., Cuttelod, S., Thiebaud, D., and Burckhardt, P. Effect of supplementation with vitamin D3 and calcium on quantitative ultrasound of bone in elderly institutionalized women: a longitudinal study. Osteoporos.Int 1999;9(6):483-488. View abstract.

38507

Fan, S. L., Almond, M. K., Ball, E., Evans, K., and Cunningham, J. Pamidronate therapy as prevention of bone loss following renal transplantation. Kidney Int 2000;57(2):684-690. View abstract.

38511

Blank, R. D. and Bockman, R. S. A review of clinical trials of therapies for osteoporosis using fracture as an end point. J Clin Densitom. 1999;2(4):435-452. View abstract.

38515

Bijlsma, J. W. Supplementation of vitamin D plus calcium is effective in corticosteroid-induced osteoporosis management. Clin Exp.Rheumatol. 2000;18(1):3-4. View abstract.

38517

Ugur, A., Guvener, N., Isiklar, I., Karakayali, H., and Erdal, R. Efficiency of preventive treatment for osteoporosis after renal transplantation. Transplant.Proc. 2000;32(3):556-557. View abstract.

38519

Ardissino, G., Schmitt, C. P., Testa, S., Claris-Appiani, A., and Mehls, O. Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure. European Study Group on Vitamin D in Children with Renal Failure. Pediatr.Nephrol 2000;14(7):664-668. View abstract.

38521

Vallecillo, G., Diez, A., Carbonell, J., and Gonzalez, Macias J. [Treatment of osteoporosis with calcium and vitamin D. Systematic review]. Med.Clin (Barc.) 6-10-2000;115(2):46-51. View abstract.

38523

Sambrook, P., Henderson, N. K., Keogh, A., MacDonald, P., Glanville, A., Spratt, P., Bergin, P., Ebeling, P., and Eisman, J. Effect of calcitriol on bone loss after cardiac or lung transplantation. J Bone Miner Res 2000;15(9):1818-1824. View abstract.

38527

Peacock, M., Liu, G., Carey, M., McClintock, R., Ambrosius, W., Hui, S., and Johnston, C. C. Effect of calcium or 25OH vitamin D3 dietary supplementation on bone loss at the hip in men and women over the age of 60. J Clin Endocrinol Metab 2000;85(9):3011-3019. View abstract.

38533

Nam, J. H., Moon, J. I., Chung, S. S., Kim, S. I., Park, K. I., Song, Y. D., Kim, K. R., Lee, H. C., Huh, K., and Lim, S. K. Pamidronate and calcitriol trial for the prevention of early bone loss after renal transplantation. Transplant.Proc. 2000;32(7):1876. View abstract.

38538

Vieth, R., Chan, P. C., and MacFarlane, G. D. Efficacy and safety of vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001;73(2):288-294. View abstract.

38540

Henderson, K., Eisman, J., Keogh, A., MacDonald, P., Glanville, A., Spratt, P., and Sambrook, P. Protective effect of short-tem calcitriol or cyclical etidronate on bone loss after cardiac or lung transplantation. J Bone Miner Res 2001;16(3):565-571. View abstract.

38541

Yosipovitch, G., Hoon, T. S., and Leok, G. C. Suggested rationale for prevention and treatment of glucocorticoid-induced bone loss in dermatologic patients. Arch Dermatol. 2001;137(4):477-481. View abstract.

38542

Pfeifer, M., Begerow, B., Minne, H. W., Nachtigall, D., and Hansen, C. Effects of a short-term vitamin D(3) and calcium supplementation on blood pressure and parathyroid hormone levels in elderly women. J Clin Endocrinol Metab 2001;86(4):1633-1637. View abstract.

38548

Grotz, W., Nagel, C., Poeschel, D., Cybulla, M., Petersen, K. G., Uhl, M., Strey, C., Kirste, G., Olschewski, M., Reichelt, A., and Rump, L. C. Effect of ibandronate on bone loss and renal function after kidney transplantation. J Am Soc Nephrol 2001;12(7):1530-1537. View abstract.

38552

Gallagher, J. C., Fowler, S. E., Detter, J. R., and Sherman, S. S. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. J Clin Endocrinol Metab 2001;86(8):3618-3628. View abstract.

38560

Giannini, S., D’Angelo, A., Carraro, G., Nobile, M., Rigotti, P., Bonfante, L., Marchini, F., Zaninotto, M., Dalle, Carbonare L., Sartori, L., and Crepaldi, G. Alendronate prevents further bone loss in renal transplant recipients. J Bone Miner Res 2001;16(11):2111-2117. View abstract.

38562

Ushiroyama, T., Ikeda, A., Sakai, M., Higashiyama, T., and Ueki, M. Effects of the combined use of calcitonin and 1 alpha-hydroxycholecalciferol on vertebral bone loss and bone turnover in women with postmenopausal osteopenia and osteoporosis: a prospective study of long-term and continuous administration with low dose calcitonin. Maturitas 12-14-2001;40(3):229-238. View abstract.

38575

De Sevaux, R. G., Hoitsma, A. J., Corstens, F. H., and Wetzels, J. F. Treatment with vitamin D and calcium reduces bone loss after renal transplantation: a randomized study. J Am Soc Nephrol 2002;13(6):1608-1614. View abstract.

38576

Schaafsma, A., van Doormaal, J. J., Muskiet, F. A., Hofstede, G. J., Pakan, I., and van, der, V. Positive effects of a chicken eggshell powder-enriched vitamin-mineral supplement on femoral neck bone mineral density in healthy late post-menopausal Dutch women. Br.J Nutr 2002;87(3):267-275. View abstract.

38581

Amin, S., LaValley, M. P., Simms, R. W., and Felson, D. T. The comparative efficacy of drug therapies used for the management of corticosteroid-induced osteoporosis: a meta-regression. J Bone Miner Res 2002;17(8):1512-1526. View abstract.

38584

Cranney, A., Wells, G., Willan, A., Griffith, L., Zytaruk, N., Robinson, V., Black, D., Adachi, J., Shea, B., Tugwell, P., and Guyatt, G. Meta-analyses of therapies for postmenopausal osteoporosis. II. Meta-analysis of alendronate for the treatment of postmenopausal women. Endocr.Rev. 2002;23(4):508-516. View abstract.

38585

Cranney, A., Tugwell, P., Adachi, J., Weaver, B., Zytaruk, N., Papaioannou, A., Robinson, V., Shea, B., Wells, G., and Guyatt, G. Meta-analyses of therapies for postmenopausal osteoporosis. III. Meta-analysis of risedronate for the treatment of postmenopausal osteoporosis. Endocr.Rev. 2002;23(4):517-523. View abstract.

38586

Cranney, A., Tugwell, P., Zytaruk, N., Robinson, V., Weaver, B., Adachi, J., Wells, G., Shea, B., and Guyatt, G. Meta-analyses of therapies for postmenopausal osteoporosis. IV. Meta-analysis of raloxifene for the prevention and treatment of postmenopausal osteoporosis. Endocr.Rev. 2002;23(4):524-528. View abstract.

38587

Wells, G., Tugwell, P., Shea, B., Guyatt, G., Peterson, J., Zytaruk, N., Robinson, V., Henry, D., O’Connell, D., and Cranney, A. Meta-analyses of therapies for postmenopausal osteoporosis. V. Meta-analysis of the efficacy of hormone replacement therapy in treating and preventing osteoporosis in postmenopausal women. Endocr.Rev. 2002;23(4):529-539. View abstract.

38588

Cranney, A., Tugwell, P., Zytaruk, N., Robinson, V., Weaver, B., Shea, B., Wells, G., Adachi, J., Waldegger, L., and Guyatt, G. Meta-analyses of therapies for postmenopausal osteoporosis. VI. Meta-analysis of calcitonin for the treatment of postmenopausal osteoporosis. Endocr.Rev. 2002;23(4):540-551. View abstract.

38589

Shea, B., Wells, G., Cranney, A., Zytaruk, N., Robinson, V., Griffith, L., Ortiz, Z., Peterson, J., Adachi, J., Tugwell, P., and Guyatt, G. Meta-analyses of therapies for postmenopausal osteoporosis. VII. Meta-analysis of calcium supplementation for the prevention of postmenopausal osteoporosis. Endocr.Rev. 2002;23(4):552-559. View abstract.

38590

Cranney, A., Guyatt, G., Griffith, L., Wells, G., Tugwell, P., and Rosen, C. Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis. Endocr.Rev. 2002;23(4):570-578. View abstract.

38594

Koc, M., Tuglular, S., Arikan, H., Ozener, C., and Akoglu, E. Alendronate increases bone mineral density in long-term renal transplant recipients. Transplant.Proc. 2002;34(6):2111-2113. View abstract.

38602

Hauselmann, H. J. and Rizzoli, R. A comprehensive review of treatments for postmenopausal osteoporosis. Osteoporos.Int 2003;14(1):2-12. View abstract.

38604

Latham, N. K., Anderson, C. S., Lee, A., Bennett, D. A., Moseley, A., and Cameron, I. D. A randomized, controlled trial of quadriceps resistance exercise and vitamin D in frail older people: the Frailty Interventions Trial in Elderly Subjects (FITNESS). J Am Geriatr Soc 2003;51(3):291-299. View abstract.

38607

Haas, M., Leko-Mohr, Z., Roschger, P., Kletzmayr, J., Schwarz, C., Mitterbauer, C., Steininger, R., Grampp, S., Klaushofer, K., Delling, G., and Oberbauer, R. Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation. Kidney Int 2003;63(3):1130-1136. View abstract.

38610

Schmitt, C. P., Ardissino, G., Testa, S., Claris-Appiani, A., and Mehls, O. Growth in children with chronic renal failure on intermittent versus daily calcitriol. Pediatr.Nephrol 2003;18(5):440-444. View abstract.

38613

McCullough, M. L., Robertson, A. S., Rodriguez, C., Jacobs, E. J., Chao, A., Carolyn, J., Calle, E. E., Willett, W. C., and Thun, M. J. Calcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort (United States). Cancer Causes Control 2003;14(1):1-12. View abstract.

38614

Cooper, L., Clifton-Bligh, P. B., Nery, M. L., Figtree, G., Twigg, S., Hibbert, E., and Robinson, B. G. Vitamin D supplementation and bone mineral density in early postmenopausal women. Am J Clin Nutr 2003;77(5):1324-1329. View abstract.

38623

Grados, F., Brazier, M., Kamel, S., Duver, S., Heurtebize, N., Maamer, M., Mathieu, M., Garabedian, M., Sebert, J. L., and Fardellone, P. Effects on bone mineral density of calcium and vitamin D supplementation in elderly women with vitamin D deficiency. Joint Bone Spine 2003;70(3):203-208. View abstract.

38624

Torregrosa, J. V., Moreno, A., Gutierrez, A., Vidal, S., and Oppenheimer, F. Alendronate for treatment of renal transplant patients with osteoporosis. Transplant.Proc. 2003;35(4):1393-1395. View abstract.

38641

Coco, M., Glicklich, D., Faugere, M. C., Burris, L., Bognar, I., Durkin, P., Tellis, V., Greenstein, S., Schechner, R., Figueroa, K., McDonough, P., Wang, G., and Malluche, H. Prevention of bone loss in renal transplant recipients: a prospective, randomized trial of intravenous pamidronate. J Am Soc Nephrol 2003;14(10):2669-2676. View abstract.

38644

El-Agroudy, A. E., El-Husseini, A. A., El-Sayed, M., and Ghoneim, M. A. Preventing bone loss in renal transplant recipients with vitamin D. J Am Soc Nephrol 2003;14(11):2975-2979. View abstract.

38646

Cesur, Y., Caksen, H., Gundem, A., Kirimi, E., and Odabas, D. Comparison of low and high dose of vitamin D treatment in nutritional vitamin D deficiency rickets. J Pediatr.Endocrinol Metab 2003;16(8):1105-1109. View abstract.

38648

Grados, F., Brazier, M., Kamel, S., Mathieu, M., Hurtebize, N., Maamer, M., Garabedian, M., Sebert, J. L., and Fardellone, P. Prediction of bone mass density variation by bone remodeling markers in postmenopausal women with vitamin D insufficiency treated with calcium and vitamin D supplementation. J Clin Endocrinol Metab 2003;88(11):5175-5179. View abstract.

38654

Jeffery, J. R., Leslie, W. D., Karpinski, M. E., Nickerson, P. W., and Rush, D. N. Prevalence and treatment of decreased bone density in renal transplant recipients: a randomized prospective trial of calcitriol versus alendronate. Transplantation 11-27-2003;76(10):1498-1502. View abstract.

38658

Fujita, T., Ohue, M., Fujii, Y., Miyauchi, A., and Takagi, Y. Reappraisal of Katsuragi calcium study, a prospective, double-blind, placebo-controlled study of the effect of active absorbable algal calcium (AAACa) on vertebral deformity and fracture. J Bone Miner Metab 2004;22(1):32-38. View abstract.

38659

Harwood, R. H., Sahota, O., Gaynor, K., Masud, T., and Hosking, D. J. A randomised, controlled comparison of different calcium and vitamin D supplementation regimens in elderly women after hip fracture: The Nottingham Neck of Femur (NONOF) Study. Age Ageing 2004;33(1):45-51. View abstract.

38660

Lewiecki, E. M. Nonresponders to osteoporosis therapy. J Clin Densitom. 2003;6(4):307-314. View abstract.

38661

Torres, A., Garcia, S., Gomez, A., Gonzalez, A., Barrios, Y., Concepcion, M. T., Hernandez, D., Garcia, J. J., Checa, M. D., Lorenzo, V., and Salido, E. Treatment with intermittent calcitriol and calcium reduces bone loss after renal transplantation. Kidney Int 2004;65(2):705-712. View abstract.

38684

Du, X., Zhu, K., Trube, A., Zhang, Q., Ma, G., Hu, X., Fraser, D. R., and Greenfield, H. School-milk intervention trial enhances growth and bone mineral accretion in Chinese girls aged 10-12 years in Beijing. Br.J Nutr 2004;92(1):159-168. View abstract.

38685

Meier, C., Woitge, H. W., Witte, K., Lemmer, B., and Seibel, M. J. Supplementation with oral vitamin D3 and calcium during winter prevents seasonal bone loss: a randomized controlled open-label prospective trial. J Bone Miner Res 2004;19(8):1221-1230. View abstract.

38687

Slattery, M. L., Neuhausen, S. L., Hoffman, M., Caan, B., Curtin, K., Ma, K. N., and Samowitz, W. Dietary calcium, vitamin D, VDR genotypes and colorectal cancer. Int J Cancer 9-20-2004;111(5):750-756. View abstract.

38689

Vieth, R., Kimball, S., Hu, A., and Walfish, P. G. Randomized comparison of the effects of the vitamin D3 adequate intake versus 100 mcg (4000 IU) per day on biochemical responses and the wellbeing of patients. Nutr J 7-19-2004;3:8. View abstract.

38690

El-Husseini, A. A., El-Agroudy, A. E., El-Sayed, M. F., Sobh, M. A., and Ghoneim, M. A. Treatment of osteopenia and osteoporosis in renal transplant children and adolescents. Pediatr.Transplant. 2004;8(4):357-361. View abstract.

38700

Ishida, Y. and Kawai, S. Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. Am.J.Med. 10-15-2004;117(8):549-555. View abstract.

38712

El-Husseini, A. A., El-Agroudy, A. E., El-Sayed, M., Sobh, M. A., and Ghoneim, M. A. A prospective randomized study for the treatment of bone loss with vitamin d during kidney transplantation in children and adolescents. Am J Transplant. 2004;4(12):2052-2057. View abstract.

38714

Weisberg, P., Scanlon, K. S., Li, R., and Cogswell, M. E. Nutritional rickets among children in the United States: review of cases reported between 1986 and 2003. Am J Clin Nutr 2004;80(6 Suppl):1697S-1705S. View abstract.

38724

Haworth, C. S., Jones, A. M., Adams, J. E., Selby, P. L., and Webb, A. K. Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis. J Cyst.Fibros. 2004;3(4):233-236. View abstract.

38726

Wissing, K. M., Broeders, N., Moreno-Reyes, R., Gervy, C., Stallenberg, B., and Abramowicz, D. A controlled study of vitamin D3 to prevent bone loss in renal-transplant patients receiving low doses of steroids. Transplantation 1-15-2005;79(1):108-115. View abstract.

38734

Greenbaum, L. A., Grenda, R., Qiu, P., Restaino, I., Wojtak, A., Paredes, A., Benador, N., Melnick, J. Z., Williams, L. A., and Salusky, I. B. Intravenous calcitriol for treatment of hyperparathyroidism in children on hemodialysis. Pediatr.Nephrol 2005;20(5):622-630. View abstract.

38735

Lin, J., Zhang, S. M., Cook, N. R., Manson, J. E., Lee, I. M., and Buring, J. E. Intakes of calcium and vitamin D and risk of colorectal cancer in women. Am J Epidemiol. 4-15-2005;161(8):755-764. View abstract.

38736

Palmer, S. C., Strippoli, G. F., and McGregor, D. O. Interventions for preventing bone disease in kidney transplant recipients: a systematic review of randomized controlled trials. Am J Kidney Dis. 2005;45(4):638-649. View abstract.

38742

Palmer, S., McGregor, D. O., and Strippoli, G. F. Interventions for preventing bone disease in kidney transplant recipients. Cochrane.Database.Syst.Rev. 2005;(2):CD005015. View abstract.

38746

Kesse, E., Boutron-Ruault, M. C., Norat, T., Riboli, E., and Clavel-Chapelon, F. Dietary calcium, phosphorus, vitamin D, dairy products and the risk of colorectal adenoma and cancer among French women of the E3N-EPIC prospective study. Int J Cancer 10-20-2005;117(1):137-144. View abstract.

38751

Stevenson, M., Jones, M. L., De, Nigris E., Brewer, N., Davis, S., and Oakley, J. A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis. Health Technol.Assess. 2005;9(22):1-160. View abstract.

38752

Salusky, I. B., Goodman, W. G., Sahney, S., Gales, B., Perilloux, A., Wang, H. J., Elashoff, R. M., and Juppner, H. Sevelamer controls parathyroid hormone-induced bone disease as efficiently as calcium carbonate without increasing serum calcium levels during therapy with active vitamin D sterols. J Am Soc Nephrol 2005;16(8):2501-2508. View abstract.

38761

Weingarten, M. A., Zalmanovici, A., and Yaphe, J. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane.Database.Syst.Rev. 2005;(3):CD003548. View abstract.

38764

Lau, E. M., Woo, J., Leung, P. C., Swaminathan, R., and Leung, D. The effects of calcium supplementation and exercise on bone density in elderly Chinese women. Osteoporos.Int 1992;2(4):168-173. View abstract.

38770

Forman, J. P., Bischoff-Ferrari, H. A., Willett, W. C., Stampfer, M. J., and Curhan, G. C. Vitamin D intake and risk of incident hypertension: results from three large prospective cohort studies. Hypertension 2005;46(4):676-682. View abstract.

38774

Flicker, L., MacInnis, R. J., Stein, M. S., Scherer, S. C., Mead, K. E., Nowson, C. A., Thomas, J., Lowndes, C., Hopper, J. L., and Wark, J. D. Should older people in residential care receive vitamin D to prevent falls? Results of a randomized trial. J Am Geriatr Soc 2005;53(11):1881-1888. View abstract.

38775

El-Hajj, Fuleihan G., Nabulsi, M., Tamim, H., Maalouf, J., Salamoun, M., Khalife, H., Choucair, M., Arabi, A., and Vieth, R. Effect of vitamin D replacement on musculoskeletal parameters in school children: a randomized controlled trial. J Clin Endocrinol Metab 2006;91(2):405-412. View abstract.

38777

Avenell, A., Grant, A. M., McGee, M., McPherson, G., Campbell, M. K., and McGee, M. A. The effects of an open design on trial participant recruitment, compliance and retention–a randomized controlled trial comparison with a blinded, placebo-controlled design. Clin Trials 2004;1(6):490-498. View abstract.

38779

Cheng, S., Lyytikainen, A., Kroger, H., Lamberg-Allardt, C., Alen, M., Koistinen, A., Wang, Q. J., Suuriniemi, M., Suominen, H., Mahonen, A., Nicholson, P. H., Ivaska, K. K., Korpela, R., Ohlsson, C., Vaananen, K. H., and Tylavsky, F. Effects of calcium, dairy product, and vitamin D supplementation on bone mass accrual and body composition in 10-12-y-old girls: a 2-y randomized trial. Am J Clin Nutr 2005;82(5):1115-1126. View abstract.

38787

Mastaglia, S. R., Mautalen, C. A., Parisi, M. S., and Oliveri, B. Vitamin D2 dose required to rapidly increase 25OHD levels in osteoporotic women. Eur.J Clin Nutr 2006;60(5):681-687. View abstract.

38789

Shiraki, M. and Orimo, H. [The effect of estrogen and, sex-steroids and thyroid hormone preparation on bone mineral density in senile osteoporosis–a comparative study of the effect of 1 alpha-hydroxycholecalciferol (1 alpha-OHD3) on senile osteoporosis]. Nippon Naibunpi Gakkai Zasshi 2-20-1991;67(2):84-95. View abstract.

38794

Pittas, A. G., Dawson-Hughes, B., Li, T., Van Dam, R. M., Willett, W. C., Manson, J. E., and Hu, F. B. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care 2006;29(3):650-656. View abstract.

38795

Brazier, M., Grados, F., Kamel, S., Mathieu, M., Morel, A., Maamer, M., Sebert, J. L., and Fardellone, P. Clinical and laboratory safety of one year’s use of a combination calcium + vitamin D tablet in ambulatory elderly women with vitamin D insufficiency: results of a multicenter, randomized, double-blind, placebo-controlled study. Clin Ther 2005;27(12):1885-1893. View abstract.

38801

Pieper, A. K., Haffner, D., Hoppe, B., Dittrich, K., Offner, G., Bonzel, K. E., John, U., Frund, S., Klaus, G., Stubinger, A., Duker, G., and Querfeld, U. A randomized crossover trial comparing sevelamer with calcium acetate in children with CKD. Am J Kidney Dis. 2006;47(4):625-635. View abstract.

38806

Prince, R. L., Devine, A., Dhaliwal, S. S., and Dick, I. M. Effects of calcium supplementation on clinical fracture and bone structure: results of a 5-year, double-blind, placebo-controlled trial in elderly women. Arch Intern.Med. 4-24-2006;166(8):869-875. View abstract.

38807

Law, M., Withers, H., Morris, J., and Anderson, F. Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation. Age Ageing 2006;35(5):482-486. View abstract.

38813

Viljakainen, H. T., Natri, A. M., Karkkainen, M., Huttunen, M. M., Palssa, A., Jakobsen, J., Cashman, K. D., Molgaard, C., and Lamberg-Allardt, C. A positive dose-response effect of vitamin D supplementation on site-specific bone mineral augmentation in adolescent girls: a double-blinded randomized placebo-controlled 1-year intervention. J Bone Miner Res 2006;21(6):836-844. View abstract.

38814

Bunout, D., Barrera, G., Leiva, L., Gattas, V., de la Maza, M. P., Avendano, M., and Hirsch, S. Effects of vitamin D supplementation and exercise training on physical performance in Chilean vitamin D deficient elderly subjects. Exp.Gerontol 2006;41(8):746-752. View abstract.

38822

Reid, I. R., Mason, B., Horne, A., Ames, R., Reid, H. E., Bava, U., Bolland, M. J., and Gamble, G. D. Randomized controlled trial of calcium in healthy older women. Am J Med. 2006;119(9):777-785. View abstract.

38835

Oliver, D., Connelly, J. B., Victor, C. R., Shaw, F. E., Whitehead, A., Genc, Y., Vanoli, A., Martin, F. C., and Gosney, M. A. Strategies to prevent falls and fractures in hospitals and care homes and effect of cognitive impairment: systematic review and meta-analyses. BMJ 1-13-2007;334(7584):82. View abstract.

38840

Bolton-Smith, C., McMurdo, M. E., Paterson, C. R., Mole, P. A., Harvey, J. M., Fenton, S. T., Prynne, C. J., Mishra, G. D., and Shearer, M. J. Two-year randomized controlled trial of vitamin K1 (phylloquinone) and vitamin D3 plus calcium on the bone health of older women. J.Bone Miner.Res. 2007;22(4):509-519. View abstract.

38843

Tilyard, M. W., Spears, G. F., Thomson, J., and Dovey, S. Treatment of postmenopausal osteoporosis with calcitriol or calcium. N.Engl.J Med. 2-6-1992;326(6):357-362. View abstract.

38849

Izaks, G. J. Fracture prevention with vitamin D supplementation: considering the inconsistent results. BMC.Musculoskelet.Disord. 2007;8:26. View abstract.

38858

Lyons, R. A., Johansen, A., Brophy, S., Newcombe, R. G., Phillips, C. J., Lervy, B., Evans, R., Wareham, K., and Stone, M. D. Preventing fractures among older people living in institutional care: a pragmatic randomised double blind placebo controlled trial of vitamin D supplementation. Osteoporos.Int 2007;18(6):811-818. View abstract.

38863

Greenbaum, L. A., Benador, N., Goldstein, S. L., Paredes, A., Melnick, J. Z., Mattingly, S., Amdahl, M., Williams, L. A., and Salusky, I. B. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis. Am J Kidney Dis. 2007;49(6):814-823. View abstract.

38871

Palmer, S. C., McGregor, D. O., and Strippoli, G. F. Interventions for preventing bone disease in kidney transplant recipients. Cochrane.Database.Syst.Rev. 2007;(3):CD005015. View abstract.

38872

Burleigh, E., McColl, J., and Potter, J. Does vitamin D stop inpatients falling? A randomised controlled trial. Age Ageing 2007;36(5):507-513. View abstract.

38875

Tang, B. M., Eslick, G. D., Nowson, C., Smith, C., and Bensoussan, A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet 8-25-2007;370(9588):657-666. View abstract.

38883

Mosekilde, L., Langdahl, B. L., Nielsen, L. R., and Vestergaard, P. [The usefulness of calcium and vitamin D supplementation after the Women’s Health Initiative trial]. Ugeskr.Laeger 9-24-2007;169(39):3273-3276. View abstract.

38886

Smith, H., Anderson, F., Raphael, H., Maslin, P., Crozier, S., and Cooper, C. Effect of annual intramuscular vitamin D on fracture risk in elderly men and women–a population-based, randomized, double-blind, placebo-controlled trial. Rheumatology.(Oxford) 2007;46(12):1852-1857. View abstract.

38888

Bischoff-Ferrari, H. A., Dawson-Hughes, B., Baron, J. A., Burckhardt, P., Li, R., Spiegelman, D., Specker, B., Orav, J. E., Wong, J. B., Staehelin, H. B., O’Reilly, E., Kiel, D. P., and Willett, W. C. Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials. Am J Clin Nutr 2007;86(6):1780-1790. View abstract.

38889

MacLean, C., Newberry, S., Maglione, M., McMahon, M., Ranganath, V., Suttorp, M., Mojica, W., Timmer, M., Alexander, A., McNamara, M., Desai, S. B., Zhou, A., Chen, S., Carter, J., Tringale, C., Valentine, D., Johnsen, B., and Grossman, J. Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis. Ann.Intern.Med. 2-5-2008;148(3):197-213. View abstract.

38890

Cranney, A., Horsley, T., O’Donnell, S., Weiler, H., Puil, L., Ooi, D., Atkinson, S., Ward, L., Moher, D., Hanley, D., Fang, M., Yazdi, F., Garritty, C., Sampson, M., Barrowman, N., Tsertsvadze, A., and Mamaladze, V. Effectiveness and safety of vitamin D in relation to bone health. Evid.Rep Technol.Assess.(Full.Rep) 2007;(158):1-235. View abstract.

38893

McCullough, M. L., Bandera, E. V., Moore, D. F., and Kushi, L. H. Vitamin D and calcium intake in relation to risk of endometrial cancer: a systematic review of the literature. Prev.Med. 2008;46(4):298-302. View abstract.

38894

Judd, S. E., Nanes, M. S., Ziegler, T. R., Wilson, P. W., and Tangpricha, V. Optimal vitamin D status attenuates the age-associated increase in systolic blood pressure in white Americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 2008;87(1):136-141. View abstract.

38910

Huncharek, M., Muscat, J., and Kupelnick, B. Impact of dairy products and dietary calcium on bone-mineral content in children: results of a meta-analysis. Bone 2008;43(2):312-321. View abstract.

38915

Pfeifer, M., Begerow, B., Minne, H. W., Suppan, K., Fahrleitner-Pammer, A., and Dobnig, H. Effects of a long-term vitamin D and calcium supplementation on falls and parameters of muscle function in community-dwelling older individuals. Osteoporos.Int 2009;20(2):315-322. View abstract.

38921

Elders, P. J., Netelenbos, J. C., Lips, P., van Ginkel, F. C., Khoe, E., Leeuwenkamp, O. R., Hackeng, W. H., and van der Stelt, P. F. Calcium supplementation reduces vertebral bone loss in perimenopausal women: a controlled trial in 248 women between 46 and 55 years of age. J Clin Endocrinol Metab 1991;73(3):533-540. View abstract.

38922

Brunner, R. L., Cochrane, B., Jackson, R. D., Larson, J., Lewis, C., Limacher, M., Rosal, M., Shumaker, S., and Wallace, R. Calcium, vitamin D supplementation, and physical function in the Women’s Health Initiative. J Am Diet Assoc. 2008;108(9):1472-1479. View abstract.

38924

Jorde, R., Sneve, M., Figenschau, Y., Svartberg, J., and Waterloo, K. Effects of vitamin D supplementation on symptoms of depression in overweight and obese subjects: randomized double blind trial. J Intern.Med. 2008;264(6):599-609. View abstract.

38930

Dawson-Hughes, B., Dallal, G. E., Krall, E. A., Harris, S., Sokoll, L. J., and Falconer, G. Effect of vitamin D supplementation on wintertime and overall bone loss in healthy postmenopausal women. Ann.Intern.Med. 10-1-1991;115(7):505-512. View abstract.

38940

Bacchetta, J., Harambat, J., and Cochat, P. [Long-term steroid therapy in children: is adjunct therapy relevant in nephrotic syndrome?]. Arch Pediatr. 2008;15(11):1685-1692. View abstract.

38941

Kukuljan, S., Nowson, C. A., Bass, S. L., Sanders, K., Nicholson, G. C., Seibel, M. J., Salmon, J., and Daly, R. M. Effects of a multi-component exercise program and calcium-vitamin-D3-fortified milk on bone mineral density in older men: a randomised controlled trial. Osteoporos.Int 2009;20(7):1241-1251. View abstract.

38942

O’Donnell, S., Moher, D., Thomas, K., Hanley, D. A., and Cranney, A. Systematic review of the benefits and harms of calcitriol and alfacalcidol for fractures and falls. J Bone Miner Metab 2008;26(6):531-542. View abstract.

38950

Larsson, S. C., Bergkvist, L., and Wolk, A. Long-term dietary calcium intake and breast cancer risk in a prospective cohort of women. Am J Clin Nutr 2009;89(1):277-282. View abstract.

38951

Huncharek, M., Muscat, J., and Kupelnick, B. Colorectal cancer risk and dietary intake of calcium, vitamin D, and dairy products: a meta-analysis of 26,335 cases from 60 observational studies. Nutr Cancer 2009;61(1):47-69. View abstract.

38962

LaCroix, A. Z., Kotchen, J., Anderson, G., Brzyski, R., Cauley, J. A., Cummings, S. R., Gass, M., Johnson, K. C., Ko, M., Larson, J., Manson, J. E., Stefanick, M. L., and Wactawski-Wende, J. Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women’s Health Initiative calcium-vitamin D randomized controlled trial. J Gerontol A Biol.Sci.Med.Sci. 2009;64(5):559-567. View abstract.

38966

Park, Y., Leitzmann, M. F., Subar, A. F., Hollenbeck, A., and Schatzkin, A. Dairy food, calcium, and risk of cancer in the NIH-AARP Diet and Health Study. Arch Intern.Med. 2-23-2009;169(4):391-401. View abstract.

38970

Bischoff-Ferrari, H. A., Willett, W. C., Wong, J. B., Stuck, A. E., Staehelin, H. B., Orav, E. J., Thoma, A., Kiel, D. P., and Henschkowski, J. Prevention of nonvertebral fractures with oral vitamin D and dose dependency: a meta-analysis of randomized controlled trials. Arch Intern.Med. 3-23-2009;169(6):551-561. View abstract.

38973

Avenell, A., Gillespie, W. J., Gillespie, L. D., and O’Connell, D. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane.Database.Syst.Rev. 2009;(2):CD000227. View abstract.

38974

Hopkins, B. and Steward, D. Outpatient thyroid surgery and the advances making it possible. Curr Opin.Otolaryngol.Head Neck Surg. 2009;17(2):95-99. View abstract.

38993

Moreira-Pfrimer, L. D., Pedrosa, M. A., Teixeira, L., and Lazaretti-Castro, M. Treatment of vitamin D deficiency increases lower limb muscle strength in institutionalized older people independently of regular physical activity: a randomized double-blind controlled trial. Ann.Nutr Metab 2009;54(4):291-300. View abstract.

38999

Ferguson, J. H. and Chang, A. B. Vitamin D supplementation for cystic fibrosis. Cochrane.Database.Syst.Rev. 2009;(4):CD007298. View abstract.

39001

Chen, P., Hu, P., Xie, D., Qin, Y., Wang, F., and Wang, H. Meta-analysis of vitamin D, calcium and the prevention of breast cancer. Breast Cancer Res Treat. 2010;121(2):469-477. View abstract.

39006

Salusky, I. B., Foley, J., Nelson, P., and Goodman, W. G. Aluminum accumulation during treatment with aluminum hydroxide and dialysis in children and young adults with chronic renal disease. N.Engl.J Med. 2-21-1991;324(8):527-531. View abstract.

39015

Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ 2010;340:b5463. View abstract.

39016

Geary, D. F., Hodson, E. M., and Craig, J. C. Interventions for bone disease in children with chronic kidney disease. Cochrane.Database.Syst.Rev. 2010;(1):CD008327. View abstract.

39018

Wang, L., Manson, J. E., Song, Y., and Sesso, H. D. Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann.Intern.Med. 3-2-2010;152(5):315-323. View abstract.

39024

Barnard, K. and Colon-Emeric, C. Extraskeletal effects of vitamin D in older adults: cardiovascular disease, mortality, mood, and cognition. Am J Geriatr Pharmacother. 2010;8(1):4-33. View abstract.

39026

Bergman, G. J., Fan, T., McFetridge, J. T., and Sen, S. S. Efficacy of vitamin D3 supplementation in preventing fractures in elderly women: a meta-analysis. Curr Med.Res Opin. 2010;26(5):1193-1201. View abstract.

39027

Janssen, H. C., Samson, M. M., and Verhaar, H. J. Muscle strength and mobility in vitamin D-insufficient female geriatric patients: a randomized controlled trial on vitamin D and calcium supplementation. Aging Clin Exp.Res 2010;22(1):78-84. View abstract.

39032

Gupta, R., Sharma, U., Gupta, N., Kalaivani, M., Singh, U., Guleria, R., Jagannathan, N. R., and Goswami, R. Effect of cholecalciferol and calcium supplementation on muscle strength and energy metabolism in vitamin D-deficient Asian Indians: a randomized, controlled trial. Clin Endocrinol (Oxf) 2010;73(4):445-451. View abstract.

39038

Kalyani, R. R., Stein, B., Valiyil, R., Manno, R., Maynard, J. W., and Crews, D. C. Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis. J Am Geriatr Soc 2010;58(7):1299-1310. View abstract.

39041

Chung, M., Balk, E. M., Brendel, M., Ip, S., Lau, J., Lee, J., Lichtenstein, A., Patel, K., Raman, G., Tatsioni, A., Terasawa, T., and Trikalinos, T. A. Vitamin D and calcium: a systematic review of health outcomes. Evid.Rep Technol.Assess.(Full.Rep) 2009;(183):1-420. View abstract.

39042

Carroll, C., Cooper, K., Papaioannou, D., Hind, D., Pilgrim, H., and Tappenden, P. Supplemental calcium in the chemoprevention of colorectal cancer: a systematic review and meta-analysis. Clin Ther 2010;32(5):789-803. View abstract.

39045

Sanabria, A., Dominguez, L. C., Vega, V., Osorio, C., and Duarte, D. Routine postoperative administration of vitamin D and calcium after total thyroidectomy: a meta-analysis. Int J Surg. 2011;9(1):46-51. View abstract.

39050

Arthur, R. S., Piraino, B., Candib, D., Cooperstein, L., Chen, T., West, C., and Puschett, J. Effect of low-dose calcitriol and calcium therapy on bone histomorphometry and urinary calcium excretion in osteopenic women. Miner Electrolyte Metab 1990;16(6):385-390. View abstract.

39051

Stockton, K. A., Mengersen, K., Paratz, J. D., Kandiah, D., and Bennell, K. L. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos.Int 2011;22(3):859-871. View abstract.

39053

Bischoff-Ferrari, H. A., Dawson-Hughes, B., Baron, J. A., Kanis, J. A., Orav, E. J., Staehelin, H. B., Kiel, D. P., Burckhardt, P., Henschkowski, J., Spiegelman, D., Li, R., Wong, J. B., Feskanich, D., and Willett, W. C. Milk intake and risk of hip fracture in men and women: a meta-analysis of prospective cohort studies. J Bone Miner Res 2011;26(4):833-839. View abstract.

39065

Orwoll, E. S., Oviatt, S. K., McClung, M. R., Deftos, L. J., and Sexton, G. The rate of bone mineral loss in normal men and the effects of calcium and cholecalciferol supplementation. Ann.Intern.Med. 1-1-1990;112(1):29-34. View abstract.

39071

Dawson-Hughes, B., Dallal, G. E., Krall, E. A., Sadowski, L., Sahyoun, N., and Tannenbaum, S. A controlled trial of the effect of calcium supplementation on bone density in postmenopausal women. N.Engl.J Med. 9-27-1990;323(13):878-883. View abstract.

39073

Gallagher, J. C. and Goldgar, D. Treatment of postmenopausal osteoporosis with high doses of synthetic calcitriol. A randomized controlled study. Ann.Intern.Med. 11-1-1990;113(9):649-655. View abstract.

39084

Honkanen, R., Alhava, E., Parviainen, M., Talasniemi, S., and Monkkonen, R. The necessity and safety of calcium and vitamin D in the elderly. J Am Geriatr Soc 1990;38(8):862-866. View abstract.

39095

Orwoll, E. S., McClung, M. R., Oviatt, S. K., Recker, R. R., and Weigel, R. M. Histomorphometric effects of calcium or calcium plus 25-hydroxyvitamin D3 therapy in senile osteoporosis. J Bone Miner Res 1989;4(1):81-88. View abstract.

39098

Gallagher, J. C., Riggs, B. L., Recker, R. R., and Goldgar, D. The effect of calcitriol on patients with postmenopausal osteoporosis with special reference to fracture frequency. Proc.Soc Exp.Biol.Med. 1989;191(3):287-292. View abstract.

39100

Di, Munno O., Beghe, F., Favini, P., Di, Giuseppe P., Pontrandolfo, A., Occhipinti, G., and Pasero, G. Prevention of glucocorticoid-induced osteopenia: effect of oral 25-hydroxyvitamin D and calcium. Clin Rheumatol. 1989;8(2):202-207. View abstract.

39105

Garland, C., Shekelle, R. B., Barrett-Connor, E., Criqui, M. H., Rossof, A. H., and Paul, O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet. 2-9-1985;1(8424):307-309. View abstract.

39110

Ott, S. M. and Chesnut, C. H., III. Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann.Intern.Med. 2-15-1989;110(4):267-274. View abstract.

39113

Shiraki, M., Orimo, H., Ito, H., Akiguchi, I., Nakao, J., Takahashi, R., and Ishizuka, S. Long-term treatment of postmenopausal osteoporosis with active vitamin D3, 1-alpha-hydroxycholecalciferol (1 alpha-OHD3) and 1, 24 Dihydroxycholecalciferol (1, 24(OH)2D3). Endocrinol Jpn. 1985;32(2):305-315. View abstract.

39118

Falch, J. A., Odegaard, O. R., Finnanger, A. M., and Matheson, I. Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol. Acta Med.Scand. 1987;221(2):199-204. View abstract.

39121

Riis, B. J., Thomsen, K., and Christiansen, C. Does 24R,25(OH)2-vitamin D3 prevent postmenopausal bone loss? Calcif Tissue Int 1986;39(3):128-132. View abstract.

39123

Hansson, T. and Roos, B. The effect of fluoride and calcium on spinal bone mineral content: a controlled, prospective (3 years) study. Calcif Tissue Int 1987;40(6):315-317. View abstract.

39127

Bijlsma, J. W., Raymakers, J. A., Mosch, C., Hoekstra, A., Derksen, R. H., Baart, de la Faille, and Duursma, S. A. Effect of oral calcium and vitamin D on glucocorticoid-induced osteopenia. Clin Exp.Rheumatol. 1988;6(2):113-119. View abstract.

39132

Watson, A. R., Kooh, S. W., Tam, C. S., Reilly, B. J., Balfe, J. W., and Vieth, R. Renal osteodystrophy in children on CAPD: a prospective trial of 1-alpha-hydroxycholecalciferol therapy. Child Nephrol Urol. 1988;9(4):220-227. View abstract.

39134

Aloia, J. F., Vaswani, A., Yeh, J. K., Ellis, K., Yasumura, S., and Cohn, S. H. Calcitriol in the treatment of postmenopausal osteoporosis. Am J Med. 1988;84(3 Pt 1):401-408. View abstract.

39138

Thomsen, K., Nilas, L., and Christiansen, C. Dietary calcium intake and blood pressure in normotensive subjects. Acta Med.Scand. 1987;222(1):51-56. View abstract.

39141

Thomsen, K., Riis, B., and Christiansen, C. Effect of estrogen/gestagen and 24R,25-dihydroxyvitamin D3 therapy on bone formation in postmenopausal women. J Bone Miner Res 1986;1(6):503-507. View abstract.

39142

Geusens, P. and Dequeker, J. Long-term effect of nandrolone decanoate, 1 alpha-hydroxyvitamin D3 or intermittent calcium infusion therapy on bone mineral content, bone remodeling and fracture rate in symptomatic osteoporosis: a double-blind controlled study. Bone Miner 1986;1(4):347-357. View abstract.

39147

Lips, P., Wiersinga, A., van Ginkel, F. C., Jongen, M. J., Netelenbos, J. C., Hackeng, W. H., Delmas, P. D., and van der Vijgh, W. J. The effect of vitamin D supplementation on vitamin D status and parathyroid function in elderly subjects. J Clin Endocrinol Metab 1988;67(4):644-650. View abstract.

39149

Orimo, H., Shiraki, M., Hayashi, T., and Nakamura, T. Reduced occurrence of vertebral crush fractures in senile osteoporosis treated with 1 alpha (OH)-vitamin D3. Bone Miner 1987;3(1):47-52. View abstract.

39152

Lamke, B., Sjoberg, H. E., and Sylven, M. Bone mineral content in women with Colles’ fracture: effect of calcium supplementation. Acta Orthop.Scand. 1978;49(2):143-146. View abstract.

39154

Wu, A. H., Paganini-Hill, A., Ross, R. K., and Henderson, B. E. Alcohol, physical activity and other risk factors for colorectal cancer: a prospective study. Br.J Cancer 1987;55(6):687-694. View abstract.

39155

Marya, R. K., Rathee, S., and Manrow, M. Effect of calcium and vitamin D supplementation on toxaemia of pregnancy. Gynecol Obstet Invest 1987;24(1):38-42. View abstract.

39160

van Beresteyn, E. C., Schaafsma, G., and de, Waard H. Oral calcium and blood pressure: a controlled intervention trial. Am J Clin Nutr 1986;44(6):883-888. View abstract.

39167

Sowers, M. R., Wallace, R. B., and Lemke, J. H. The association of intakes of vitamin D and calcium with blood pressure among women. Am J Clin Nutr 1985;42(1):135-142. View abstract.

39169

Hodson, E. M., Evans, R. A., Dunstan, C. R., Hills, E., Wong, S. Y., Rosenberg, A. R., and Roy, L. P. Treatment of childhood renal osteodystrophy with calcitriol or ergocalciferol. Clin Nephrol 1985;24(4):192-200. View abstract.

39171

Jensen, G. F., Meinecke, B., Boesen, J., and Transbol, I. Does 1,25(OH)2D3 accelerate spinal bone loss? A controlled therapeutic trial in 70-year-old women. Clin Orthop.Relat Res 1985;(192):215-221. View abstract.

39174

Mak, R. H., Turner, C., Thompson, T., Powell, H., Haycock, G. B., and Chantler, C. Suppression of secondary hyperparathyroidism in children with chronic renal failure by high dose phosphate binders: calcium carbonate versus aluminium hydroxide. Br.Med.J (Clin Res Ed) 9-7-1985;291(6496):623-627. View abstract.

39176

Corless, D., Dawson, E., Fraser, F., Ellis, M., Evans, S. J., Perry, J. D., Reisner, C., Silver, C. P., Beer, M., Boucher, B. J., and . Do vitamin D supplements improve the physical capabilities of elderly hospital patients? Age Ageing 1985;14(2):76-84. View abstract.

39187

Christiansen, C., Christensen, M. S., McNair, P., Hagen, C., Stocklund, K. E., and Transbol, I. Prevention of early postmenopausal bone loss: controlled 2-year study in 315 normal females. Eur.J Clin Invest 1980;10(4):273-279. View abstract.

39189

Dykman, T. R., Haralson, K. M., Gluck, O. S., Murphy, W. A., Teitelbaum, S. L., Hahn, T. J., and Hahn, B. H. Effect of oral 1,25-dihydroxyvitamin D and calcium on glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1984;27(12):1336-1343. View abstract.

39191

Inkovaara, J., Gothoni, G., Halttula, R., Heikinheimo, R., and Tokola, O. Calcium, vitamin D and anabolic steroid in treatment of aged bones: double-blind placebo-controlled long-term clinical trial. Age Ageing 1983;12(2):124-130. View abstract.

39192

Eke, F. U. and Winterborn, M. H. Effect of low dose 1 alpha-hydroxycholecalciferol on glomerular filtration rate in moderate renal failure. Arch Dis.Child 1983;58(10):810-813. View abstract.

39193

Neubauer, E., Neubauer, N., Ritz, E., Dreikorn, K., and Krause, K. H. Bone mineral content after renal transplantation. Placebo-controlled prospective study with 1,25-dihydroxy vitamin D3. Klin.Wochenschr. 1-16-1984;62(2):93-96. View abstract.

39196

Caniggia, A., Delling, G., Nuti, R., Lore, F., and Vattimo, A. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis. Acta Vitaminol.Enzymol. 1984;6(2):117-128. View abstract.

39203

Christiansen, C., Christensen, M. S., Rodbro, P., Hagen, C., and Transbol, I. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis. Eur.J Clin Invest 1981;11(4):305-309. View abstract.

39207

Jensen, G. F., Christiansen, C., and Transbol, I. Treatment of post menopausal osteoporosis. A controlled therapeutic trial comparing oestrogen/gestagen, 1,25-dihydroxy-vitamin D3 and calcium. Clin Endocrinol (Oxf) 1982;16(5):515-524. View abstract.

39214

Prince, R., Devine, A., Dick, I., Criddle, A., Kerr, D., Kent, N., Price, R., and Randell, A. The effects of calcium supplementation (milk powder or tablets) and exercise on bone density in postmenopausal women. J Bone Miner Res 1995;10(7):1068-1075. View abstract.

39226

Sambrook, P., Birmingham, J., Kelly, P., Kempler, S., Nguyen, T., Pocock, N., and Eisman, J. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N.Engl.J Med. 6-17-1993;328(24):1747-1752. View abstract.

39230

Reid, I. R., Ames, R. W., Evans, M. C., Gamble, G. D., and Sharpe, S. J. Long-term effects of calcium supplementation on bone loss and fractures in postmenopausal women: a randomized controlled trial. Am J Med. 1995;98(4):331-335. View abstract.

39231

Ooms, M. E., Roos, J. C., Bezemer, P. D., van der Vijgh, W. J., Bouter, L. M., and Lips, P. Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial. J Clin Endocrinol Metab 1995;80(4):1052-1058. View abstract.

39234

Dickersin, K., Scherer, R., and Lefebvre, C. Identifying relevant studies for systematic reviews. BMJ 11-12-1994;309(6964):1286-1291. View abstract.

39236

Dawson-Hughes, B., Harris, S. S., Krall, E. A., Dallal, G. E., Falconer, G., and Green, C. L. Rates of bone loss in postmenopausal women randomly assigned to one of two dosages of vitamin D. Am J Clin Nutr 1995;61(5):1140-1145. View abstract.

39241

Chevalley, T., Rizzoli, R., Nydegger, V., Slosman, D., Rapin, C. H., Michel, J. P., Vasey, H., and Bonjour, J. P. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-replete elderly patients. Osteoporos.Int 1994;4(5):245-252. View abstract.

39249

Jones, C. L., Vieth, R., Spino, M., Ledermann, S., Kooh, S. W., Balfe, J., and Balfe, J. W. Comparisons between oral and intraperitoneal 1,25-dihydroxyvitamin D3 therapy in children treated with peritoneal dialysis. Clin Nephrol 1994;42(1):44-49. View abstract.

39259

Warady, B. D., Lindsley, C. B., Robinson, F. G., and Lukert, B. P. Effects of nutritional supplementation on bone mineral status of children with rheumatic diseases receiving corticosteroid therapy. J Rheumatol. 1994;21(3):530-535. View abstract.

39263

Orimo, H., Shiraki, M., Hayashi, Y., Hoshino, T., Onaya, T., Miyazaki, S., Kurosawa, H., Nakamura, T., and Ogawa, N. Effects of 1 alpha-hydroxyvitamin D3 on lumbar bone mineral density and vertebral fractures in patients with postmenopausal osteoporosis. Calcif Tissue Int 1994;54(5):370-376. View abstract.

39269

Zeghoud, F., Ben-Mekhbi, H., Djeghri, N., and Garabedian, M. Vitamin D prophylaxis during infancy: comparison of the long-term effects of three intermittent doses (15, 5, or 2.5 mg) on 25-hydroxyvitamin D concentrations. Am J Clin Nutr 1994;60(3):393-396. View abstract.

39277

Menczel, J., Foldes, J., Steinberg, R., Leichter, I., Shalita, B., Bdolah-Abram, T., Kadosh, S., Mazor, Z., and Ladkani, D. Alfacalcidol (alpha D3) and calcium in osteoporosis. Clin Orthop.Relat Res 1994;(300):241-247. View abstract.

39280

Chan, J. C., McEnery, P. T., Chinchilli, V. M., Abitbol, C. L., Boineau, F. G., Friedman, A. L., Lum, G. M., Roy, S., III, Ruley, E. J., and Strife, C. F. A prospective, double-blind study of growth failure in children with chronic renal insufficiency and the effectiveness of treatment with calcitriol versus dihydrotachysterol. The Growth Failure in Children with Renal Diseases Investigators. J Pediatr. 1994;124(4):520-528. View abstract.

39283

Chapuy, M. C., Arlot, M. E., Delmas, P. D., and Meunier, P. J. Effect of calcium and cholecalciferol treatment for three years on hip fractures in elderly women. BMJ 4-23-1994;308(6936):1081-1082. View abstract.

39284

Pan, W. H., Wang, C. Y., Li, L. A., Kao, L. S., and Yeh, S. H. No significant effect of calcium and vitamin D supplementation on blood pressure and calcium metabolism in elderly Chinese. Chin J Physiol 1993;36(2):85-94. View abstract.

39286

Aloia, J. F., Vaswani, A., Yeh, J. K., Ross, P. L., Flaster, E., and Dilmanian, F. A. Calcium supplementation with and without hormone replacement therapy to prevent postmenopausal bone loss. Ann.Intern.Med. 1-15-1994;120(2):97-103. View abstract.

39306

Reid, I. R., Ames, R. W., Evans, M. C., Gamble, G. D., and Sharpe, S. J. Effect of calcium supplementation on bone loss in postmenopausal women. N.Engl.J Med. 2-18-1993;328(7):460-464. View abstract.

39342

Lippuner, K., Haller, B., Casez, J. P., Montandon, A., and Jaeger, P. Effect of disodium monofluorophosphate, calcium and vitamin D supplementation on bone mineral density in patients chronically treated with glucocorticosteroids: a prospective, randomized, double-blind study. Miner Electrolyte Metab 1996;22(4):207-213. View abstract.

39354

Talalaj, M., Gradowska, L., Marcinowska-Suchowierska, E., Durlik, M., Gaciong, Z., and Lao, M. Efficiency of preventive treatment of glucocorticoid-induced osteoporosis with 25-hydroxyvitamin D3 and calcium in kidney transplant patients. Transplant.Proc. 1996;28(6):3485-3487. View abstract.

39355

Recker, R. R., Hinders, S., Davies, K. M., Heaney, R. P., Stegman, M. R., Lappe, J. M., and Kimmel, D. B. Correcting calcium nutritional deficiency prevents spine fractures in elderly women. J Bone Miner Res 1996;11(12):1961-1966. View abstract.

39357

Healey, J. H., Paget, S. A., Williams-Russo, P., Szatrowski, T. P., Schneider, R., Spiera, H., Mitnick, H., Ales, K., and Schwartzberg, P. A randomized controlled trial of salmon calcitonin to prevent bone loss in corticosteroid-treated temporal arteritis and polymyalgia rheumatica. Calcif Tissue Int 1996;58(2):73-80. View abstract.

39361

Shikari, M., Kushida, K., Yamazaki, K., Nagai, T., Inoue, T., and Orimo, H. Effects of 2 years’ treatment of osteoporosis with 1 alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr.J 1996;43(2):211-220. View abstract.

39364

Garcia-Delgado, I., Prieto, S., Gil-Fraguas, L., Robles, E., Rufilanchas, J. J., and Hawkins, F. Calcitonin, etidronate, and calcidiol treatment in bone loss after cardiac transplantation. Calcif Tissue Int 1997;60(2):155-159. View abstract.

39369

Sato, Y., Maruoka, H., and Oizumi, K. Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin D3 and calcium supplementation. Stroke 1997;28(4):736-739. View abstract.

39376

Chen, J. T., Shiraki, M., Hasumi, K., Tanaka, N., Katase, K., Kato, T., Hirai, Y., Nakamura, T., and Ogata, E. 1-alpha-Hydroxyvitamin D3 treatment decreases bone turnover and modulates calcium-regulating hormones in early postmenopausal women. Bone 1997;20(6):557-562. View abstract.

39388

Boutsen, Y., Jamart, J., Esselinckx, W., Stoffel, M., and Devogelaer, J. P. Primary prevention of glucocorticoid-induced osteoporosis with intermittent intravenous pamidronate: a randomized trial. Calcif Tissue Int 1997;61(4):266-271. View abstract.

39408

Saag, K. G., Emkey, R., Schnitzer, T. J., Brown, J. P., Hawkins, F., Goemaere, S., Thamsborg, G., Liberman, U. A., Delmas, P. D., Malice, M. P., Czachur, M., and Daifotis, A. G. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N.Engl.J Med. 7-30-1998;339(5):292-299. View abstract.

39410

Pitt, P., Li, F., Todd, P., Webber, D., Pack, S., and Moniz, C. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment. Thorax 1998;53(5):351-356. View abstract.

39411

Krause, R., Buhring, M., Hopfenmuller, W., Holick, M. F., and Sharma, A. M. Ultraviolet B and blood pressure. Lancet 8-29-1998;352(9129):709-710. View abstract.

39412

Salusky, I. B., Kuizon, B. D., Belin, T. R., Ramirez, J. A., Gales, B., Segre, G. V., and Goodman, W. G. Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. Kidney Int 1998;54(3):907-914. View abstract.

39418

Grotz, W. H., Rump, L. C., Niessen, A., Schmidt-Gayk, H., Reichelt, A., Kirste, G., Olschewski, M., and Schollmeyer, P. J. Treatment of osteopenia and osteoporosis after kidney transplantation. Transplantation 10-27-1998;66(8):1004-1008. View abstract.

50010

Christiansen, C., Rodbro, P., and Nielsen, C. T. Iatrogenic osteomalacia in epileptic children. A controlled therapeutic trial. Acta Paediatr.Scand 1975;64(2):219-224. View abstract.

50124

Ranganathan, L. N. and Ramaratnam, S. Vitamins for epilepsy. Cochrane.Database.Syst.Rev 2005;(2):CD004304. View abstract.

50495

Lazzeroni, M., Gandini, S., Puntoni, M., Bonanni, B., Gennari, A., and Decensi, A. The science behind vitamins and natural compounds for breast cancer prevention. Getting the most prevention out of it. Breast 2011;20 Suppl 3:S36-S41. View abstract.

50514

Marik, P. E. and Flemmer, M. Do dietary supplements have beneficial health effects in industrialized nations: what is the evidence? JPEN J.Parenter.Enteral Nutr. 2012;36(2):159-168. View abstract.

50520

Mayne, S. T., Ferrucci, L. M., and Cartmel, B. Lessons learned from randomized clinical trials of micronutrient supplementation for cancer prevention. Annu.Rev.Nutr. 8-21-2012;32:369-390. View abstract.

50538

Morse, N. L. Benefits of docosahexaenoic acid, folic acid, vitamin D and iodine on foetal and infant brain development and function following maternal supplementation during pregnancy and lactation. Nutrients. 2012;4(7):799-840. View abstract.

50540

Vargas, A. J. and Thompson, P. A. Diet and nutrient factors in colorectal cancer risk. Nutr.Clin Pract. 2012;27(5):613-623. View abstract.

50921

Henrotin, Y., Lambert, C., Couchourel, D., Ripoll, C., and Chiotelli, E. Nutraceuticals: do they represent a new era in the management of osteoarthritis? – a narrative review from the lessons taken with five products. Osteoarthritis.Cartilage. 2011;19(1):1-21. View abstract.

60414

Itsiopoulos, C., Hodge, A., and Kaimakamis, M. Can the Mediterranean diet prevent prostate cancer? Mol.Nutr.Food Res. 2009;53(2):227-239. View abstract.

61015

Hovdenak, N. and Haram, K. Influence of mineral and vitamin supplements on pregnancy outcome. Eur J Obstet.Gynecol.Reprod.Biol. 2012;164(2):127-132. View abstract.

66151

Bath-Hextall, F. J., Jenkinson, C., Humphreys, R., and Williams, H. C. Dietary supplements for established atopic eczema. Cochrane.Database.Syst.Rev. 2012;2:CD005205. View abstract.

69580

Escribano, J., Balaguer, A., Pagone, F., Feliu, A., and Roque, I. Figuls. Pharmacological interventions for preventing complications in idiopathic hypercalciuria. Cochrane.Database.Syst.Rev. 2009;(1):CD004754. View abstract.

76531

Boonen, S., Laan, R. F., Barton, I. P., and Watts, N. B. Effect of osteoporosis treatments on risk of non-vertebral fractures: review and meta-analysis of intention-to-treat studies. Osteoporos.Int. 2005;16(10):1291-1298. View abstract.

76549

Black, D. M., Delmas, P. D., Eastell, R., Reid, I. R., Boonen, S., Cauley, J. A., Cosman, F., Lakatos, P., Leung, P. C., Man, Z., Mautalen, C., Mesenbrink, P., Hu, H., Caminis, J., Tong, K., Rosario-Jansen, T., Krasnow, J., Hue, T. F., Sellmeyer, D., Eriksen, E. F., and Cummings, S. R. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. N.Engl.J.Med. 5-3-2007;356(18):1809-1822. View abstract.

77366

Avenell, A. and Handoll, H. H. Nutritional supplementation for hip fracture aftercare in the elderly. Cochrane Database Syst Rev 2000;(2):CD001880. View abstract.

77378

Avenell, A. and Handoll, H. H. Nutritional supplementation for hip fracture aftercare in the elderly. Cochrane Database Syst Rev 2000;(4):CD001880. View abstract.

77435

Avenell, A. and Handoll, H. H. Nutritional supplementation for hip fracture aftercare in the elderly. Cochrane Database Syst Rev 2004;(1):CD001880. View abstract.

77452

Avenell, A. and Handoll, H. H. Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database Syst Rev 2005;(2):CD001880. View abstract.

77484

Avenell, A. and Handoll, H. H. Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database Syst Rev 2006;(4):CD001880. View abstract.

77535

Avenell, A. and Handoll, H. H. Nutritional supplementation for hip fracture aftercare in older people. Cochrane Database Syst Rev 2010;(1):CD001880. View abstract.

82209

Giannetti, A., Coppini, M., Bertazzoni, M. G., Califano, A., Altieri, E., Pazzaglia, A., Lega, M., Lombardo, M., Pelfini, C., Veller, Fornasa C., Rabbiosi, G., and Cespa, M. Clinical trial of the efficacy and safety of oral etretinate with calcipotriol cream compared with etretinate alone in moderate-severe psoriasis. J Eur.Acad.Dermatol.Venereol. 1999;13(2):91-95. View abstract.

82297

Rim, J. H., Park, J. Y., Choe, Y. B., and Youn, J. I. The efficacy of calcipotriol + acitretin combination therapy for psoriasis: comparison with acitretin monotherapy. Am J Clin.Dermatol. 2003;4(7):507-510. View abstract.

82368

Range, N., Andersen, A. B., Magnussen, P., Mugomela, A., and Friis, H. The effect of micronutrient supplementation on treatment outcome in patients with pulmonary tuberculosis: a randomized controlled trial in Mwanza, Tanzania. Trop.Med Int Health 2005;10(9):826-832. View abstract.

82384

Nursyam, E. W., Amin, Z., and Rumende, C. M. The effect of vitamin D as supplementary treatment in patients with moderately advanced pulmonary tuberculous lesion. Acta Med Indones. 2006;38(1):3-5. View abstract.

82426

Ezquerra, G. M., Regana, M. S., and Millet, P. U. Combination of acitretin and oral calcitriol for treatment of plaque-type psoriasis. Acta Derm.Venereol. 2007;87(5):449-450. View abstract.

82475

Wejse, C., Gomes, V. F., Rabna, P., Gustafson, P., Aaby, P., Lisse, I. M., Andersen, P. L., Glerup, H., and Sodemann, M. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir.Crit Care Med 5-1-2009;179(9):843-850. View abstract.

82534

PrayGod, G., Range, N., Faurholt-Jepsen, D., Jeremiah, K., Faurholt-Jepsen, M., Aabye, M. G., Jensen, L., Jensen, A. V., Grewal, H. M., Magnussen, P., Changalucha, J., Andersen, A. B., and Friis, H. Daily multi-micronutrient supplementation during tuberculosis treatment increases weight and grip strength among HIV-uninfected but not HIV-infected patients in Mwanza, Tanzania. J Nutr 4-1-2011;141(4):685-691. View abstract.

82570

Sinclair, D., Abba, K., Grobler, L., and Sudarsanam, T. D. Nutritional supplements for people being treated for active tuberculosis. Cochrane.Database.Syst.Rev. 2011;(11):CD006086. View abstract.

82572

Bailey, E. E., Ference, E. H., Alikhan, A., Hession, M. T., and Armstrong, A. W. Combination treatments for psoriasis: a systematic review and meta-analysis. Arch.Dermatol. 2012;148(4):511-522. View abstract.

82573

Albrecht, L., Bourcier, M., Ashkenas, J., Papp, K., Shear, N., Toole, J., Vender, R., and Wasel, N. Topical psoriasis therapy in the age of biologics: evidence-based treatment recommendations. J Cutan.Med.Surg. 2011;15(6):309-321. View abstract.

82750

van de Kerkhof, P. C., Cambazard, F., Hutchinson, P. E., Haneke, E., Wong, E., Souteyrand, P., Damstra, R. J., Combemale, P., Neumann, M. H., Chalmers, R. J., Olsen, L., and Revuz, J. The effect of addition of calcipotriol ointment (50 micrograms/g) to acitretin therapy in psoriasis. Br.J Dermatol. 1998;138(1):84-89. View abstract.

82755

Morcos, M. M., Gabr, A. A., Samuel, S., Kamel, M., el, Baz M., el, Beshry M., and Michail, R. R. Vitamin D administration to tuberculous children and its value. Boll.Chim.Farm. 1998;137(5):157-164. View abstract.

82903

Etgen, T., Sander, D., Bickel, H., and Forstl, H. Mild cognitive impairment and dementia: the importance of modifiable risk factors. Dtsch.Arztebl.Int 2011;108(44):743-750. View abstract.

83385

Camargo, C. A., Jr., Rifas-Shiman, S. L., Litonjua, A. A., Rich-Edwards, J. W., Weiss, S. T., Gold, D. R., Kleinman, K., and Gillman, M. W. Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am.J Clin.Nutr 2007;85(3):788-795. View abstract.

83441

Erkkola, M., Kaila, M., Nwaru, B. I., Kronberg-Kippila, C., Ahonen, S., Nevalainen, J., Veijola, R., Pekkanen, J., Ilonen, J., Simell, O., Knip, M., and Virtanen, S. M. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin.Exp.Allergy 2009;39(6):875-882. View abstract.

83747

No author. Vitamin D supplement in early childhood and risk for Type I (insulin-dependent) diabetes mellitus. The EURODIAB Substudy 2 Study Group. Diabetologia 1999;42(1):51-54. View abstract.

83748

Elst, E. F., Van Suijlekom-Smit, L. W., and Oranje, A. P. Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children. Pediatr Dermatol 1999;16(1):53-58. View abstract.

83750

Giovannucci, E. Dietary influences of 1,25(OH)2 vitamin D in relation to prostate cancer: a hypothesis. Cancer Causes Control 1998;9(6):567-582. View abstract.

83751

Kriesel, J. D. and Spruance, J. Calcitriol (1,25-dihydroxy-vitamin D3) coadministered with influenza vaccine does not enhance humoral immunity in human volunteers. Vaccine 4-9-1999;17(15-16):1883-1888. View abstract.

83752

Kanis, J. A. and McCloskey, E. V. Effect of calcitonin on vertebral and other fractures. QJM. 1999;92(3):143-149. View abstract.

83753

Homik, J. E., Cranney, A., Shea, B., Tugwell, P., Wells, G., Adachi, J. D., and Suarez-Almazor, M. E. A metaanalysis on the use of bisphosphonates in corticosteroid induced osteoporosis. J Rheumatol 1999;26(5):1148-1157. View abstract.

83755

Lundin, A. C., Soderkvist, P., Eriksson, B., Bergman-Jungestrom, M., and Wingren, S. Association of breast cancer progression with a vitamin D receptor gene polymorphism. South-East Sweden Breast Cancer Group. Cancer Res 5-15-1999;59(10):2332-2334. View abstract.

83756

Peichl, P., Rintelen, B., Kumpan, W., and Broll, H. Increase of axial and appendicular trabecular and cortical bone density in established osteoporosis with intermittent nasal salmon calcitonin therapy. Gynecol.Endocrinol. 1999;13(1):7-14. View abstract.

83757

Thys-Jacobs, S., Donovan, D., Papadopoulos, A., Sarrel, P., and Bilezikian, J. P. Vitamin D and calcium dysregulation in the polycystic ovarian syndrome. Steroids 1999;64(6):430-435. View abstract.

83758

Khoo, B. P., Tay, Y. K., and Goh, C. L. Calcipotriol ointment vs. betamethasone 17-valerate ointment in the treatment of lichen amyloidosis. Int J Dermatol 1999;38(7):539-541. View abstract.

83759

Andjelkovic, Z., Vojinovic, J., Pejnovic, N., Popovic, M., Dujic, A., Mitrovic, D., Pavlica, L., and Stefanovic, D. Disease modifying and immunomodulatory effects of high dose 1 alpha (OH) D3 in rheumatoid arthritis patients. Clin Exp.Rheumatol 1999;17(4):453-456. View abstract.

83760

Barker, J. N., Ashton, R. E., Marks, R., Harris, R. I., and Berth-Jones, J. Topical maxacalcitol for the treatment of psoriasis vulgaris: a placebo-controlled, double-blind, dose-finding study with active comparator. Br J Dermatol 1999;141(2):274-278. View abstract.

83761

Parsad, D., Saini, R., and Nagpal, R. Calcipotriol in vitiligo: a preliminary study. Pediatr Dermatol 1999;16(4):317-320. View abstract.

83762

Sato, Y., Kuno, H., Asoh, T., Honda, Y., and Oizumi, K. Effect of immobilization on vitamin D status and bone mass in chronically hospitalized disabled stroke patients. Age Ageing 1999;28(3):265-269. View abstract.

83763

Stempfle, H. U., Werner, C., Echtler, S., Wehr, U., Rambeck, W. A., Siebert, U., Uberfuhr, P., Angermann, C. E., Theisen, K., and Gartner, R. Prevention of osteoporosis after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 8-27-1999;68(4):523-530. View abstract.

83764

Ringe, J. D., Coster, A., Meng, T., Schacht, E., and Umbach, R. Treatment of glucocorticoid-induced osteoporosis with alfacalcidol/calcium versus vitamin D/calcium. Calcif.Tissue Int 1999;65(4):337-340. View abstract.

83765

Molin, L. Topical calcipotriol combined with phototherapy for psoriasis. The results of two randomized trials and a review of the literature. Calcipotriol-UVB Study Group. Dermatology 1999;198(4):375-381. View abstract.

83773

Caca-Biljanovska, N. G., Vlckova-Laskoska, M. T., Dervendi, D. V., Pesic, N. P., and Laskoski, D. S. Treatment of generalized morphea with oral 1,25-dihydroxyvitamin D3. Adv.Exp.Med Biol. 1999;455:299-304. View abstract.

83776

Ramsay, C. A., Schwartz, B. E., Lowson, D., Papp, K., Bolduc, A., and Gilbert, M. Calcipotriol cream combined with twice weekly broad-band UVB phototherapy: a safe, effective and UVB-sparing antipsoriatric combination treatment. The Canadian Calcipotriol and UVB Study Group. Dermatology 2000;200(1):17-24. View abstract.

83780

Ashcroft, D. M., Po, A. L., Williams, H. C., and Griffiths, C. E. Systematic review of comparative efficacy and tolerability of calcipotriol in treating chronic plaque psoriasis. BMJ 4-8-2000;320(7240):963-967. View abstract.

83781

Khajehdehi, P. Effect of vitamins on the lipid profile of patients on regular hemodialysis. Scand.J Urol.Nephrol. 2000;34(1):62-66. View abstract.

83783

Lakatos, P., Nagy, Z., Kiss, L., Horvath, C., Takacs, I., Foldes, J., Speer, G., and Bossanyi, A. Prevention of corticosteroid-induced osteoporosis by alfacalcidol. Z Rheumatol 2000;59 Suppl 1:48-52. View abstract.

83784

Dequeker, J., Borghs, H., Van, Cleemput J., Nevens, F., Verleden, G., and Nijs, J. Transplantation osteoporosis and corticosteroid-induced osteoporosis in autoimmune diseases: experience with alfacalcidol. Z.Rheumatol. 2000;59 Suppl 1:53-57. View abstract.

83787

Cranney, A., Welch, V., Adachi, J. D., Homik, J., Shea, B., Suarez-Almazor, M. E., Tugwell, P., and Wells, G. Calcitonin for the treatment and prevention of corticosteroid-induced osteoporosis. Cochrane Database Syst Rev 2000;(2):CD001983. View abstract.

83789

Wong, S. S. and Goh, C. L. Double-blind, right/left comparison of calcipotriol ointment and betamethasone ointment in the treatment of Prurigo nodularis. Arch Dermatol 2000;136(6):807-808. View abstract.

83790

Jekovec-Vrhovsek, M., Kocijancic, A., and Prezelj, J. Effect of vitamin D and calcium on bone mineral density in children with CP and epilepsy in full-time care. Dev.Med Child Neurol. 2000;42(6):403-405. View abstract.

83791

Gloth, F. M., III, Alam, W., and Hollis, B. Vitamin D vs broad spectrum phototherapy in the treatment of seasonal affective disorder. J Nutr Health Aging 1999;3(1):5-7. View abstract.

83792

Shaw, N. J., Boivin, C. M., and Crabtree, N. J. Intravenous pamidronate in juvenile osteoporosis. Arch Dis.Child 2000;83(2):143-145. View abstract.

83793

Lambrinoudaki, I., Chan, D. T., Lau, C. S., Wong, R. W., Yeung, S. S., and Kung, A. W. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study. J Rheumatol 2000;27(7):1759-1765. View abstract.

83794

Bianda, T., Linka, A., Junga, G., Brunner, H., Steinert, H., Kiowski, W., and Schmid, C. Prevention of osteoporosis in heart transplant recipients: a comparison of calcitriol with calcitonin and pamidronate. Calcif.Tissue Int 2000;67(2):116-121. View abstract.

83796

Schaafsma, A., Muskiet, F. A., Storm, H., Hofstede, G. J., Pakan, I., and Van, der, V. Vitamin D(3) and vitamin K(1) supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. Eur J Clin Nutr 2000;54(8):626-631. View abstract.

83797

Thacher, T. D., Fischer, P. R., Pettifor, J. M., Lawson, J. O., Isichei, C. O., and Chan, G. M. Case-control study of factors associated with nutritional rickets in Nigerian children. J Pediatr 2000;137(3):367-373. View abstract.

83800

Bianchi, M. L., Cimaz, R., Bardare, M., Zulian, F., Lepore, L., Boncompagni, A., Galbiati, E., Corona, F., Luisetto, G., Giuntini, D., Picco, P., Brandi, M. L., and Falcini, F. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. Arthritis Rheum. 2000;43(9):1960-1966. View abstract.

83801

Goldman, B. D. Common dermatoses of the male genitalia. Recognition of differences in genital rashes and lesions is essential and attainable. Postgrad.Med. 9-15-2000;108(4):89-6. View abstract.

83802

Stene, L. C., Ulriksen, J., Magnus, P., and Joner, G. Use of cod liver oil during pregnancy associated with lower risk of Type I diabetes in the offspring. Diabetologia 2000;43(9):1093-1098. View abstract.

83805

Hutchinson, P. E., Marks, R., and White, J. The efficacy, safety and tolerance of calcitriol 3 microg/g ointment in the treatment of plaque psoriasis: a comparison with short-contact dithranol. Dermatology 2000;201(2):139-145. View abstract.

83809

Hunter, D., Major, P., Arden, N., Swaminathan, R., Andrew, T., MacGregor, A. J., Keen, R., Snieder, H., and Spector, T. D. A randomized controlled trial of vitamin D supplementation on preventing postmenopausal bone loss and modifying bone metabolism using identical twin pairs. J Bone Miner.Res 2000;15(11):2276-2283. View abstract.

83810

Hulshof, M. M., Bouwes Bavinck, J. N., Bergman, W., Masclee, A. A., Heickendorff, L., Breedveld, F. C., and Dijkmans, B. A. Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol 2000;43(6):1017-1023. View abstract.

83811

Ashcroft, D. M., Li Wan, Po A., Williams, H. C., and Griffiths, C. E. Combination regimens of topical calcipotriene in chronic plaque psoriasis: systematic review of efficacy and tolerability. Arch Dermatol 2000;136(12):1536-1543. View abstract.

83813

Salmhofer, W., Maier, H., Soyer, H. P., Honigsmann, H., and Hodl, S. Double-blind, placebo-controlled, randomized, right-left study comparing calcipotriol monotherapy with a combined treatment of calcipotriol and diflucortolone valerate in chronic plaque psoriasis. Acta Derm.Venereol.Suppl (Stockh) 2000;(211):5-8. View abstract.

83814

Ring, J., Kowalzick, L., Christophers, E., Schill, W. B., Schopf, E., Stander, M., Wolff, H. H., and Altmeyer, P. Calcitriol 3 microg g-1 ointment in combination with ultraviolet B phototherapy for the treatment of plaque psoriasis: results of a comparative study. Br.J Dermatol. 2001;144(3):495-499. View abstract.

83815

Durakovic, C., Malabanan, A., and Holick, M. F. Rationale for use and clinical responsiveness of hexafluoro-1,25-dihydroxyvitamin D3 for the treatment of plaque psoriasis: a pilot study. Br J Dermatol 2001;144(3):500-506. View abstract.

83816

Messer, G., Degitz, K., Plewig, G., and Rocken, M. Pretreatment of psoriasis with the vitamin D3 derivative tacalcitol increases the responsiveness to 311-nm ultraviolet B: results of a controlled, right/left study. Br.J Dermatol. 2001;144(3):628-629. View abstract.

83818

Kovac, D., Lindic, J., Kandus, A., and Bren, A. F. Prevention of bone loss in kidney graft recipients. Transplant.Proc 2001;33(1-2):1144-1145. View abstract.

83820

Cranney, A., Guyatt, G., Krolicki, N., Welch, V., Griffith, L., Adachi, J. D., Shea, B., Tugwell, P., and Wells, G. A meta-analysis of etidronate for the treatment of postmenopausal osteoporosis. Osteoporos Int 2001;12(2):140-151. View abstract.

83822

Torgerson, D. J. and Bell-Syer, S. E. Hormone replacement therapy and prevention of nonvertebral fractures: a meta-analysis of randomized trials. JAMA 6-13-2001;285(22):2891-2897. View abstract.

83823

Patel, R., Collins, D., Bullock, S., Swaminathan, R., Blake, G. M., and Fogelman, I. The effect of season and vitamin D supplementation on bone mineral density in healthy women: a double-masked crossover study. Osteoporos Int 2001;12(4):319-325. View abstract.

83824

Myers, G. O. A college founded on the needs of physicians. Md State Med.J 1975;24(6):48-49. View abstract.

83826

Langner, A., Stapor, W., and Ambroziak, M. Efficacy and tolerance of topical calcitriol 3 microg g(-1) in psoriasis treatment: a review of our experience in Poland. Br J Dermatol 2001;144 Suppl 58:11-16. View abstract.

83828

Chandra, R. K. Effect of vitamin and trace-element supplementation on cognitive function in elderly subjects. Nutrition 2001;17(9):709-712. View abstract.

83829

Ermis, O., Alpsoy, E., Cetin, L., and Yilmaz, E. Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study. Br J Dermatol 2001;145(3):472-475. View abstract.

83830

Lau, E. M., Woo, J., Lam, V., and Hong, A. Milk supplementation of the diet of postmenopausal Chinese women on a low calcium intake retards bone loss. J Bone Miner.Res 2001;16(9):1704-1709. View abstract.

83831

Melin, A., Wilske, J., Ringertz, H., and Saaf, M. Seasonal variations in serum levels of 25-hydroxyvitamin D and parathyroid hormone but no detectable change in femoral neck bone density in an older population with regular outdoor exposure. J Am Geriatr Soc 2001;49(9):1190-1196. View abstract.

83832

Moe, S. M., Zekonis, M., Harezlak, J., Ambrosius, W. T., Gassensmith, C. M., Murphy, C. L., Russell, R. R., and Batiuk, T. D. A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol. Am J Kidney Dis. 2001;38(4):792-802. View abstract.

83833

Cranney, A., Welch, V., Adachi, J. D., Guyatt, G., Krolicki, N., Griffith, L., Shea, B., Tugwell, P., and Wells, G. Etidronate for treating and preventing postmenopausal osteoporosis. Cochrane Database Syst Rev 2001;(4):CD003376. View abstract.

83835

Guzel, R., Kozanoglu, E., Guler-Uysal, F., Soyupak, S., and Sarpel, T. Vitamin D status and bone mineral density of veiled and unveiled Turkish women. J Womens Health Gend.Based Med 2001;10(8):765-770. View abstract.

83836

Guillemant, J., Le, H. T., Maria, A., Allemandou, A., Peres, G., and Guillemant, S. Wintertime vitamin D deficiency in male adolescents: effect on parathyroid function and response to vitamin D3 supplements. Osteoporos Int 2001;12(10):875-879. View abstract.

83837

Torgerson, D. J. and Bell-Syer, S. E. Hormone replacement therapy and prevention of vertebral fractures: a meta-analysis of randomised trials. BMC.Musculoskelet.Disord 2001;2:7. View abstract.

83838

Holt, P. R., Arber, N., Halmos, B., Forde, K., Kissileff, H., McGlynn, K. A., Moss, S. F., Kurihara, N., Fan, K., Yang, K., and Lipkin, M. Colonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D. Cancer Epidemiol.Biomarkers Prev. 2002;11(1):113-119. View abstract.

83840

Reid, I. R., Brown, J. P., Burckhardt, P., Horowitz, Z., Richardson, P., Trechsel, U., Widmer, A., Devogelaer, J. P., Kaufman, J. M., Jaeger, P., Body, J. J., Brandi, M. L., Broell, J., Di, Micco R., Genazzani, A. R., Felsenberg, D., Happ, J., Hooper, M. J., Ittner, J., Leb, G., Mallmin, H., Murray, T., Ortolani, S., Rubinacci, A., Saaf, M., Samsioe, G., Verbruggen, L., and Meunier, P. J. Intravenous zoledronic acid in postmenopausal women with low bone mineral density. N.Engl.J Med 2-28-2002;346(9):653-661. View abstract.

83842

Stempfle, H. U., Werner, C., Siebert, U., Assum, T., Wehr, U., Rambeck, W. A., Meiser, B., Theisen, K., and Gartner, R. The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. Transplantation 2-27-2002;73(4):547-552. View abstract.

83843

Holm, E. A. and Jemec, G. B. The therapeutic potential of calcipotriol in diseases other than psoriasis. Int J Dermatol 2002;41(1):38-43. View abstract.

83844

Mason, J., Mason, A. R., and Cork, M. J. Topical preparations for the treatment of psoriasis: a systematic review. Br J Dermatol 2002;146(3):351-364. View abstract.

83846

Dhesi, J. K., Bearne, L. M., Moniz, C., Hurley, M. V., Jackson, S. H., Swift, C. G., and Allain, T. J. Neuromuscular and psychomotor function in elderly subjects who fall and the relationship with vitamin D status. J Bone Miner.Res 2002;17(5):891-897. View abstract.

83847

Martinez, M. E., Marshall, J. R., Sampliner, R., Wilkinson, J., and Alberts, D. S. Calcium, vitamin D, and risk of adenoma recurrence (United States). Cancer Causes Control 2002;13(3):213-220. View abstract.

83848

Deroisy, R., Collette, J., Albert, A., Jupsin, I., and Reginster, J. Y. Administration of a supplement containing both calcium and vitamin D is more effective than calcium alone to reduce secondary hyperparathyroidism in postmenopausal women with low 25(OH)vitamin D circulating levels. Aging Clin Exp.Res 2002;14(1):13-17. View abstract.

83849

Verreault, R., Semba, R. D., Volpato, S., Ferrucci, L., Fried, L. P., and Guralnik, J. M. Low serum vitamin d does not predict new disability or loss of muscle strength in older women. J Am Geriatr Soc 2002;50(5):912-917. View abstract.

83850

Jensen, C., Holloway, L., Block, G., Spiller, G., Gildengorin, G., Gunderson, E., Butterfield, G., and Marcus, R. Long-term effects of nutrient intervention on markers of bone remodeling and calciotropic hormones in late-postmenopausal women. Am J Clin Nutr 2002;75(6):1114-1120. View abstract.

83851

van de Kerkhof, P. C., Green, C., Hamberg, K. J., Hutchinson, P. E., Jensen, J. K., Kidson, P., Kragballe, K., Larsen, F. G., Munro, C. S., and Tillman, D. M. Safety and efficacy of combined high-dose treatment with calcipotriol ointment and solution in patients with psoriasis. Dermatology 2002;204(3):214-221. View abstract.

83852

Chiaverini, C., Passeron, T., and Ortonne, J. P. Treatment of vitiligo by topical calcipotriol. J Eur Acad Dermatol Venereol. 2002;16(2):137-138. View abstract.

83854

Douglas, W. S., Poulin, Y., Decroix, J., Ortonne, J. P., Mrowietz, U., Gulliver, W., Krogstad, A. L., Larsen, F. G., Iglesias, L., Buckley, C., and Bibby, A. J. A new calcipotriol/betamethasone formulation with rapid onset of action was superior to monotherapy with betamethasone dipropionate or calcipotriol in psoriasis vulgaris. Acta Derm.Venereol. 2002;82(2):131-135. View abstract.

83855

Erem, C., Tanakol, R., Alagol, F., Omer, B., and Cetin, O. Relationship of bone turnover parameters, endogenous hormones and vit D deficiency to hip fracture in elderly postmenopausal women. Int J Clin Pract. 2002;56(5):333-337. View abstract.

83856

Gollnick, H., Altmeyer, P., Kaufmann, R., Ring, J., Christophers, E., Pavel, S., and Ziegler, J. Topical calcipotriol plus oral fumaric acid is more effective and faster acting than oral fumaric acid monotherapy in the treatment of severe chronic plaque psoriasis vulgaris. Dermatology 2002;205(1):46-53. View abstract.

83857

Harris, S. S. and Dawson-Hughes, B. Plasma vitamin D and 25OHD responses of young and old men to supplementation with vitamin D3. J Am Coll Nutr 2002;21(4):357-362. View abstract.

83858

Guenther, L., van de Kerkhof, P. C., Snellman, E., Kragballe, K., Chu, A. C., Tegner, E., Garcia-Diez, A., and Springborg, J. Efficacy and safety of a new combination of calcipotriol and betamethasone dipropionate (once or twice daily) compared to calcipotriol (twice daily) in the treatment of psoriasis vulgaris: a randomized, double-blind, vehicle-controlled clinical trial. Br J Dermatol 2002;147(2):316-323. View abstract.

83859

Buechner, S. A. Common skin disorders of the penis. BJU.Int 2002;90(5):498-506. View abstract.

83860

Cimaz, R., Gattorno, M., Sormani, M. P., Falcini, F., Zulian, F., Lepore, L., Bardare, M., Chiesa, S., Corona, F., Dubini, A., Lenhardt, A., Martini, G., Masi, L., and Bianchi, M. L. Changes in markers of bone turnover and inflammatory variables during alendronate therapy in pediatric patients with rheumatic diseases. J Rheumatol 2002;29(8):1786-1792. View abstract.

83861

Datta, S., Alfaham, M., Davies, D. P., Dunstan, F., Woodhead, S., Evans, J., and Richards, B. Vitamin D deficiency in pregnant women from a non-European ethnic minority population–an interventional study. BJOG. 2002;109(8):905-908. View abstract.

83862

Rim, J. H., Choe, Y. B., and Youn, J. I. Positive effect of using calcipotriol ointment with narrow-band ultraviolet B phototherapy in psoriatic patients. Photodermatol.Photoimmunol.Photomed. 2002;18(3):131-134. View abstract.

83863

Monastirli, A., Georgiou, S., Pasmatzi, E., Sakkis, T., Badavanis, G., Drainas, D., Sagriotis, A., and Tsambaos, D. Calcipotriol plus short-contact dithranol: a novel topical combination therapy for chronic plaque psoriasis. Skin Pharmacol.Appl.Skin Physiol 2002;15(4):246-251. View abstract.

83865

Sentongo, T. A., Semaeo, E. J., Stettler, N., Piccoli, D. A., Stallings, V. A., and Zemel, B. S. Vitamin D status in children, adolescents, and young adults with Crohn disease. Am J Clin Nutr 2002;76(5):1077-1081. View abstract.

83866

Kaufmann, R., Bibby, A. J., Bissonnette, R., Cambazard, F., Chu, A. C., Decroix, J., Douglas, W. S., Lowson, D., Mascaro, J. M., Murphy, G. M., and Stymne, B. A new calcipotriol/betamethasone dipropionate formulation (Daivobet) is an effective once-daily treatment for psoriasis vulgaris. Dermatology 2002;205(4):389-393. View abstract.

83867

Lehtonen-Veromaa, M. K., Mottonen, T. T., Nuotio, I. O., Irjala, K. M., Leino, A. E., and Viikari, J. S. Vitamin D and attainment of peak bone mass among peripubertal Finnish girls: a 3-y prospective study. Am J Clin Nutr 2002;76(6):1446-1453. View abstract.

83869

Smith, M. R. Osteoporosis and other adverse body composition changes during androgen deprivation therapy for prostate cancer. Cancer Metastasis Rev. 2002;21(2):159-166. View abstract.

83870

Bellantone, R., Lombardi, C. P., Raffaelli, M., Boscherini, M., Alesina, P. F., De, Crea C., Traini, E., and Princi, P. Is routine supplementation therapy (calcium and vitamin D) useful after total thyroidectomy? Surgery 2002;132(6):1109-1112. View abstract.

83871

Berruti, A., Tucci, M., Terrone, C., Gorzegno, G., Scarpa, R. M., Angeli, A., and Dogliotti, L. Background to and management of treatment-related bone loss in prostate cancer. Drugs Aging 2002;19(12):899-910. View abstract.

83872

Heaney, R. P., Davies, K. M., Chen, T. C., Holick, M. F., and Barger-Lux, M. J. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77(1):204-210. View abstract.

83874

Papp, K. A., Guenther, L., Boyden, B., Larsen, F. G., Harvima, R. J., Guilhou, J. J., Kaufmann, R., Rogers, S., van de Kerkhof, P. C., Hanssen, L. I., Tegner, E., Burg, G., Talbot, D., and Chu, A. Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol 2003;48(1):48-54. View abstract.

83875

Xu, Y., Shibata, A., McNeal, J. E., Stamey, T. A., Feldman, D., and Peehl, D. M. Vitamin D receptor start codon polymorphism (FokI) and prostate cancer progression. Cancer Epidemiol Biomarkers Prev. 2003;12(1):23-27. View abstract.

83876

Smith, M. R. Diagnosis and management of treatment-related osteoporosis in men with prostate carcinoma. Cancer 2-1-2003;97(3 Suppl):789-795. View abstract.

83877

de Jong, E. M., Mork, N. J., Seijger, M. M., De La Brassine, M., Lauharanta, J., Jansen, C. T., Guilhou, J. J., Guillot, B., Ostrojic, A., Souteyrand, P., Vaillant, L., Barnes, L., Rogers, S., Klaber, M. R., and van de Kerkhof, P. C. The combination of calcipotriol and methotrexate compared with methotrexate and vehicle in psoriasis: results of a multicentre placebo-controlled randomized trial. Br J Dermatol 2003;148(2):318-325. View abstract.

83878

Ortonne, J. P., Humbert, P., Nicolas, J. F., Tsankov, N., Tonev, S. D., Janin, A., Czernielewski, J., Lahfa, M., and Dubertret, L. Intra-individual comparison of the cutaneous safety and efficacy of calcitriol 3 microg g(-1) ointment and calcipotriol 50 microg g(-1) ointment on chronic plaque psoriasis localized in facial, hairline, retroauricular or flexural areas. Br J Dermatol 2003;148(2):326-333. View abstract.

83879

del, Puente A., Esposito, A., Savastano, S., Carpinelli, A., Postiglione, L., and Oriente, P. Dietary calcium intake and serum vitamin D are major determinants of bone mass variations in women. A longitudinal study. Aging Clin Exp.Res 2002;14(5):382-388. View abstract.

83883

Bruner, C. R., Feldman, S. R., Ventrapragada, M., and Fleischer, A. B., Jr. A systematic review of adverse effects associated with topical treatments for psoriasis. Dermatol Online.J 2003;9(1):2. View abstract.

83885

Achiron, A., Barak, Y., Miron, S., Izhak, Y., Faibel, M., and Edelstein, S. Alfacalcidol treatment in multiple sclerosis. Clin.Neuropharmacol. 2003;26(2):53. View abstract.

83886

Khajehdehi, P. and Taheri, S. Effect of oral calcitriol pulse therapy on the lipid, calcium, and glucose homeostasis of hemodialysis-patients: its safety in a combination with oral calcium carbonate. J Ren Nutr 2003;13(2):78-83. View abstract.

83888

Baysal, V., Yildirim, M., Erel, A., and Kesici, D. Is the combination of calcipotriol and PUVA effective in vitiligo? J Eur.Acad.Dermatol.Venereol. 2003;17(3):299-302. View abstract.

83889

Ringe, J. D., Dorst, A., Faber, H., Ibach, K., and Preuss, J. Three-monthly ibandronate bolus injection offers favourable tolerability and sustained efficacy advantage over two years in established corticosteroid-induced osteoporosis. Rheumatology.(Oxford) 2003;42(6):743-749. View abstract.

83890

Sambrook, P. N., Kotowicz, M., Nash, P., Styles, C. B., Naganathan, V., Henderson-Briffa, K. N., Eisman, J. A., and Nicholson, G. C. Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. J Bone Miner.Res 2003;18(5):919-924. View abstract.

83895

Smith, M. R., Eastham, J., Gleason, D. M., Shasha, D., Tchekmedyian, S., and Zinner, N. Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer. J Urol. 2003;169(6):2008-2012. View abstract.

83897

Noguera, A., Ros, J. B., Pavia, C., Alcover, E., Valls, C., Villaronga, M., and Gonzalez, E. Bisphosphonates, a new treatment for glucocorticoid-induced osteoporosis in children. J Pediatr Endocrinol.Metab 2003;16(4):529-536. View abstract.

83898

Borissova, A. M., Tankova, T., Kirilov, G., Dakovska, L., and Kovacheva, R. The effect of vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract. 2003;57(4):258-261. View abstract.

83900

Mirzaei, S., Zajicek, H. K., Knoll, P., Hahn, M., Levi, M., Kohn, H., and Pohl, W. Effect of rocaltrol on bone mass in patients with pulmonary disease treated with corticosteroids. J Asthma 2003;40(3):251-255. View abstract.

83901

Chlebna-Sokol, D., Blaszczyk, A., Rusinska, A., and Loba-Jakubowska, E. [Treatment of osteoporosis and osteopenia in children–own experience]. Przegl.Lek. 2003;60(1):5-11. View abstract.

83902

Hayes, C. E., Nashold, F. E., Spach, K. M., and Pedersen, L. B. The immunological functions of the vitamin D endocrine system. Cell Mol.Biol.(Noisy.-le-grand) 2003;49(2):277-300. View abstract.

83904

Latham, N. K., Anderson, C. S., and Reid, I. R. Effects of vitamin D supplementation on strength, physical performance, and falls in older persons: a systematic review. J Am Geriatr Soc 2003;51(9):1219-1226. View abstract.

83907

Gandrud, L. M., Cheung, J. C., Daniels, M. W., and Bachrach, L. K. Low-dose intravenous pamidronate reduces fractures in childhood osteoporosis. J Pediatr Endocrinol.Metab 2003;16(6):887-892. View abstract.

83908

Katoh, N. and Kishimoto, S. Combination of calcipotriol and clobetasol propionate as a premixed ointment for the treatment of psoriasis. Eur.J Dermatol. 2003;13(4):382-384. View abstract.

83910

Myrup, B., Jensen, G. F., and McNair, P. Cardiovascular risk factors during estrogen-norethindrone and cholecalciferol treatment. Arch Intern Med 1992;152(11):2265-2268. View abstract.

83911

Jekler, J. and Swanbeck, G. One-minute dithranol therapy in psoriasis: a placebo-controlled paired comparative study. Acta Derm.Venereol. 1992;72(6):449-450. View abstract.

83914

Berth-Jones, J., Chu, A. C., Dodd, W. A., Ganpule, M., Griffiths, W. A., Haydey, R. P., Klaber, M. R., Murray, S. J., Rogers, S., and Jurgensen, H. J. A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasis. Br J Dermatol 1992;127(3):266-271. View abstract.

83916

MacDonald, D., Lau, E., Chan, E. L., Mak, T., Woo, J., Leung, P. C., and Swaminathan, R. Serum intact parathyroid hormone levels in elderly Chinese females with hip fracture. Calcif.Tissue Int 1992;51(6):412-414. View abstract.

83922

Ebeling, P. R. and Russell, R. G. Teriparatide (rhPTH 1-34) for the treatment of osteoporosis. Int J Clin.Pract. 2003;57(8):710-718. View abstract.

83923

Fronczak, C. M., Baron, A. E., Chase, H. P., Ross, C., Brady, H. L., Hoffman, M., Eisenbarth, G. S., Rewers, M., and Norris, J. M. In utero dietary exposures and risk of islet autoimmunity in children. Diabetes Care 2003;26(12):3237-3242. View abstract.

83924

Bartram, S. A., Peaston, R. T., Rawlings, D. J., Francis, R. M., and Thompson, N. P. A randomized controlled trial of calcium with vitamin D, alone or in combination with intravenous pamidronate, for the treatment of low bone mineral density associated with Crohn’s disease. Aliment.Pharmacol Ther. 2003;18(11-12):1121-1127. View abstract.

83925

Plotnikoff, G. A. and Quigley, J. M. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin.Proc. 2003;78(12):1463-1470. View abstract.

83926

Stene, L. C. and Joner, G. Use of cod liver oil during the first year of life is associated with lower risk of childhood-onset type 1 diabetes: a large, population-based, case-control study. Am J Clin Nutr 2003;78(6):1128-1134. View abstract.

83928

Chang, S. S. Exploring the effects of luteinizing hormone-releasing hormone agonist therapy on bone health: implications in the management of prostate cancer. Urology 12-22-2003;62(6 Suppl 1):29-35. View abstract.

83933

Richy, F., Ethgen, O., Bruyere, O., and Reginster, J. Y. Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate. Osteoporos Int 2004;15(4):301-310. View abstract.

83934

Goode, L. R., Brolin, R. E., Chowdhury, H. A., and Shapses, S. A. Bone and gastric bypass surgery: effects of dietary calcium and vitamin D. Obes.Res 2004;12(1):40-47. View abstract.

83937

Dubertret, L., Wallach, D., Souteyrand, P., Perussel, M., Kalis, B., Meynadier, J., Chevrant-Breton, J., Beylot, C., Bazex, J. A., and Jurgensen, H. J. Efficacy and safety of calcipotriol (MC 903) ointment in psoriasis vulgaris. A randomized, double-blind, right/left comparative, vehicle-controlled study. J Am Acad Dermatol 1992;27(6 Pt 1):983-988. View abstract.

83938

Yeksan, M., Turk, S., Polat, M., Cigli, A., and Erdogan, Y. Effects of 1,25 (OH)2D3 treatment on lipid levels in uremic hemodialysis patients. Int J Artif.Organs 1992;15(12):704-707. View abstract.

83940

Diamond, T. H., Higano, C. S., Smith, M. R., Guise, T. A., and Singer, F. R. Osteoporosis in men with prostate carcinoma receiving androgen-deprivation therapy: recommendations for diagnosis and therapies. Cancer 3-1-2004;100(5):892-899. View abstract.

83941

Sato, Y., Kanoko, T., Yasuda, H., Satoh, K., and Iwamoto, J. Beneficial effect of etidronate therapy in immobilized hip fracture patients. Am J Phys.Med Rehabil 2004;83(4):298-303. View abstract.

83942

Rix, M., Eskildsen, P., and Olgaard, K. Effect of 18 months of treatment with alfacalcidol on bone in patients with mild to moderate chronic renal failure. Nephrol.Dial.Transplant. 2004;19(4):870-876. View abstract.

83945

Holzbeierlein, J. M., Castle, E., and Thrasher, J. B. Complications of androgen deprivation therapy: prevention and treatment. Oncology (Williston.Park) 2004;18(3):303-309. View abstract.

83947

Anderson, G. L., Limacher, M., Assaf, A. R., Bassford, T., Beresford, S. A., Black, H., Bonds, D., Brunner, R., Brzyski, R., Caan, B., Chlebowski, R., Curb, D., Gass, M., Hays, J., Heiss, G., Hendrix, S., Howard, B. V., Hsia, J., Hubbell, A., Jackson, R., Johnson, K. C., Judd, H., Kotchen, J. M., Kuller, L., LaCroix, A. Z., Lane, D., Langer, R. D., Lasser, N., Lewis, C. E., Manson, J., Margolis, K., Ockene, J., O’Sullivan, M. J., Phillips, L., Prentice, R. L., Ritenbaugh, C., Robbins, J., Rossouw, J. E., Sarto, G., Stefanick, M. L., Van, Horn L., Wactawski-Wende, J., Wallace, R., and Wassertheil-Smoller, S. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women’s Health Initiative randomized controlled trial. JAMA 4-14-2004;291(14):1701-1712. View abstract.

83951

Coburn, J. W., Maung, H. M., Elangovan, L., Germain, M. J., Lindberg, J. S., Sprague, S. M., Williams, M. E., and Bishop, C. W. Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4. Am J Kidney Dis. 2004;43(5):877-890. View abstract.

83955

de Nijs, R. N., Jacobs, J. W., Algra, A., Lems, W. F., and Bijlsma, J. W. Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies. Osteoporos Int 2004;15(8):589-602. View abstract.

83957

Nuti, R., Martini, G., Valenti, R., Gambera, D., Gennari, L., Salvadori, S., and Avanzati, A. Vitamin D status and bone turnover in women with acute hip fracture. Clin Orthop.Relat Res 2004;(422):208-213. View abstract.

83958

Kragballe, K., Noerrelund, K. L., Lui, H., Ortonne, J. P., Wozel, G., Uurasmaa, T., Fleming, C., Estebaranz, J. L., Hanssen, L. I., and Persson, L. M. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris. Br J Dermatol 2004;150(6):1167-1173. View abstract.

83959

Dukas, L., Schacht, E., Mazor, Z., and Stahelin, H. B. Treatment with alfacalcidol in elderly people significantly decreases the high risk of falls associated with a low creatinine clearance of <65 ml/min. Osteoporos.Int 2005;16(2):198-203. View abstract.

83960

Gallagher, J. C. The effects of calcitriol on falls and fractures and physical performance tests. J Steroid Biochem.Mol.Biol. 2004;89-90(1-5):497-501. View abstract.

83962

Peacey, S. R. Routine biochemistry in suspected vitamin D deficiency. J R.Soc Med 2004;97(7):322-325. View abstract.

83963

Grant, W. B. and Garland, C. F. A critical review of studies on vitamin D in relation to colorectal cancer. Nutr Cancer 2004;48(2):115-123. View abstract.

83965

Halsall, J. A., Osborne, J. E., Potter, L., Pringle, J. H., and Hutchinson, P. E. A novel polymorphism in the 1A promoter region of the vitamin D receptor is associated with altered susceptibilty and prognosis in malignant melanoma. Br.J Cancer 8-16-2004;91(4):765-770. View abstract.

83967

de Torrente de la Jara, Pecoud, A., and Favrat, B. Musculoskeletal pain in female asylum seekers and hypovitaminosis D3. BMJ 7-17-2004;329(7458):156-157. View abstract.

83968

Elliot-Gibson, V., Bogoch, E. R., Jamal, S. A., and Beaton, D. E. Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review. Osteoporos Int 2004;15(10):767-778. View abstract.

83971

Durakovic, C., Ray, S., and Holick, M. F. Topical paricalcitol (19-nor-1 alpha,25-dihydroxyvitamin D2) is a novel, safe and effective treatment for plaque psoriasis: a pilot study. Br J Dermatol 2004;151(1):190-195. View abstract.

83972

Smith, M. R., Fallon, M. A., Lee, H., and Finkelstein, J. S. Raloxifene to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer: a randomized controlled trial. J Clin.Endocrinol.Metab 2004;89(8):3841-3846. View abstract.

83973

McCullough, P. A., Sandberg, K. R., Dumler, F., and Yanez, J. E. Determinants of coronary vascular calcification in patients with chronic kidney disease and end-stage renal disease: a systematic review. J Nephrol. 2004;17(2):205-215. View abstract.

83974

Fernandes, J. L., Viana, S. L., Rocha, A. L., Ribeiro, M. C., and Castro, L. C. Biphosphonate-induced radiographic changes in two pediatric patients with rheumatic diseases. Skeletal Radiol. 2004;33(12):732-736. View abstract.

83976

Di, Monaco M., Vallero, F., Di, Monaco R., Mautino, F., and Cavanna, A. Primary hyperparathyroidism in elderly patients with hip fracture. J Bone Miner.Metab 2004;22(5):491-495. View abstract.

83980

Williams, H., Powell, I. J., Land, S. J., Sakr, W. A., Hughes, M. R., Patel, N. P., Heilbrun, L. K., and Everson, R. B. Vitamin D receptor gene polymorphisms and disease free survival after radical prostatectomy. Prostate 11-1-2004;61(3):267-275. View abstract.

83982

Papapoulos, S. E., Quandt, S. A., Liberman, U. A., Hochberg, M. C., and Thompson, D. E. Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women. Osteoporos Int 2005;16(5):468-474. View abstract.

83983

Morabito, N., Gaudio, A., Lasco, A., Catalano, A., Atteritano, M., Trifiletti, A., Anastasi, G., Melloni, D., and Frisina, N. Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer. J Bone Miner.Res 2004;19(11):1766-1770. View abstract.

83984

Ringe, J. D. Questions on the superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatol.Int 2004;24(6):370. View abstract.

83985

Dhesi, J. K., Jackson, S. H., Bearne, L. M., Moniz, C., Hurley, M. V., Swift, C. G., and Allain, T. J. Vitamin D supplementation improves neuromuscular function in older people who fall. Age Ageing 2004;33(6):589-595. View abstract.

83988

Ortonne, J. P., Kaufmann, R., Lecha, M., and Goodfield, M. Efficacy of treatment with calcipotriol/betamethasone dipropionate followed by calcipotriol alone compared with tacalcitol for the treatment of psoriasis vulgaris: a randomised, double-blind trial. Dermatology 2004;209(4):308-313. View abstract.

83991

Okada, N. [Measures for osteoporosis in the dermatological field–vitamin D3 and bisphosphonate]. Clin Calcium 2004;14(10):145-149. View abstract.

83992

Sahin, M. O., Canda, A. E., Yorukoglu, K., Mungan, M. U., Sade, M., and Kirkali, Z. 1,25 Dihydroxyvitamin D(3) receptor expression in superficial transitional cell carcinoma of the bladder: a possible prognostic factor? Eur.Urol. 2005;47(1):52-57. View abstract.

83993

Heaney, R. P. Functional indices of vitamin D status and ramifications of vitamin D deficiency. Am J Clin.Nutr 2004;80(6 Suppl):1706S-1709S. View abstract.

83998

Fenton, C. and Plosker, G. L. Calcipotriol/betamethasone dipropionate: a review of its use in the treatment of psoriasis vulgaris. Am J Clin Dermatol 2004;5(6):463-478. View abstract.

84001

Hartman, T. J., Albert, P. S., Snyder, K., Slattery, M. L., Caan, B., Paskett, E., Iber, F., Kikendall, J. W., Marshall, J., Shike, M., Weissfeld, J., Brewer, B., Schatzkin, A., and Lanza, E. The association of calcium and vitamin D with risk of colorectal adenomas. J Nutr 2005;135(2):252-259. View abstract.

84002

Acott, P. D., Wong, J. A., Lang, B. A., and Crocker, J. F. Pamidronate treatment of pediatric fracture patients on chronic steroid therapy. Pediatr Nephrol. 2005;20(3):368-373. View abstract.

84003

Richy, F., Schacht, E., Bruyere, O., Ethgen, O., Gourlay, M., and Reginster, J. Y. Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis. Calcif.Tissue Int 2005;76(3):176-186. View abstract.

84004

Rudge, S., Hailwood, S., Horne, A., Lucas, J., Wu, F., and Cundy, T. Effects of once-weekly oral alendronate on bone in children on glucocorticoid treatment. Rheumatology.(Oxford) 2005;44(6):813-818. View abstract.

84005

Schwarz, S. and Leweling, H. Multiple sclerosis and nutrition. Mult.Scler. 2005;11(1):24-32. View abstract.

84007

Trager, J. D. What’s your diagnosis? Well-demarcated vulvar erythema in two girls. J Pediatr.Adolesc.Gynecol. 2005;18(1):43-46. View abstract.

84008

Ada, S., Sahin, S., Boztepe, G., Karaduman, A., and Kolemen, F. No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo. Photodermatol.Photoimmunol.Photomed. 2005;21(2):79-83. View abstract.

84012

Kananen, K., Volin, L., Laitinen, K., Alfthan, H., Ruutu, T., and Valimaki, M. J. Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol.Metab 2005;90(7):3877-3885. View abstract.

84013

Mihara, M., Inoue, D., and Matsumoto, T. [Vitamin D and its derivatives as anti-osteoporotic drugs]. Clin Calcium 2005;15(4):597-604. View abstract.

84014

Sone, T. [Increase in bone mineral density and its effect on fracture risk]. Clin Calcium 2005;15(4):625-629. View abstract.

84015

Magno, C., Anastasi, G., Morabito, N., Gaudio, A., Maisano, D., Franchina, F., Gali, A., Frisina, N., and Melloni, D. Preventing bone loss during androgen deprivation therapy for prostate cancer: early experience with neridronate. Eur.Urol. 2005;47(5):575-580. View abstract.

84016

Cunliffe, W. J., Berth-Jones, J., Claudy, A., Fairiss, G., Goldin, D., Gratton, D., Henderson, C. A., Holden, C. A., Maddin, W. S., Ortonne, J. P., and . Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris. J Am Acad.Dermatol. 1992;26(5 Pt 1):736-743. View abstract.

84018

Boyle, M. P., Noschese, M. L., Watts, S. L., Davis, M. E., Stenner, S. E., and Lechtzin, N. Failure of high-dose ergocalciferol to correct vitamin D deficiency in adults with cystic fibrosis. Am J Respir.Crit Care Med 7-15-2005;172(2):212-217. View abstract.

84019

Moyad, M. A. Promoting general health during androgen deprivation therapy (ADT): a rapid 10-step review for your patients. Urol.Oncol. 2005;23(1):56-64. View abstract.

84022

van de Kerkhof, P. C., Wasel, N., Kragballe, K., Cambazard, F., and Murray, S. A two-compound product containing calcipotriol and betamethasone dipropionate provides rapid, effective treatment of psoriasis vulgaris regardless of baseline disease severity. Dermatology 2005;210(4):294-299. View abstract.

84025

Gulati, S., Sharma, R. K., Gulati, K., Singh, U., and Srivastava, A. Longitudinal follow-up of bone mineral density in children with nephrotic syndrome and the role of calcium and vitamin D supplements. Nephrol.Dial.Transplant. 2005;20(8):1598-1603. View abstract.

84027

Larsen, E. R., Mosekilde, L., and Foldspang, A. Vitamin D and calcium supplementation prevents severe falls in elderly community-dwelling women: a pragmatic population-based 3-year intervention study. Aging Clin Exp.Res 2005;17(2):125-132. View abstract.

84028

Gaugris, S., Heaney, R. P., Boonen, S., Kurth, H., Bentkover, J. D., and Sen, S. S. Vitamin D inadequacy among post-menopausal women: a systematic review. QJM. 2005;98(9):667-676. View abstract.

84029

Sato, Y., Iwamoto, J., Kanoko, T., and Satoh, K. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer’s disease: a randomized controlled trial. J Bone Miner.Res 2005;20(8):1327-1333. View abstract.

84030

Sawka, A. M., Papaioannou, A., Adachi, J. D., Gafni, A., Hanley, D. A., and Thabane, L. Does alendronate reduce the risk of fracture in men? A meta-analysis incorporating prior knowledge of anti-fracture efficacy in women. BMC.Musculoskelet.Disord. 2005;6:39. View abstract.

84031

Vieth, R. The role of vitamin D in the prevention of osteoporosis. Ann.Med 2005;37(4):278-285. View abstract.

84032

Avenell, A., Gillespie, W. J., Gillespie, L. D., and O’Connell, D. L. Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis. Cochrane Database Syst Rev 2005;(3):CD000227. View abstract.

84033

Mitsuhashi, Y., Kawaguchi, M., Hozumi, Y., and Kondo, S. Topical vitamin D3 is effective in treating senile warts possibly by inducing apoptosis. J Dermatol 2005;32(6):420-423. View abstract.

84034

Sato, Y., Kanoko, T., Satoh, K., and Iwamoto, J. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. Arch Intern Med 8-8-2005;165(15):1737-1742. View abstract.

84037

Sato, Y., Iwamoto, J., Kanoko, T., and Satoh, K. Low-dose vitamin D prevents muscular atrophy and reduces falls and hip fractures in women after stroke: a randomized controlled trial. Cerebrovasc.Dis. 2005;20(3):187-192. View abstract.

84040

Tartaglia, F., Giuliani, A., Sgueglia, M., Biancari, F., Juvonen, T., and Campana, F. P. Randomized study on oral administration of calcitriol to prevent symptomatic hypocalcemia after total thyroidectomy. Am J Surg 2005;190(3):424-429. View abstract.

84041

Wingerchuk, D. M., Lesaux, J., Rice, G. P., Kremenchutzky, M., and Ebers, G. C. A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J Neurol.Neurosurg.Psychiatry 2005;76(9):1294-1296. View abstract.

84043

Hartmann, A., Lurz, C., Hamm, H., Brocker, E. B., and Hofmann, U. B. Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo. Int J Dermatol. 2005;44(9):736-742. View abstract.

84044

Ringe, J. D., Faber, H., Fahramand, P., and Schacht, E. Alfacalcidol versus plain vitamin D in the treatment of glucocorticoid/inflammation-induced osteoporosis. J Rheumatol Suppl 2005;76:33-40. View abstract.

84046

Koeffler, H. P., Aslanian, N., and O’Kelly, J. Vitamin D(2) analog (Paricalcitol; Zemplar) for treatment of myelodysplastic syndrome. Leuk.Res 2005;29(11):1259-1262. View abstract.

84049

Gallacher, S. J., McQuillian, C., Harkness, M., Finlay, F., Gallagher, A. P., and Dixon, T. Prevalence of vitamin D inadequacy in Scottish adults with non-vertebral fragility fractures. Curr Med Res Opin. 2005;21(9):1355-1361. View abstract.

84050

Seeman, E., Crans, G. G., Diez-Perez, A., Pinette, K. V., and Delmas, P. D. Anti-vertebral fracture efficacy of raloxifene: a meta-analysis. Osteoporos Int 2006;17(2):313-316. View abstract.

84051

Gorham, E. D., Garland, C. F., Garland, F. C., Grant, W. B., Mohr, S. B., Lipkin, M., Newmark, H. L., Giovannucci, E., Wei, M., and Holick, M. F. Vitamin D and prevention of colorectal cancer. J Steroid Biochem.Mol.Biol. 2005;97(1-2):179-194. View abstract.

84052

Tauchmanova, L., De, Simone G., Musella, T., Orio, F., Ricci, P., Nappi, C., Lombardi, G., Colao, A., Rotoli, B., and Selleri, C. Effects of various antireabsorptive treatments on bone mineral density in hypogonadal young women after allogeneic stem cell transplantation. Bone Marrow Transplant. 2006;37(1):81-88. View abstract.

84053

Jeffcoat, M. The association between osteoporosis and oral bone loss. J Periodontol. 2005;76(11 Suppl):2125-2132. View abstract.

84054

Zisman, A. L., Ghantous, W., Schinleber, P., Roberts, L., and Sprague, S. M. Inhibition of parathyroid hormone: a dose equivalency study of paricalcitol and doxercalciferol. Am J Nephrol. 2005;25(6):591-595. View abstract.

84055

Miller, P. D., Roux, C., Boonen, S., Barton, I. P., Dunlap, L. E., and Burgio, D. E. Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials. J Bone Miner.Res 2005;20(12):2105-2115. View abstract.

84056

Poole, K. E., Loveridge, N., Barker, P. J., Halsall, D. J., Rose, C., Reeve, J., and Warburton, E. A. Reduced vitamin D in acute stroke. Stroke 2006;37(1):243-245. View abstract.

84057

Bakhtiyarova, S., Lesnyak, O., Kyznesova, N., Blankenstein, M. A., and Lips, P. Vitamin D status among patients with hip fracture and elderly control subjects in Yekaterinburg, Russia. Osteoporos Int 2006;17(3):441-446. View abstract.

84058

Obradovic, D., Gronemeyer, H., Lutz, B., and Rein, T. Cross-talk of vitamin D and glucocorticoids in hippocampal cells. J Neurochem. 2006;96(2):500-509. View abstract.

84061

Bischoff-Ferrari, H. A., Zhang, Y., Kiel, D. P., and Felson, D. T. Positive association between serum 25-hydroxyvitamin D level and bone density in osteoarthritis. Arthritis Rheum. 12-15-2005;53(6):821-826. View abstract.

84064

Holt, P. R., Bresalier, R. S., Ma, C. K., Liu, K. F., Lipkin, M., Byrd, J. C., and Yang, K. Calcium plus vitamin D alters preneoplastic features of colorectal adenomas and rectal mucosa. Cancer 1-15-2006;106(2):287-296. View abstract.

84066

Moniz, C., Dew, T., and Dixon, T. Prevalence of vitamin D inadequacy in osteoporotic hip fracture patients in London. Curr Med Res Opin. 2005;21(12):1891-1894. View abstract.

84067

Wondale, Y., Shiferaw, F., and Lulseged, S. A systematic review of nutritional rickets in Ethiopia: status and prospects. Ethiop.Med J 2005;43(3):203-210. View abstract.

84068

Pisaniello, D., Parmeggiani, D., Piatto, A., Avenia, N., d’Ajello, M., Monacelli, M., Calzolari, F., Sanguinetti, A., Parmeggiani, U., and Sperlongano, P. Which therapy to prevent post-thyroidectomy hypocalcemia? G.Chir 2005;26(10):357-361. View abstract.

84069

Bak, M., Serdaroglu, E., and Guclu, R. Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome. Pediatr.Nephrol. 2006;21(3):350-354. View abstract.

84072

Ryan, P. and Dixon, T. Prevalence of vitamin D inadequacy in patients attending a metabolic bone clinic in Medway. Curr Med Res Opin. 2006;22(1):211-216. View abstract.

84074

Coyne, D., Acharya, M., Qiu, P., Abboud, H., Batlle, D., Rosansky, S., Fadem, S., Levine, B., Williams, L., Andress, D. L., and Sprague, S. M. Paricalcitol capsule for the treatment of secondary hyperparathyroidism in stages 3 and 4 CKD. Am J Kidney Dis. 2006;47(2):263-276. View abstract.

84075

Whitton, M. E., Ashcroft, D. M., Barrett, C. W., and Gonzalez, U. Interventions for vitiligo. Cochrane Database Syst Rev 2006;(1):CD003263. View abstract.

84076

Bula, C. [Geriatrics]. Rev Med Suisse 1-4-2006;2(47):19, 21-19, 24. View abstract.

84077

Dixon, T., Mitchell, P., Beringer, T., Gallacher, S., Moniz, C., Patel, S., Pearson, G., and Ryan, P. An overview of the prevalence of 25-hydroxy-vitamin D inadequacy amongst elderly patients with or without fragility fracture in the United Kingdom. Curr Med Res Opin. 2006;22(2):405-415. View abstract.

84078

Leone, G., Pacifico, A., Iacovelli, P., Paro, Vidolin A., and Picardo, M. Tacalcitol and narrow-band phototherapy in patients with vitiligo. Clin Exp.Dermatol 2006;31(2):200-205. View abstract.

84080

Thacher, T. D., Fischer, P. R., Strand, M. A., and Pettifor, J. M. Nutritional rickets around the world: causes and future directions. Ann.Trop.Paediatr. 2006;26(1):1-16. View abstract.

84081

Wong, T. S., Lau, V. M., Lim, W., and Fung, G. A survey of vitamin D level in people with learning disability in long-stay hospital wards in Hong Kong. J Intellect.Disabil. 2006;10(1):47-59. View abstract.

84082

McClung, M. R., Lewiecki, E. M., Cohen, S. B., Bolognese, M. A., Woodson, G. C., Moffett, A. H., Peacock, M., Miller, P. D., Lederman, S. N., Chesnut, C. H., Lain, D., Kivitz, A. J., Holloway, D. L., Zhang, C., Peterson, M. C., and Bekker, P. J. Denosumab in postmenopausal women with low bone mineral density. N.Engl.J Med 2-23-2006;354(8):821-831. View abstract.

84083

Kumaran, M. S., Kaur, I., and Kumar, B. Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo. J Eur Acad Dermatol Venereol. 2006;20(3):269-273. View abstract.

84085

Bischoff-Ferrari, H. A., Conzelmann, M., Stahelin, H. B., Dick, W., Carpenter, M. G., Adkin, A. L., Theiler, R., Pfeifer, M., and Allum, J. H. Is fall prevention by vitamin D mediated by a change in postural or dynamic balance? Osteoporos Int 2006;17(5):656-663. View abstract.

84086

Nguyen, N. D., Eisman, J. A., and Nguyen, T. V. Anti-hip fracture efficacy of biophosphonates: a Bayesian analysis of clinical trials. J Bone Miner.Res 2006;21(2):340-349. View abstract.

84087

Sato, Y., Iwamoto, J., Kanoko, T., and Satoh, K. Alendronate and vitamin D2 for prevention of hip fracture in Parkinson’s disease: a randomized controlled trial. Mov Disord 2006;21(7):924-929. View abstract.

84090

Giangregorio, L., Papaioannou, A., Cranney, A., Zytaruk, N., and Adachi, J. D. Fragility fractures and the osteoporosis care gap: an international phenomenon. Semin.Arthritis Rheum. 2006;35(5):293-305. View abstract.

84091

Holzbeierlein, J. M. Managing complications of androgen deprivation therapy for prostate cancer. Urol.Clin.North Am 2006;33(2):181-90, vi. View abstract.

84092

Bonnick, S., Saag, K. G., Kiel, D. P., McClung, M., Hochberg, M., Burnett, S. M., Sebba, A., Kagan, R., Chen, E., Thompson, D. E., and de Papp, A. E. Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years. J Clin Endocrinol.Metab 2006;91(7):2631-2637. View abstract.

84093

Mannion, C. A., Gray-Donald, K., and Koski, K. G. Association of low intake of milk and vitamin D during pregnancy with decreased birth weight. CMAJ. 4-25-2006;174(9):1273-1277. View abstract.

84094

Snijder, M. B., van Schoor, N. M., Pluijm, S. M., Van Dam, R. M., Visser, M., and Lips, P. Vitamin D status in relation to one-year risk of recurrent falling in older men and women. J Clin.Endocrinol.Metab 2006;91(8):2980-2985. View abstract.

84095

Arca, E., Tastan, H. B., Erbil, A. H., Sezer, E., Koc, E., and Kurumlu, Z. Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo. J Dermatol 2006;33(5):338-343. View abstract.

84097

Kragballe, K., Gjertsen, B. T., De, Hoop D., Karlsmark, T., van de Kerkhof, P. C., Larko, O., Nieboer, C., Roed-Petersen, J., Strand, A., and Tikjob, G. Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris. Lancet 1-26-1991;337(8735):193-196. View abstract.

84098

Matkovics, A. [Recent changes in concepts of antioxidant treatment]. Orv.Hetil. 4-23-2006;147(16):747-752. View abstract.

84099

White, S., Vender, R., Thaci, D., Haverkamp, C., Naeyaert, J. M., Foster, R., Martinez Escribano, J. A., Cambazard, F., and Bibby, A. Use of calcipotriene cream (Dovonex cream) following acute treatment of psoriasis vulgaris with the calcipotriene/betamethasone dipropionate two-compound product (Taclonex): a randomized, parallel-group clinical trial. Am J Clin Dermatol 2006;7(3):177-184. View abstract.

84100

Vogel, V. G., Costantino, J. P., Wickerham, D. L., Cronin, W. M., Cecchini, R. S., Atkins, J. N., Bevers, T. B., Fehrenbacher, L., Pajon, E. R., Jr., Wade, J. L., III, Robidoux, A., Margolese, R. G., James, J., Lippman, S. M., Runowicz, C. D., Ganz, P. A., Reis, S. E., McCaskill-Stevens, W., Ford, L. G., Jordan, V. C., and Wolmark, N. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. JAMA 6-21-2006;295(23):2727-2741. View abstract.

84101

Sato, Y., Honda, Y., and Iwamoto, J. Etidronate for fracture prevention in amyotrophic lateral sclerosis: a randomized controlled trial. Bone 2006;39(5):1080-1086. View abstract.

84102

Faulkner, K. A., Cauley, J. A., Zmuda, J. M., Landsittel, D. P., Newman, A. B., Studenski, S. A., Redfern, M. S., Ensrud, K. E., Fink, H. A., Lane, N. E., and Nevitt, M. C. Higher 1,25-dihydroxyvitamin D3 concentrations associated with lower fall rates in older community-dwelling women. Osteoporos Int 2006;17(9):1318-1328. View abstract.

84105

Bonnetblanc, J. M. [Psoriasis]. Ann.Dermatol.Venereol. 2006;133(3):298-299. View abstract.

84106

Lovell, D. J., Glass, D., Ranz, J., Kramer, S., Huang, B., Sierra, R. I., Henderson, C. J., Passo, M., Graham, B., Bowyer, S., Higgins, G., Rennebohm, R., Schikler, K. N., and Giannini, E. A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis. Arthritis Rheum. 2006;54(7):2235-2242. View abstract.

84107

Bischoff-Ferrari, H. A., Giovannucci, E., Willett, W. C., Dietrich, T., and Dawson-Hughes, B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr 2006;84(1):18-28. View abstract.

84108

Pfeifer, M. and Minne, H. W. [The role of vitamin D in the treatment of osteoporosis in the elderly]. Med Klin.(Munich) 2006;101 Suppl 1:15-19. View abstract.

84109

Benson, J., Wilson, A., Stocks, N., and Moulding, N. Muscle pain as an indicator of vitamin D deficiency in an urban Australian Aboriginal population. Med.J Aust. 7-17-2006;185(2):76-77. View abstract.

84110

Pironi, L., Maghetti, A., Zolezzi, C., Ruggeri, E., Incasa, E., Gnudi, S., Pizzoferrato, A., Barbara, L., and Miglioli, M. Bone turnover in patients on home parenteral nutrition: a longitudinal observation by biochemical markers. Clin.Nutr 1996;15(4):157-163. View abstract.

84111

Sakuma, M., Endo, N., Oinuma, T., Hayami, T., Endo, E., Yazawa, T., Watanabe, K., and Watanabe, S. Vitamin D and intact PTH status in patients with hip fracture. Osteoporos Int 2006;17(11):1608-1614. View abstract.

84112

Arden, N. K., Crozier, S., Smith, H., Anderson, F., Edwards, C., Raphael, H., and Cooper, C. Knee pain, knee osteoarthritis, and the risk of fracture. Arthritis Rheum. 8-15-2006;55(4):610-615. View abstract.

84113

Ryan, C. W., Huo, D., Demers, L. M., Beer, T. M., and Lacerna, L. V. Zoledronic acid initiated during the first year of androgen deprivation therapy increases bone mineral density in patients with prostate cancer. J Urol. 2006;176(3):972-978. View abstract.

84114

Kanaji, A., Higashi, M., Namisato, M., Nishio, M., Ando, K., and Yamada, H. Effects of risedronate on lumbar bone mineral density, bone resorption, and incidence of vertebral fracture in elderly male patients with leprosy. Lepr.Rev 2006;77(2):147-153. View abstract.

84115

Pitocco, D., Crino, A., Di, Stasio E., Manfrini, S., Guglielmi, C., Spera, S., Anguissola, G. B., Visalli, N., Suraci, C., Matteoli, M. C., Patera, I. P., Cavallo, M. G., Bizzarri, C., and Pozzilli, P. The effects of calcitriol and nicotinamide on residual pancreatic beta-cell function in patients with recent-onset Type 1 diabetes (IMDIAB XI). Diabet.Med 2006;23(8):920-923. View abstract.

84116

Ragi-Eis, S., Zerbini, C. A., Provenza, J. R., Griz, L. H., de Gregorio, L. H., Russo, L. A., Silva, N. A., Borges, J. L., de Souza, A. C., Castro, M. L., and Lewiecki, E. M. Is it ethical to use placebos in osteoporosis trials? J Clin Densitom. 2006;9(3):274-280. View abstract.

84117

Weingard, K. K. Nursing implications of androgen deprivation therapy-associated bone loss. Urol.Nurs. 2006;26(4):261-269. View abstract.

84118

Helliwell, P. S., Ibrahim, G. H., Karim, Z., Sokoll, K., and Johnson, H. Unexplained musculoskeletal pain in people of South Asian ethnic group referred to a rheumatology clinic – relationship to biochemical osteomalacia, persistence over time and response to treatment with calcium and vitamin D. Clin.Exp.Rheumatol. 2006;24(4):424-427. View abstract.

84120

Aloia, J. F., Talwar, S. A., Pollack, S., Feuerman, M., and Yeh, J. K. Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr 2006;84(3):602-609. View abstract.

84124

Hypponen, E. and Power, C. Vitamin D status and glucose homeostasis in the 1958 British birth cohort: the role of obesity. Diabetes Care 2006;29(10):2244-2246. View abstract.

84125

Gallagher, J. C., Rapuri, P. B., and Smith, L. M. An age-related decrease in creatinine clearance is associated with an increase in number of falls in untreated women but not in women receiving calcitriol treatment. J Clin Endocrinol.Metab 2007;92(1):51-58. View abstract.

84126

Greenspan, S. L., Bhattacharya, R. K., Sereika, S. M., Brufsky, A., and Vogel, V. G. Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trial. J Clin Endocrinol.Metab 2007;92(1):131-136. View abstract.

84127

Stolzenberg-Solomon, R. Z., Vieth, R., Azad, A., Pietinen, P., Taylor, P. R., Virtamo, J., and Albanes, D. A prospective nested case-control study of vitamin D status and pancreatic cancer risk in male smokers. Cancer Res 10-15-2006;66(20):10213-10219. View abstract.

84128

Roh, J. L. and Park, C. I. Routine oral calcium and vitamin D supplements for prevention of hypocalcemia after total thyroidectomy. Am J Surg 2006;192(5):675-678. View abstract.

84129

Pappa, H. M., Gordon, C. M., Saslowsky, T. M., Zholudev, A., Horr, B., Shih, M. C., and Grand, R. J. Vitamin D status in children and young adults with inflammatory bowel disease. Pediatrics 2006;118(5):1950-1961. View abstract.

84130

Imanishi, Y. and Nishizawa, Y. [Activate vitamin D3 or bisphosphonate in glucocorticoid-induced osteoporosis]. Clin Calcium 2006;16(11):1844-1850. View abstract.

84131

Giusti, A., Barone, A., Razzano, M., Pizzonia, M., Oliveri, M., Palummeri, E., and Pioli, G. High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol.Invest 2006;29(9):809-813. View abstract.

84132

Zhou, W., Heist, R. S., Liu, G., Neuberg, D. S., Asomaning, K., Su, L., Wain, J. C., Lynch, T. J., Giovannucci, E., and Christiani, D. C. Polymorphisms of vitamin D receptor and survival in early-stage non-small cell lung cancer patients. Cancer Epidemiol Biomarkers Prev. 2006;15(11):2239-2245. View abstract.

84136

Eastham, J. A. Bone health in men receiving androgen deprivation therapy for prostate cancer. J Urol. 2007;177(1):17-24. View abstract.

84137

Ali, O., Shim, M., Fowler, E., Greenberg, M., Perkins, D., Oppenheim, W., and Cohen, P. Growth hormone therapy improves bone mineral density in children with cerebral palsy: a preliminary pilot study. J Clin Endocrinol.Metab 2007;92(3):932-937. View abstract.

84139

Recker, R. R., Kendler, D., Recknor, C. P., Rooney, T. W., Lewiecki, E. M., Utian, W. H., Cauley, J. A., Lorraine, J., Qu, Y., Kulkarni, P. M., Gaich, C. L., Wong, M., Plouffe, L., Jr., and Stock, J. L. Comparative effects of raloxifene and alendronate on fracture outcomes in postmenopausal women with low bone mass. Bone 2007;40(4):843-851. View abstract.

84140

Felson, D. T., Niu, J., Clancy, M., Aliabadi, P., Sack, B., Guermazi, A., Hunter, D. J., Amin, S., Rogers, G., and Booth, S. L. Low levels of vitamin D and worsening of knee osteoarthritis: results of two longitudinal studies. Arthritis Rheum. 2007;56(1):129-136. View abstract.

84141

Grant, W. B. A meta-analysis of second cancers after a diagnosis of nonmelanoma skin cancer: additional evidence that solar ultraviolet-B irradiance reduces the risk of internal cancers. J Steroid Biochem.Mol.Biol. 2007;103(3-5):668-674. View abstract.

84142

Hathcock, J. N., Shao, A., Vieth, R., and Heaney, R. Risk assessment for vitamin D. Am J Clin Nutr 2007;85(1):6-18. View abstract.

84143

Park, S. Y., Murphy, S. P., Wilkens, L. R., Nomura, A. M., Henderson, B. E., and Kolonel, L. N. Calcium and vitamin D intake and risk of colorectal cancer: the Multiethnic Cohort Study. Am J Epidemiol. 4-1-2007;165(7):784-793. View abstract.

84144

Saab, G., Young, D. O., Gincherman, Y., Giles, K., Norwood, K., and Coyne, D. W. Prevalence of vitamin D deficiency and the safety and effectiveness of monthly ergocalciferol in hemodialysis patients. Nephron Clin.Pract. 2007;105(3):c132-c138. View abstract.

84147

Pittas, A. G., Harris, S. S., Stark, P. C., and Dawson-Hughes, B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007;30(4):980-986. View abstract.

84149

Albagha, O. M. and Ralston, S. H. Genetics and osteoporosis. Rheum.Dis.Clin North Am 2006;32(4):659-680. View abstract.

84150

Zhou, W., Heist, R. S., Liu, G., Asomaning, K., Neuberg, D. S., Hollis, B. W., Wain, J. C., Lynch, T. J., Giovannucci, E., Su, L., and Christiani, D. C. Circulating 25-hydroxyvitamin D levels predict survival in early-stage non-small-cell lung cancer patients. J Clin.Oncol. 2-10-2007;25(5):479-485. View abstract.

84153

Grant, W. B., Garland, C. F., and Gorham, E. D. An estimate of cancer mortality rate reductions in Europe and the US with 1,000 IU of oral vitamin D per day. Recent Results Cancer Res 2007;174:225-234. View abstract.

84154

Beer, T. M., Ryan, C. W., Venner, P. M., Petrylak, D. P., Chatta, G. S., Ruether, J. D., Redfern, C. H., Fehrenbacher, L., Saleh, M. N., Waterhouse, D. M., Carducci, M. A., Vicario, D., Dreicer, R., Higano, C. S., Ahmann, F. R., Chi, K. N., Henner, W. D., Arroyo, A., and Clow, F. W. Double-blinded randomized study of high-dose calcitriol plus docetaxel compared with placebo plus docetaxel in androgen-independent prostate cancer: a report from the ASCENT Investigators. J Clin.Oncol. 2-20-2007;25(6):669-674. View abstract.

84155

Jackson, C., Gaugris, S., Sen, S. S., and Hosking, D. The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis. QJM. 2007;100(4):185-192. View abstract.

84156

Kanis, J. A., Stevenson, M., McCloskey, E. V., Davis, S., and Lloyd-Jones, M. Glucocorticoid-induced osteoporosis: a systematic review and cost-utility analysis. Health Technol Assess. 2007;11(7):iii-xi, 1. View abstract.

84157

Brekke, H. K. and Ludvigsson, J. Vitamin D supplementation and diabetes-related autoimmunity in the ABIS study. Pediatr.Diabetes 2007;8(1):11-14. View abstract.

84158

Yoshida, Y., Sato, N., Furumura, M., and Nakayama, J. Treatment of pigmented lesions of neurofibromatosis 1 with intense pulsed-radio frequency in combination with topical application of vitamin D3 ointment. J Dermatol 2007;34(4):227-230. View abstract.

84159

Aloia, J. F. and Li-Ng, M. Re: epidemic influenza and vitamin D. Epidemiol.Infect. 2007;135(7):1095-1096. View abstract.

84160

Tenconi, M. T., Devoti, G., Comelli, M., Pinon, M., Capocchiano, A., Calcaterra, V., and Pretti, G. Major childhood infectious diseases and other determinants associated with type 1 diabetes: a case-control study. Acta Diabetol. 2007;44(1):14-19. View abstract.

84161

Michaelson, M. D., Kaufman, D. S., Lee, H., McGovern, F. J., Kantoff, P. W., Fallon, M. A., Finkelstein, J. S., and Smith, M. R. Randomized controlled trial of annual zoledronic acid to prevent gonadotropin-releasing hormone agonist-induced bone loss in men with prostate cancer. J Clin.Oncol. 3-20-2007;25(9):1038-1042. View abstract.

84162

Greenspan, S. L., Nelson, J. B., Trump, D. L., and Resnick, N. M. Effect of once-weekly oral alendronate on bone loss in men receiving androgen deprivation therapy for prostate cancer: a randomized trial. Ann.Intern.Med. 3-20-2007;146(6):416-424. View abstract.

84163

Zhu, X., Wang, B., Zhao, G., Gu, J., Chen, Z., Briantais, P., and Andres, P. An investigator-masked comparison of the efficacy and safety of twice daily applications of calcitriol 3 microg/g ointment vs. calcipotriol 50 microg/g ointment in subjects with mild to moderate chronic plaque-type psoriasis. J Eur Acad Dermatol Venereol. 2007;21(4):466-472. View abstract.

84164

Oh, K., Willett, W. C., Wu, K., Fuchs, C. S., and Giovannucci, E. L. Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women. Am J Epidemiol. 5-15-2007;165(10):1178-1186. View abstract.

84165

Binkley, N., Novotny, R., Krueger, D., Kawahara, T., Daida, Y. G., Lensmeyer, G., Hollis, B. W., and Drezner, M. K. Low vitamin D status despite abundant sun exposure. J Clin.Endocrinol.Metab 2007;92(6):2130-2135. View abstract.

84166

Viapiana, O., Gatti, D., Rossini, M., Idolazzi, L., Fracassi, E., and Adami, S. [Vitamin D and fractures: a systematic review]. Reumatismo. 2007;59(1):15-19. View abstract.

84169

Martineau, A. R., Wilkinson, R. J., Wilkinson, K. A., Newton, S. M., Kampmann, B., Hall, B. M., Packe, G. E., Davidson, R. N., Eldridge, S. M., Maunsell, Z. J., Rainbow, S. J., Berry, J. L., and Griffiths, C. J. A single dose of vitamin D enhances immunity to mycobacteria. Am J Respir.Crit Care Med 7-15-2007;176(2):208-213. View abstract.

84170

Bischoff-Ferrari, H. A. and Dawson-Hughes, B. Where do we stand on vitamin D? Bone 2007;41(1 Suppl 1):S13-S19. View abstract.

84171

Seubwai, W., Wongkham, C., Puapairoj, A., Khuntikeo, N., and Wongkham, S. Overexpression of vitamin D receptor indicates a good prognosis for cholangiocarcinoma: implications for therapeutics. Cancer 6-15-2007;109(12):2497-2505. View abstract.

84172

Oken, E., Ning, Y., Rifas-Shiman, S. L., Rich-Edwards, J. W., Olsen, S. F., and Gillman, M. W. Diet during pregnancy and risk of preeclampsia or gestational hypertension. Ann.Epidemiol. 2007;17(9):663-668. View abstract.

84173

Arnaud, S. B., Stickler, G. B., and Haworth, J. C. Serum 25-hydroxyvitamin D in infantile rickets. Pediatrics 1976;57(2):221-225. View abstract.

84175

Forschner, T., Buchholtz, S., and Stockfleth, E. Current state of vitiligo therapy–evidence-based analysis of the literature. J Dtsch.Dermatol Ges. 2007;5(6):467-475. View abstract.

84177

Israeli, R. S., Rosenberg, S. J., Saltzstein, D. R., Gottesman, J. E., Goldstein, H. R., Hull, G. W., Tran, D. N., Warsi, G. M., and Lacerna, L. V. The effect of zoledronic acid on bone mineral density in patients undergoing androgen deprivation therapy. Clin.Genitourin.Cancer 2007;5(4):271-277. View abstract.

84179

Obara, W., Suzuki, Y., Kato, K., Tanji, S., Konda, R., and Fujioka, T. Vitamin D receptor gene polymorphisms are associated with increased risk and progression of renal cell carcinoma in a Japanese population. Int J Urol. 2007;14(6):483-487. View abstract.

84180

Swanenburg, J., de Bruin, E. D., Stauffacher, M., Mulder, T., and Uebelhart, D. Effects of exercise and nutrition on postural balance and risk of falling in elderly people with decreased bone mineral density: randomized controlled trial pilot study. Clin Rehabil 2007;21(6):523-534. View abstract.

84186

Costenbader, K. H., Feskanich, D., Holmes, M., Karlson, E. W., and Benito-Garcia, E. Vitamin D intake and risks of systemic lupus erythematosus and rheumatoid arthritis in women. Ann.Rheum.Dis. 2008;67(4):530-535. View abstract.

84188

Schleithoff, S. S., Zittermann, A., Tenderich, G., Berthold, H. K., Stehle, P., and Koerfer, R. Combined calcium and vitamin D supplementation is not superior to calcium supplementation alone in improving disturbed bone metabolism in patients with congestive heart failure. Eur J Clin Nutr 2008;62(12):1388-1394. View abstract.

84189

Avenell, A., Cook, J. A., MacLennan, G. S., and Macpherson, G. C. Vitamin D supplementation to prevent infections: a sub-study of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 2007;36(5):574-577. View abstract.

84190

Obara, W., Konda, R., Akasaka, S., Nakamura, S., Sugawara, A., and Fujioka, T. Prognostic significance of vitamin D receptor and retinoid X receptor expression in renal cell carcinoma. J Urol. 2007;178(4 Pt 1):1497-1503. View abstract.

84191

Kimball, S. M., Ursell, M. R., O’Connor, P., and Vieth, R. Safety of vitamin D3 in adults with multiple sclerosis. Am J Clin Nutr 2007;86(3):645-651. View abstract.

84193

Lyles, K. W., Colon-Emeric, C. S., Magaziner, J. S., Adachi, J. D., Pieper, C. F., Mautalen, C., Hyldstrup, L., Recknor, C., Nordsletten, L., Moore, K. A., Lavecchia, C., Zhang, J., Mesenbrink, P., Hodgson, P. K., Abrams, K., Orloff, J. J., Horowitz, Z., Eriksen, E. F., and Boonen, S. Zoledronic acid and clinical fractures and mortality after hip fracture. N.Engl.J Med 11-1-2007;357(18):1799-1809. View abstract.

84194

Ross, E. A., Tian, J., Abboud, H., Hippensteel, R., Melnick, J. Z., Pradhan, R. S., Williams, L. A., Hamm, L. L., and Sprague, S. M. Oral paricalcitol for the treatment of secondary hyperparathyroidism in patients on hemodialysis or peritoneal dialysis. Am J Nephrol. 2008;28(1):97-106. View abstract.

84196

Saraceno, R., Andreassi, L., Ayala, F., Bongiorno, M. R., Giannetti, A., Lisi, P., Martini, P., Peris, K., Peserico, A., and Chimenti, S. Efficacy, safety and quality of life of calcipotriol/betamethasone dipropionate (Dovobet) versus calcipotriol (Daivonex) in the treatment of psoriasis vulgaris: a randomized, multicentre, clinical trial. J Dermatolog.Treat. 2007;18(6):361-365. View abstract.

84198

Ryan, P. J. Vitamin D therapy in clinical practice. One dose does not fit all. Int J Clin Pract. 2007;61(11):1894-1899. View abstract.

84199

Williams, F. M. and Spector, T. D. The genetics of osteoporosis. Acta Reumatol.Port. 2007;32(3):231-240. View abstract.

84201

Berggren, M., Stenvall, M., Olofsson, B., and Gustafson, Y. Evaluation of a fall-prevention program in older people after femoral neck fracture: a one-year follow-up. Osteoporos.Int 2008;19(6):801-809. View abstract.

84203

Talwar, S. A., Aloia, J. F., Pollack, S., and Yeh, J. K. Dose response to vitamin D supplementation among postmenopausal African American women. Am J Clin Nutr 2007;86(6):1657-1662. View abstract.

84204

Rovner, A. J., Stallings, V. A., Schall, J. I., Leonard, M. B., and Zemel, B. S. Vitamin D insufficiency in children, adolescents, and young adults with cystic fibrosis despite routine oral supplementation. Am J Clin Nutr 2007;86(6):1694-1699. View abstract.

84206

Israeli, R. S., Ryan, C. W., and Jung, L. L. Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy. J Urol. 2008;179(2):414-423. View abstract.

84207

Palmer, S. C., McGregor, D. O., Macaskill, P., Craig, J. C., Elder, G. J., and Strippoli, G. F. Meta-analysis: vitamin D compounds in chronic kidney disease. Ann.Intern Med 12-18-2007;147(12):840-853. View abstract.

84208

Holick, M. F., Biancuzzo, R. M., Chen, T. C., Klein, E. K., Young, A., Bibuld, D., Reitz, R., Salameh, W., Ameri, A., and Tannenbaum, A. D. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. J Clin.Endocrinol.Metab 2008;93(3):677-681. View abstract.

84209

Lind, L., Wengle, B., Lithell, H., and Ljunghall, S. No major metabolic alterations accompany the hypotensive effect of active vitamin D. Ups.J Med.Sci 1991;96(3):199-204. View abstract.

84210

Freyschuss, B., Ljunggren, O., Saaf, M., Mellstrom, D., and Avenell, A. Calcium and vitamin D for prevention of osteoporotic fractures. Lancet 12-22-2007;370(9605):2098-2099. View abstract.

84211

Compher, C. W., Badellino, K. O., and Boullata, J. I. Vitamin D and the bariatric surgical patient: a review. Obes.Surg 2008;18(2):220-224. View abstract.

84212

Okamoto, R., Akagi, T., and Koeffler, P. Vitamin D compounds and myelodysplastic syndrome. Leuk.Lymphoma 2008;49(1):12-13. View abstract.

84213

Andersen, R., Molgaard, C., Skovgaard, L. T., Brot, C., Cashman, K. D., Jakobsen, J., Lamberg-Allardt, C., and Ovesen, L. Effect of vitamin D supplementation on bone and vitamin D status among Pakistani immigrants in Denmark: a randomised double-blinded placebo-controlled intervention study. Br J Nutr 2008;100(1):197-207. View abstract.

84214

de Boer, I. H., Tinker, L. F., Connelly, S., Curb, J. D., Howard, B. V., Kestenbaum, B., Larson, J. C., Manson, J. E., Margolis, K. L., Siscovick, D. S., and Weiss, N. S. Calcium plus vitamin D supplementation and the risk of incident diabetes in the Women’s Health Initiative. Diabetes Care 2008;31(4):701-707. View abstract.

84215

Richy, F., Dukas, L., and Schacht, E. Differential effects of D-hormone analogs and native vitamin D on the risk of falls: a comparative meta-analysis. Calcif.Tissue Int 2008;82(2):102-107. View abstract.

84216

Bjorkman, M., Sorva, A., and Tilvis, R. Responses of parathyroid hormone to vitamin D supplementation: a systematic review of clinical trials. Arch Gerontol.Geriatr 2009;48(2):160-166. View abstract.

84217

Nnoaham, K. E. and Clarke, A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. Int J Epidemiol. 2008;37(1):113-119. View abstract.

84218

Weingarten, M. A., Zalmanovici, A., and Yaphe, J. Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps. Cochrane Database Syst Rev 2008;(1):CD003548. View abstract.

84219

Ewers, B., Gasbjerg, A., Moelgaard, C., Frederiksen, A. M., and Marckmann, P. Vitamin D status in kidney transplant patients: need for intensified routine supplementation. Am J Clin Nutr 2008;87(2):431-437. View abstract.

84220

Sugden, J. A., Davies, J. I., Witham, M. D., Morris, A. D., and Struthers, A. D. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabet.Med 2008;25(3):320-325. View abstract.

84221

Thornton, J., Ashcroft, D., O’Neill, T., Elliott, R., Adams, J., Roberts, C., Rooney, M., and Symmons, D. A systematic review of the effectiveness of strategies for reducing fracture risk in children with juvenile idiopathic arthritis with additional data on long-term risk of fracture and cost of disease management. Health Technol Assess. 2008;12(3):iii-xiv, 1. View abstract.

84224

Lister, T. Should long-term care residents be supplemented with vitamin D? Can.J Diet Pract.Res 2008;69(1):28-31. View abstract.

84225

Zipitis, C. S. and Akobeng, A. K. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis.Child 2008;93(6):512-517. View abstract.

84226

Cannell, J. J. and Hollis, B. W. Use of vitamin D in clinical practice. Altern Med Rev 2008;13(1):6-20. View abstract.

84228

Olgaard, K. and Lewin, E. Use (or misuse) of vitamin D treatment in CKD and dialysis patients: A recent meta-analysis on vitamin D compounds in chronic kidney disease [1] and an editorial comment [2] accompanying this meta-analysis have already been published. We believe that these papers deserve some comments in the interest of the NDT readership. Nephrol.Dial.Transplant. 2008;23(6):1786-1789. View abstract.

84230

Attia, S., Eickhoff, J., Wilding, G., McNeel, D., Blank, J., Ahuja, H., Jumonville, A., Eastman, M., Shevrin, D., Glode, M., Alberti, D., Staab, M. J., Horvath, D., Straus, J., Marnocha, R., and Liu, G. Randomized, double-blinded phase II evaluation of docetaxel with or without doxercalciferol in patients with metastatic, androgen-independent prostate cancer. Clin.Cancer Res 4-15-2008;14(8):2437-2443. View abstract.

84231

Takeda, S., Kaneoka, H., and Saito, T. Effect of alendronate on glucocorticoid-induced osteoporosis in Japanese women with systemic autoimmune diseases: versus alfacalcidol. Mod.Rheumatol. 2008;18(3):271-276. View abstract.

84232

Warner, A. E. and Arnspiger, S. A. Diffuse musculoskeletal pain is not associated with low vitamin D levels or improved by treatment with vitamin D. J Clin Rheumatol 2008;14(1):12-16. View abstract.

84236

Sidbury, R., Sullivan, A. F., Thadhani, R. I., and Camargo, C. A., Jr. Randomized controlled trial of vitamin D supplementation for winter-related atopic dermatitis in Boston: a pilot study. Br.J Dermatol. 2008;159(1):245-247. View abstract.

84237

Knekt, P., Laaksonen, M., Mattila, C., Harkanen, T., Marniemi, J., Heliovaara, M., Rissanen, H., Montonen, J., and Reunanen, A. Serum vitamin D and subsequent occurrence of type 2 diabetes. Epidemiology 2008;19(5):666-671. View abstract.

84238

Carbone, L. D., Rosenberg, E. W., Tolley, E. A., Holick, M. F., Hughes, T. A., Watsky, M. A., Barrow, K. D., Chen, T. C., Wilkin, N. K., Bhattacharya, S. K., Dowdy, J. C., Sayre, R. M., and Weber, K. T. 25-Hydroxyvitamin D, cholesterol, and ultraviolet irradiation. Metabolism 2008;57(6):741-748. View abstract.

84239

Oudshoorn, C., Mattace-Raso, F. U., Van, der, V, Colin, E. M., and van der Cammen, T. J. Higher serum vitamin D3 levels are associated with better cognitive test performance in patients with Alzheimer’s disease. Dement.Geriatr Cogn Disord 2008;25(6):539-543. View abstract.

84241

Iwasaki, T., Takei, K., Nakamura, S., Hosoda, N., Yokota, Y., and Ishii, M. Secondary osteoporosis in long-term bedridden patients with cerebral palsy. Pediatr Int 2008;50(3):269-275. View abstract.

84242

Heaney, R. P., Armas, L. A., Shary, J. R., Bell, N. H., Binkley, N., and Hollis, B. W. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. Am J Clin Nutr 2008;87(6):1738-1742. View abstract.

84243

Aloia, J. F., Patel, M., Dimaano, R., Li-Ng, M., Talwar, S. A., Mikhail, M., Pollack, S., and Yeh, J. K. Vitamin D intake to attain a desired serum 25-hydroxyvitamin D concentration. Am J Clin Nutr 2008;87(6):1952-1958. View abstract.

84244

Coyne, D. W. Vitamin D compounds in chronic kidney disease. Ann.Intern Med 6-17-2008;148(12):969-970. View abstract.

84245

Ng, K., Meyerhardt, J. A., Wu, K., Feskanich, D., Hollis, B. W., Giovannucci, E. L., and Fuchs, C. S. Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer. J Clin.Oncol. 6-20-2008;26(18):2984-2991. View abstract.

84246

Wagner, D., Sidhom, G., Whiting, S. J., Rousseau, D., and Vieth, R. The bioavailability of vitamin D from fortified cheeses and supplements is equivalent in adults. J Nutr 2008;138(7):1365-1371. View abstract.

84247

Jean, G., Terrat, J. C., Vanel, T., Hurot, J. M., Lorriaux, C., Mayor, B., and Chazot, C. Daily oral 25-hydroxycholecalciferol supplementation for vitamin D deficiency in haemodialysis patients: effects on mineral metabolism and bone markers. Nephrol.Dial.Transplant. 2008;23(11):3670-3676. View abstract.

84248

Gissel, T., Rejnmark, L., Mosekilde, L., and Vestergaard, P. Intake of vitamin D and risk of breast cancer–a meta-analysis. J Steroid Biochem.Mol.Biol. 2008;111(3-5):195-199. View abstract.

84249

Forouhi, N. G., Luan, J., Cooper, A., Boucher, B. J., and Wareham, N. J. Baseline serum 25-hydroxy vitamin d is predictive of future glycemic status and insulin resistance: the Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008;57(10):2619-2625. View abstract.

84250

Tokmak, F., Quack, I., Schieren, G., Sellin, L., Rattensperger, D., Holland-Letz, T., Weiner, S. M., and Rump, L. C. High-dose cholecalciferol to correct vitamin D deficiency in haemodialysis patients. Nephrol.Dial.Transplant. 2008;23(12):4016-4020. View abstract.

84251

Alborzi, P., Patel, N. A., Peterson, C., Bills, J. E., Bekele, D. M., Bunaye, Z., Light, R. P., and Agarwal, R. Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension 2008;52(2):249-255. View abstract.

84252

Neuhouser, M. L., Sorensen, B., Hollis, B. W., Ambs, A., Ulrich, C. M., McTiernan, A., Bernstein, L., Wayne, S., Gilliland, F., Baumgartner, K., Baumgartner, R., and Ballard-Barbash, R. Vitamin D insufficiency in a multiethnic cohort of breast cancer survivors. Am J Clin Nutr 2008;88(1):133-139. View abstract.

84253

Pilz, S., Dobnig, H., Fischer, J. E., Wellnitz, B., Seelhorst, U., Boehm, B. O., and Marz, W. Low vitamin d levels predict stroke in patients referred to coronary angiography. Stroke 2008;39(9):2611-2613. View abstract.

84255

Tai, K., Need, A. G., Horowitz, M., and Chapman, I. M. Glucose tolerance and vitamin D: effects of treating vitamin D deficiency. Nutrition 2008;24(10):950-956. View abstract.

84256

Cranney, A., Weiler, H. A., O’Donnell, S., and Puil, L. Summary of evidence-based review on vitamin D efficacy and safety in relation to bone health. Am J Clin Nutr 2008;88(2):513S-519S. View abstract.

84258

Theodoratou, E., Farrington, S. M., Tenesa, A., McNeill, G., Cetnarskyj, R., Barnetson, R. A., Porteous, M. E., Dunlop, M. G., and Campbell, H. Modification of the inverse association between dietary vitamin D intake and colorectal cancer risk by a FokI variant supports a chemoprotective action of Vitamin D intake mediated through VDR binding. Int J Cancer 11-1-2008;123(9):2170-2179. View abstract.

84259

Cuppari, L., Carvalho, A. B., and Draibe, S. A. Vitamin D status of chronic kidney disease patients living in a sunny country. J Ren Nutr 2008;18(5):408-414. View abstract.

84260

Murphy, P. K. and Wagner, C. L. Vitamin D and mood disorders among women: an integrative review. J Midwifery Womens Health 2008;53(5):440-446. View abstract.

84261

Ringe, J. D., Farahmand, P., Faber, H., and Dorst, A. Sustained efficacy of risedronate in men with primary and secondary osteoporosis: results of a 2-year study. Rheumatol.Int 2009;29(3):311-315. View abstract.

84262

Yu, C. K., Sykes, L., Sethi, M., Teoh, T. G., and Robinson, S. Vitamin D deficiency and supplementation during pregnancy. Clin.Endocrinol.(Oxf) 2009;70(5):685-690. View abstract.

84263

Berk, M., Jacka, F. N., Williams, L. J., Ng, F., Dodd, S., and Pasco, J. A. Is this D vitamin to worry about? Vitamin D insufficiency in an inpatient sample. Aust N.Z J Psychiatry 2008;42(10):874-878. View abstract.

84265

Brandao, C. M., Lima, M. G., Silva, A. L., Silva, G. D., Guerra, A. A., Jr., and Acurcio, Fde A. Treatment of postmenopausal osteoporosis in women: a systematic review. Cad.Saude Publica 2008;24 Suppl 4:s592-s606. View abstract.

84267

Inoue, D. [Evidence for efficacy of active vitamin D3 as an anti-osteoporotic drug]. Clin Calcium 2008;18(10):1469-1475. View abstract.

84268

Tanaka, H. [Nutrition and bone health during childhood]. Clin Calcium 2008;18(10):1504-1509. View abstract.

84270

Mizoue, T., Kimura, Y., Toyomura, K., Nagano, J., Kono, S., Mibu, R., Tanaka, M., Kakeji, Y., Maehara, Y., Okamura, T., Ikejiri, K., Futami, K., Yasunami, Y., Maekawa, T., Takenaka, K., Ichimiya, H., and Imaizumi, N. Calcium, dairy foods, vitamin D, and colorectal cancer risk: the Fukuoka Colorectal Cancer Study. Cancer Epidemiol.Biomarkers Prev. 2008;17(10):2800-2807. View abstract.

84271

Bjorkman, M., Sorva, A., and Tilvis, R. Vitamin D supplementation has no major effect on pain or pain behavior in bedridden geriatric patients with advanced dementia. Aging Clin Exp.Res 2008;20(4):316-321. View abstract.

84272

Chaidemenos, G., Stratigos, A., Papakonstantinou, M., and Tsatsou, F. Prevention of malignant melanoma. Hippokratia. 2008;12(1):17-21. View abstract.

84273

Johnson, M. A., Fischer, J. G., and Park, S. Vitamin D deficiency and insufficiency in the Georgia Older Americans Nutrition Program. J Nutr Elder. 2008;27(1-2):29-46. View abstract.

84274

Heist, R. S., Zhou, W., Wang, Z., Liu, G., Neuberg, D., Su, L., Asomaning, K., Hollis, B. W., Lynch, T. J., Wain, J. C., Giovannucci, E., and Christiani, D. C. Circulating 25-hydroxyvitamin D, VDR polymorphisms, and survival in advanced non-small-cell lung cancer. J Clin.Oncol. 12-1-2008;26(34):5596-5602. View abstract.

84275

Jakobsen, J., Bysted, A., Andersen, R., Bennett, T., Brot, C., Bugel, S., Cashman, K. D., Denk, E., Harrington, M., Teucher, B., Walczyk, T., and Ovesen, L. Vitamin D status assessed by a validated HPLC method: within and between variation in subjects supplemented with vitamin D3. Scand J Clin Lab Invest 2009;69(2):190-197. View abstract.

84276

Body, J. J. [Update on treatment of postmenopausal osteoporosis]. Rev Med Brux. 2008;29(4):301-309. View abstract.

84277

Cecilia, D., Jodar, E., Fernandez, C., Resines, C., and Hawkins, F. Effect of alendronate in elderly patients after low trauma hip fracture repair. Osteoporos.Int 2009;20(6):903-910. View abstract.

84278

Suzuki, T. [Risk factors of musculoskeletal ambulation disability symptom complex (MADS). Frequent falls and sarcopenia according to aging ]. Clin Calcium 2008;18(11):1581-1587. View abstract.

84279

Bonakdaran, S., Ayatollahi, H., Mojahedi, M. J., Sharifipoor, F., and Shakeri, M. Impact of treatment with oral calcitriol on glucose intolerance and dyslipidemia(s) in hemodialysis patients. Saudi.J Kidney Dis.Transpl. 2008;19(6):942-947. View abstract.

84280

Wei, M. Y., Garland, C. F., Gorham, E. D., Mohr, S. B., and Giovannucci, E. Vitamin D and prevention of colorectal adenoma: a meta-analysis. Cancer Epidemiol.Biomarkers Prev. 2008;17(11):2958-2969. View abstract.

84281

Leventis, P. and Kiely, P. D. The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency. Scand J Rheumatol 2009;38(2):149-153. View abstract.

84282

Carlin, A. M., Rao, D. S., Yager, K. M., Parikh, N. J., and Kapke, A. Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg.Obes.Relat Dis. 2009;5(4):444-449. View abstract.

84283

Panju, A. H., Breunis, H., Cheung, A. M., Leach, M., Fleshner, N., Warde, P., Duff-Canning, S., Krahn, M., Naglie, G., Tannock, I., Tomlinson, G., and Alibhai, S. M. Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer. BJU.Int 2009;103(6):753-757. View abstract.

84284

Scholl, T. O. and Chen, X. Vitamin D intake during pregnancy: association with maternal characteristics and infant birth weight. Early Hum.Dev. 2009;85(4):231-234. View abstract.

84286

Rodriguez-Martin, M., Garcia, Bustinduy M., Saez, Rodriguez M., and Noda, Cabrera A. Randomized, double-blind clinical trial to evaluate the efficacy of topical tacalcitol and sunlight exposure in the treatment of adult nonsegmental vitiligo. Br.J Dermatol. 2009;160(2):409-414. View abstract.

84287

Tentori, F., Albert, J. M., Young, E. W., Blayney, M. J., Robinson, B. M., Pisoni, R. L., Akiba, T., Greenwood, R. N., Kimata, N., Levin, N. W., Piera, L. M., Saran, R., Wolfe, R. A., and Port, F. K. The survival advantage for haemodialysis patients taking vitamin D is questioned: findings from the Dialysis Outcomes and Practice Patterns Study. Nephrol.Dial.Transplant. 2009;24(3):963-972. View abstract.

84289

Cashman, K. D., Hill, T. R., Lucey, A. J., Taylor, N., Seamans, K. M., Muldowney, S., Fitzgerald, A. P., Flynn, A., Barnes, M. S., Horigan, G., Bonham, M. P., Duffy, E. M., Strain, J. J., Wallace, J. M., and Kiely, M. Estimation of the dietary requirement for vitamin D in healthy adults. Am J Clin Nutr 2008;88(6):1535-1542. View abstract.

84291

Bartley, J. Prevalence of vitamin D deficiency among patients attending a multidisciplinary tertiary pain clinic. N.Z.Med.J 11-28-2008;121(1286):57-62. View abstract.

84292

Ruiz-Irastorza, G., Ramos-Casals, M., Brito-Zeron, P., and Khamashta, M. A. Clinical efficacy and side effects of antimalarials in systemic lupus erythematosus: a systematic review. Ann.Rheum.Dis. 2010;69(1):20-28. View abstract.

84294

Lipworth, L., Bender, T. J., Rossi, M., Bosetti, C., Negri, E., Talamini, R., Giacosa, A., Franceschi, S., McLaughlin, J. K., and La, Vecchia C. Dietary vitamin D intake and cancers of the colon and rectum: a case-control study in Italy. Nutr Cancer 2009;61(1):70-75. View abstract.

84295

Arpadi, S. M., McMahon, D., Abrams, E. J., Bamji, M., Purswani, M., Engelson, E. S., Horlick, M., and Shane, E. Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics 2009;123(1):e121-e126. View abstract.

84296

Nagpal, J., Pande, J. N., and Bhartia, A. A double-blind, randomized, placebo-controlled trial of the short-term effect of vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet.Med 2009;26(1):19-27. View abstract.

84297

Davison, B. J., Oliffe, J. L., Pickles, T., and Mroz, L. Factors influencing men undertaking active surveillance for the management of low-risk prostate cancer. Oncol.Nurs.Forum 2009;36(1):89-96. View abstract.

84298

Tretli, S., Hernes, E., Berg, J. P., Hestvik, U. E., and Robsahm, T. E. Association between serum 25(OH)D and death from prostate cancer. Br.J Cancer 2-10-2009;100(3):450-454. View abstract.

84299

Ringe, J. D. and Schacht, E. Potential of alfacalcidol for reducing increased risk of falls and fractures. Rheumatol.Int 2009;29(10):1177-1185. View abstract.

84300

Yetley, E. A., Brule, D., Cheney, M. C., Davis, C. D., Esslinger, K. A., Fischer, P. W., Friedl, K. E., Greene-Finestone, L. S., Guenther, P. M., Klurfeld, D. M., L’Abbe, M. R., McMurry, K. Y., Starke-Reed, P. E., and Trumbo, P. R. Dietary reference intakes for vitamin D: justification for a review of the 1997 values. Am J Clin Nutr 2009;89(3):719-727. View abstract.

84302

Kooienga, L., Fried, L., Scragg, R., Kendrick, J., Smits, G., and Chonchol, M. The effect of combined calcium and vitamin D3 supplementation on serum intact parathyroid hormone in moderate CKD. Am J Kidney Dis. 2009;53(3):408-416. View abstract.

84303

Mohr, S. B. A brief history of vitamin d and cancer prevention. Ann.Epidemiol. 2009;19(2):79-83. View abstract.

84304

Reed, A., Haugen, M., Pachman, L. M., and Langman, C. B. 25-Hydroxyvitamin D therapy in children with active juvenile rheumatoid arthritis: short-term effects on serum osteocalcin levels and bone mineral density. J Pediatr 1991;119(4):657-660. View abstract.

84305

Parikh, S., Avorn, J., and Solomon, D. H. Pharmacological management of osteoporosis in nursing home populations: a systematic review. J Am Geriatr Soc 2009;57(2):327-334. View abstract.

84306

Stolzenberg-Solomon, R. Z., Hayes, R. B., Horst, R. L., Anderson, K. E., Hollis, B. W., and Silverman, D. T. Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial. Cancer Res 2-15-2009;69(4):1439-1447. View abstract.

84307

Smith, S. M., Gardner, K. K., Locke, J., and Zwart, S. R. Vitamin D supplementation during Antarctic winter. Am J Clin Nutr 2009;89(4):1092-1098. View abstract.

84308

Baker, P. N., Wheeler, S. J., Sanders, T. A., Thomas, J. E., Hutchinson, C. J., Clarke, K., Berry, J. L., Jones, R. L., Seed, P. T., and Poston, L. A prospective study of micronutrient status in adolescent pregnancy. Am J Clin.Nutr 2009;89(4):1114-1124. View abstract.

84311

Katikaneni, R., Ponnapakkam, T., Ponnapakkam, A., and Gensure, R. Breastfeeding does not protect against urinary tract infection in the first 3 months of life, but vitamin D supplementation increases the risk by 76%. Clin Pediatr (Phila) 2009;48(7):750-755. View abstract.

84312

Grant, W. B. and Mohr, S. B. Ecological studies of ultraviolet B, vitamin D and cancer since 2000. Ann.Epidemiol. 2009;19(7):446-454. View abstract.

84313

Haiyang, Zhou and Chenggang, Xu. Comparison of intermittent intravenous and oral calcitriol in the treatment of secondary hyperparathyroidism in chronic hemodialysis patients: a meta-analysis of randomized controlled trials. Clin Nephrol. 2009;71(3):276-285. View abstract.

84314

Li-Ng, M., Aloia, J. F., Pollack, S., Cunha, B. A., Mikhail, M., Yeh, J., and Berbari, N. A randomized controlled trial of vitamin D3 supplementation for the prevention of symptomatic upper respiratory tract infections. Epidemiol.Infect. 2009;137(10):1396-1404. View abstract.

84315

Ginde, A. A., Liu, M. C., and Camargo, C. A., Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med 3-23-2009;169(6):626-632. View abstract.

84316

Zittermann, A., Frisch, S., Berthold, H. K., Gotting, C., Kuhn, J., Kleesiek, K., Stehle, P., Koertke, H., and Koerfer, R. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009;89(5):1321-1327. View abstract.

84317

Gaal, J., Lakos, G., Szodoray, P., Kiss, J., Horvath, I., Horkay, E., Nagy, G., and Szegedi, A. Immunological and clinical effects of alphacalcidol in patients with psoriatic arthropathy: results of an open, follow-up pilot study. Acta Derm.Venereol. 2009;89(2):140-144. View abstract.

84318

Lee, E. S., Ahn, J., and Park, H. M. Serum vitamin D status of Korean postmenopausal women during the winter months. Asia Pac.J Clin Nutr 2009;18(1):29-33. View abstract.

84320

Chang, H. C., Chen, C. L., Chiu, T. L., Chen, S. I., Yen, A. M., and Chen, T. H. Effectiveness of recombinant human erythropoietin, vitamin D3 and iron therapy on long-term survival of patients with end-stage renal disease receiving haemodialysis: analysis of 702 patients after 10-year follow-up. Public Health Nutr 2009;12(12):2410-2415. View abstract.

84321

Crew, K. D., Shane, E., Cremers, S., McMahon, D. J., Irani, D., and Hershman, D. L. High prevalence of vitamin D deficiency despite supplementation in premenopausal women with breast cancer undergoing adjuvant chemotherapy. J Clin Oncol. 5-1-2009;27(13):2151-2156. View abstract.

84322

Andersen, R., Brot, C., Mejborn, H., Molgaard, C., Skovgaard, L. T., Trolle, E., and Ovesen, L. Vitamin D supplementation does not affect serum lipids and lipoproteins in Pakistani immigrants. Eur.J Clin.Nutr 2009;63(9):1150-1153. View abstract.

84323

Kinney, D. K., Teixeira, P., Hsu, D., Napoleon, S. C., Crowley, D. J., Miller, A., Hyman, W., and Huang, E. Relation of schizophrenia prevalence to latitude, climate, fish consumption, infant mortality, and skin color: a role for prenatal vitamin d deficiency and infections? Schizophr.Bull. 2009;35(3):582-595. View abstract.

84324

Jorde, R. and Figenschau, Y. Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels. Eur J Nutr 2009;48(6):349-354. View abstract.

84325

Mason, A. R., Mason, J., Cork, M., Dooley, G., and Edwards, G. Topical treatments for chronic plaque psoriasis. Cochrane Database Syst Rev 2009;(2):CD005028. View abstract.

84326

Gillespie, L. D., Robertson, M. C., Gillespie, W. J., Lamb, S. E., Gates, S., Cumming, R. G., and Rowe, B. H. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009;(2):CD007146. View abstract.

84327

Benitez-Aguirre, P. Z., Wood, N. J., Biesheuvel, C., Moreira, C., and Munns, C. F. The natural history of vitamin D deficiency in African refugees living in Sydney. Med J Aust 4-20-2009;190(8):426-428. View abstract.

84328

Hiremath, G. S., Cettomai, D., Baynes, M., Ratchford, J. N., Newsome, S., Harrison, D., Kerr, D., Greenberg, B. M., and Calabresi, P. A. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis. Mult.Scler. 2009;15(6):735-740. View abstract.

84329

Yin, L., Grandi, N., Raum, E., Haug, U., Arndt, V., and Brenner, H. Meta-analysis: longitudinal studies of serum vitamin D and colorectal cancer risk. Aliment.Pharmacol.Ther 7-1-2009;30(2):113-125. View abstract.

84330

Grady, D., Halloran, B., Cummings, S., Leveille, S., Wells, L., Black, D., and Byl, N. 1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: a randomized controlled trial. J Clin Endocrinol.Metab 1991;73(5):1111-1117. View abstract.

84331

Wilkins, C. H., Birge, S. J., Sheline, Y. I., and Morris, J. C. Vitamin D deficiency is associated with worse cognitive performance and lower bone density in older African Americans. J Natl Med Assoc 2009;101(4):349-354. View abstract.

84332

Pierrot-Deseilligny, C. Clinical implications of a possible role of vitamin D in multiple sclerosis. J Neurol. 2009;256(9):1468-1479. View abstract.

84333

Seamans, K. M. and Cashman, K. D. Existing and potentially novel functional markers of vitamin D status: a systematic review. Am J Clin Nutr 2009;89(6):1997S-2008S. View abstract.

84334

Raimondi, S., Johansson, H., Maisonneuve, P., and Gandini, S. Review and meta-analysis on vitamin D receptor polymorphisms and cancer risk. Carcinogenesis 2009;30(7):1170-1180. View abstract.

84335

Miheller, P., Muzes, G., Hritz, I., Lakatos, G., Pregun, I., Lakatos, P. L., Herszenyi, L., and Tulassay, Z. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn’s disease patients. Inflamm.Bowel.Dis. 2009;15(11):1656-1662. View abstract.

84337

Naldi, L. and Rzany, B. Psoriasis (chronic plaque). Clin Evid.(Online.) 2009;2009 View abstract.

84338

Mosekilde, L., Vestergaard, P., and Langdahl, B. Fracture prevention in postmenopausal women. Clin Evid.(Online.) 2007;2007 View abstract.

84339

Goodwin, P. J., Ennis, M., Pritchard, K. I., Koo, J., and Hood, N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. J Clin.Oncol. 8-10-2009;27(23):3757-3763. View abstract.

84340

Haugen, M., Brantsaeter, A. L., Trogstad, L., Alexander, J., Roth, C., Magnus, P., and Meltzer, H. M. Vitamin D supplementation and reduced risk of preeclampsia in nulliparous women. Epidemiology 2009;20(5):720-726. View abstract.

84342

Sahu, M., Das, V., Aggarwal, A., Rawat, V., Saxena, P., and Bhatia, V. Vitamin D replacement in pregnant women in rural north India: a pilot study. Eur.J Clin.Nutr 2009;63(9):1157-1159. View abstract.

84343

Elemraid, M. A., Mackenzie, I. J., Fraser, W. D., and Brabin, B. J. Nutritional factors in the pathogenesis of ear disease in children: a systematic review. Ann Trop.Paediatr. 2009;29(2):85-99. View abstract.

84344

Li, X., Liao, L., Yan, X., Huang, G., Lin, J., Lei, M., Wang, X., and Zhou, Z. Protective effects of 1-alpha-hydroxyvitamin D3 on residual beta-cell function in patients with adult-onset latent autoimmune diabetes (LADA). Diabetes Metab Res Rev 2009;25(5):411-416. View abstract.

84345

Yamshchikov, A. V., Desai, N. S., Blumberg, H. M., Ziegler, T. R., and Tangpricha, V. Vitamin D for treatment and prevention of infectious diseases: a systematic review of randomized controlled trials. Endocr.Pract. 2009;15(5):438-449. View abstract.

84346

Handoll, H. Update of a systematic review of vitamin D for preventing osteoporotic fractures. Inj.Prev. 2009;15(3):213. View abstract.

84347

Tiwari, A. Elocalcitol, a vitamin D3 analog for the potential treatment of benign prostatic hyperplasia, overactive bladder and male infertility. IDrugs. 2009;12(6):381-393. View abstract.

84348

Al-Said, Y. A., Al-Rached, H. S., Al-Qahtani, H. A., and Jan, M. M. Severe proximal myopathy with remarkable recovery after vitamin D treatment. Can.J Neurol.Sci 2009;36(3):336-339. View abstract.

84349

van der Putten, G. J., Vanobbergen, J., De, Visschere L., Schols, J., and de, Baat C. Association of some specific nutrient deficiencies with periodontal disease in elderly people: A systematic literature review. Nutrition 2009;25(7-8):717-722. View abstract.

84350

von Restorff, C., Bischoff-Ferrari, H. A., and Theiler, R. High-dose oral vitamin D3 supplementation in rheumatology patients with severe vitamin D3 deficiency. Bone 2009;45(4):747-749. View abstract.

84351

Tremblay, A. and Gilbert, J. A. Milk products, insulin resistance syndrome and type 2 diabetes. J Am Coll Nutr 2009;28 Suppl 1:91S-102S. View abstract.

84352

Rashidi, B., Haghollahi, F., Shariat, M., and Zayerii, F. The effects of calcium-vitamin D and metformin on polycystic ovary syndrome: a pilot study. Taiwan.J Obstet.Gynecol. 2009;48(2):142-147. View abstract.

84353

Witham, M. D., Nadir, M. A., and Struthers, A. D. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. J Hypertens. 2009;27(10):1948-1954. View abstract.

84354

Fishbane, S., Chittineni, H., Packman, M., Dutka, P., Ali, N., and Durie, N. Oral paricalcitol in the treatment of patients with CKD and proteinuria: a randomized trial. Am J Kidney Dis. 2009;54(4):647-652. View abstract.

84355

Shipowick, C. D., Moore, C. B., Corbett, C., and Bindler, R. Vitamin D and depressive symptoms in women during the winter: a pilot study. Appl.Nurs.Res 2009;22(3):221-225. View abstract.

84356

Avenell, A., Cook, J. A., MacLennan, G. S., and McPherson, G. C. Vitamin D supplementation and type 2 diabetes: a substudy of a randomised placebo-controlled trial in older people (RECORD trial, ISRCTN 51647438). Age Ageing 2009;38(5):606-609. View abstract.

84358

Zhou, G., Stoitzfus, J., and Swan, B. A. Optimizing vitamin D status to reduce colorectal cancer risk: an evidentiary review. Clin J Oncol.Nurs. 2009;13(4):E3-E17. View abstract.

84359

Vacca, A., Cormier, C., Piras, M., Mathieu, A., Kahan, A., and Allanore, Y. Vitamin D deficiency and insufficiency in 2 independent cohorts of patients with systemic sclerosis. J Rheumatol 2009;36(9):1924-1929. View abstract.

84360

Annweiler, C., Allali, G., Allain, P., Bridenbaugh, S., Schott, A. M., Kressig, R. W., and Beauchet, O. Vitamin D and cognitive performance in adults: a systematic review. Eur J Neurol. 2009;16(10):1083-1089. View abstract.

84361

Reis, J. P., von, Muhlen D., Miller, E. R., III, Michos, E. D., and Appel, L. J. Vitamin D status and cardiometabolic risk factors in the United States adolescent population. Pediatrics 2009;124(3):e371-e379. View abstract.

84362

Smith, M. R., Egerdie, B., Hernandez, Toriz N., Feldman, R., Tammela, T. L., Saad, F., Heracek, J., Szwedowski, M., Ke, C., Kupic, A., Leder, B. Z., and Goessl, C. Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N.Engl.J Med. 8-20-2009;361(8):745-755. View abstract.

84363

Bierschenk, L., Alexander, J., Wasserfall, C., Haller, M., Schatz, D., and Atkinson, M. Vitamin D levels in subjects with and without type 1 diabetes residing in a solar rich environment. Diabetes Care 2009;32(11):1977-1979. View abstract.

84364

Pilz, S., Tomaschitz, A., Ritz, E., and Pieber, T. R. Vitamin D status and arterial hypertension: a systematic review. Nat.Rev Cardiol 2009;6(10):621-630. View abstract.

84365

Zittermann, A., Gummert, J. F., and Borgermann, J. Vitamin D deficiency and mortality. Curr Opin.Clin Nutr Metab Care 2009;12(6):634-639. View abstract.

84366

Rhee, H. V., Coebergh, J. W., and Vries, E. D. Sunlight, vitamin D and the prevention of cancer: a systematic review of epidemiological studies. Eur J Cancer Prev. 8-26-2009; View abstract.

84367

Bhoopalam, N., Campbell, S. C., Moritz, T., Broderick, W. R., Iyer, P., Arcenas, A. G., Van Veldhuizen, P. J., Friedman, N., Reda, D., Warren, S., and Garewal, H. Intravenous zoledronic acid to prevent osteoporosis in a veteran population with multiple risk factors for bone loss on androgen deprivation therapy. J Urol. 2009;182(5):2257-2264. View abstract.

84368

Newton-Bishop, J. A., Beswick, S., Randerson-Moor, J., Chang, Y. M., Affleck, P., Elliott, F., Chan, M., Leake, S., Karpavicius, B., Haynes, S., Kukalizch, K., Whitaker, L., Jackson, S., Gerry, E., Nolan, C., Bertram, C., Marsden, J., Elder, D. E., Barrett, J. H., and Bishop, D. T. Serum 25-hydroxyvitamin D3 levels are associated with breslow thickness at presentation and survival from melanoma. J Clin.Oncol. 11-10-2009;27(32):5439-5444. View abstract.

84369

Ceglia, L. Vitamin D and its role in skeletal muscle. Curr Opin.Clin Nutr Metab Care 2009;12(6):628-633. View abstract.

84370

von Hurst, P. R., Stonehouse, W., and Coad, J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and vitamin D deficient – a randomised, placebo-controlled trial. Br J Nutr 2010;103(4):549-555. View abstract.

84371

Annweiler, C. and Beauchet, O. Relationship between bone, fracture, and exercise: the key role of vitamin D. Arch Intern Med 9-28-2009;169(17):1638. View abstract.

84372

Carson, S. A. Nineteenth century Mexican statures in the United States and their relationship with insolation and vitamin D. J Biosoc.Sci 2010;42(1):113-128. View abstract.

84373

Tauchmanova, L., Guerra, E., Pivonello, R., De Martino, M. C., De, Leo M., Caggiano, F., Lombardi, G., and Colao, A. Weekly clodronate treatment prevents bone loss and vertebral fractures in women with subclinical Cushing’s syndrome. J Endocrinol.Invest 2009;32(5):390-394. View abstract.

84374

Bischoff-Ferrari, H. A., Dawson-Hughes, B., Staehelin, H. B., Orav, J. E., Stuck, A. E., Theiler, R., Wong, J. B., Egli, A., Kiel, D. P., and Henschkowski, J. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009;339:b3692. View abstract.

84375

Manders, M., de Groot, L. C., Hoefnagels, W. H., Dhonukshe-Rutten, R. A., Wouters-Wesseling, W., Mulders, A. J., and van Staveren, W. A. The effect of a nutrient dense drink on mental and physical function in institutionalized elderly people. J Nutr Health Aging 2009;13(9):760-767. View abstract.

84376

Palmer, S. C., McGregor, D. O., Craig, J. C., Elder, G., Macaskill, P., and Strippoli, G. F. Vitamin D compounds for people with chronic kidney disease requiring dialysis. Cochrane.Database.Syst.Rev. 2009;(4):CD005633. View abstract.

84377

Palmer, S. C., McGregor, D. O., Craig, J. C., Elder, G., Macaskill, P., and Strippoli, G. F. Vitamin D compounds for people with chronic kidney disease not requiring dialysis. Cochrane.Database.Syst.Rev. 2009;(4):CD008175. View abstract.

84378

Kirii, K., Mizoue, T., Iso, H., Takahashi, Y., Kato, M., Inoue, M., Noda, M., and Tsugane, S. Calcium, vitamin D and dairy intake in relation to type 2 diabetes risk in a Japanese cohort. Diabetologia 2009;52(12):2542-2550. View abstract.

84379

Kilpinen-Loisa, P., Arvio, M., Ilvesmaki, V., and Makitie, O. Vitamin D status and optimal supplementation in institutionalized adults with intellectual disability. J Intellect.Disabil.Res 2009;53(12):1014-1023. View abstract.

84380

Stransky, M. and Rysava, L. Nutrition as prevention and treatment of osteoporosis. Physiol Res 2009;58 Suppl 1:S7-S11. View abstract.

84381

Bolland, M. J., Grey, A., and Reid, I. R. Vitamin D and falls. Time for a moratorium on vitamin D meta-analyses? BMJ 2009;339:b4394. View abstract.

84382

Meyer, G. and Kopke, S. Vitamin D and falls. Information on harm is missing. BMJ 2009;339:b4395. View abstract.

84383

Tamez, S., Norizoe, C., Ochiai, K., Takahashi, D., Shimojima, A., Tsutsumi, Y., Yanaihara, N., Tanaka, T., Okamoto, A., and Urashima, M. Vitamin D receptor polymorphisms and prognosis of patients with epithelial ovarian cancer. Br.J Cancer 12-15-2009;101(12):1957-1960. View abstract.

84384

Watson, P. E. and McDonald, B. W. The association of maternal diet and dietary supplement intake in pregnant New Zealand women with infant birthweight. Eur.J Clin.Nutr 2010;64(2):184-193. View abstract.

84385

Annweiler, C., Schott, A. M., Berrut, G., Fantino, B., and Beauchet, O. Vitamin D-related changes in physical performance: a systematic review. J Nutr Health Aging 2009;13(10):893-898. View abstract.

84386

Sanders, K. M., Stuart, A. L., Merriman, E. N., Read, M. L., Kotowicz, M. A., Young, D., Taylor, R., Blair-Holt, I., Mander, A. G., and Nicholson, G. C. Trials and tribulations of recruiting 2,000 older women onto a clinical trial investigating falls and fractures: Vital D study. BMC.Med.Res Methodol. 2009;9:78. View abstract.

84387

Pignotti, G. A., Genaro, P. S., Pinheiro, M. M., Szejnfeld, V. L., and Martini, L. A. Is a lower dose of vitamin D supplementation enough to increase 25(OH)D status in a sunny country? Eur J Nutr 2010;49(5):277-283. View abstract.

84388

Bischoff-Ferrari, H. A., Shao, A., Dawson-Hughes, B., Hathcock, J., Giovannucci, E., and Willett, W. C. Benefit-risk assessment of vitamin D supplementation. Osteoporos.Int 2010;21(7):1121-1132. View abstract.

84390

Janssens, W., Bouillon, R., Claes, B., Carremans, C., Lehouck, A., Buysschaert, I., Coolen, J., Mathieu, C., Decramer, M., and Lambrechts, D. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010;65(3):215-220. View abstract.

84391

Tombal, B. A holistic approach to androgen deprivation therapy: treating the cancer without hurting the patient. Urol.Int 2009;83(4):373-378. View abstract.

84392

Laaksonen, M. A., Knekt, P., Rissanen, H., Harkanen, T., Virtala, E., Marniemi, J., Aromaa, A., Heliovaara, M., and Reunanen, A. The relative importance of modifiable potential risk factors of type 2 diabetes: a meta-analysis of two cohorts. Eur J Epidemiol. 2010;25(2):115-124. View abstract.

84393

Straube, S., Moore, R. A., Derry, S., Hallier, E., and McQuay, H. J. Vitamin d and chronic pain in immigrant and ethnic minority patients-investigation of the relationship and comparison with native Western populations. Int J Endocrinol. 2010;2010:753075. View abstract.

84394

Parker, J., Hashmi, O., Dutton, D., Mavrodaris, A., Stranges, S., Kandala, N. B., Clarke, A., and Franco, O. H. Levels of vitamin D and cardiometabolic disorders: systematic review and meta-analysis. Maturitas 2010;65(3):225-236. View abstract.

84395

Ambrus, C., Marton, A., Nemeth, Z. K., and Mucsi, I. Bone mineral density in patients on maintenance dialysis. Int Urol.Nephrol. 2010;42(3):723-739. View abstract.

84399

Karkkainen, M. K., Tuppurainen, M., Salovaara, K., Sandini, L., Rikkonen, T., Sirola, J., Honkanen, R., Arokoski, J., Alhava, E., and Kroger, H. Does daily vitamin D 800 IU and calcium 1000 mg supplementation decrease the risk of falling in ambulatory women aged 65-71 years? A 3-year randomized population-based trial (OSTPRE-FPS). Maturitas 2010;65(4):359-365. View abstract.

84400

Sutherland, E. R., Goleva, E., Jackson, L. P., Stevens, A. D., and Leung, D. Y. Vitamin D levels, lung function, and steroid response in adult asthma. Am J Respir.Crit Care Med 4-1-2010;181(7):699-704. View abstract.

84401

Maruotti, N. and Cantatore, F. P. Vitamin D and the immune system. J Rheumatol. 2010;37(3):491-495. View abstract.

84402

Kuwabara, A., Tsugawa, N., Tanaka, K., Fujii, M., Kawai, N., Mukae, S., Kato, Y., Kojima, Y., Takahashi, K., Omura, K., Kagawa, R., Inoue, A., Noike, T., Kido, S., and Okano, T. Improvement of vitamin D status in Japanese institutionalized elderly by supplementation with 800 IU of vitamin D(3). J Nutr Sci Vitaminol.(Tokyo) 2009;55(6):453-458. View abstract.

84404

Cameron, I. D., Murray, G. R., Gillespie, L. D., Robertson, M. C., Hill, K. D., Cumming, R. G., and Kerse, N. Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev 2010;(1):CD005465. View abstract.

84405

Straube, S., Derry, S., Moore, R. A., and McQuay, H. J. Vitamin D for the treatment of chronic painful conditions in adults. Cochrane Database Syst Rev 2010;(1):CD007771. View abstract.

84406

Audran, M. and Briot, K. Critical reappraisal of vitamin D deficiency. Joint Bone Spine 2010;77(2):115-119. View abstract.

84407

Witham, M. D., Crighton, L. J., Gillespie, N. D., Struthers, A. D., and McMurdo, M. E. The effects of vitamin D supplementation on physical function and quality of life in older patients with heart failure: a randomized controlled trial. Circ.Heart Fail. 2010;3(2):195-201. View abstract.

84408

Hough, J. P., Boyd, R. N., and Keating, J. L. Systematic review of interventions for low bone mineral density in children with cerebral palsy. Pediatrics 2010;125(3):e670-e678. View abstract.

84409

Lips, P., Binkley, N., Pfeifer, M., Recker, R., Samanta, S., Cohn, D. A., Chandler, J., Rosenberg, E., and Papanicolaou, D. A. Once-weekly dose of 8400 IU vitamin D(3) compared with placebo: effects on neuromuscular function and tolerability in older adults with vitamin D insufficiency. Am J Clin Nutr 2010;91(4):985-991. View abstract.

84410

Jorde, R., Sneve, M., Torjesen, P., and Figenschau, Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with vitamin D3 for 1 year. J Intern Med 2010;267(5):462-472. View abstract.

84411

Robison, R. and Kumar, R. The effect of prenatal and postnatal dietary exposures on childhood development of atopic disease. Curr Opin.Allergy Clin Immunol. 2010;10(2):139-144. View abstract.

84412

Onal, H., Adal, E., Alpaslan, S., Ersen, A., and Aydin, A. Is daily 400 IU of vitamin D supplementation appropriate for every country: a cross-sectional study. Eur J Nutr 2010;49(7):395-400. View abstract.

84413

Ryan, L. M., Brandoli, C., Freishtat, R. J., Wright, J. L., Tosi, L., and Chamberlain, J. M. Prevalence of vitamin D insufficiency in African American children with forearm fractures: a preliminary study. J Pediatr Orthop. 2010;30(2):106-109. View abstract.

84414

Rajpathak, S. N., Xue, X., Wassertheil-Smoller, S., Van, Horn L., Robinson, J. G., Liu, S., Allison, M., Martin, L. W., Ho, G. Y., and Rohan, T. E. Effect of 5 y of calcium plus vitamin D supplementation on change in circulating lipids: results from the Women’s Health Initiative. Am J Clin Nutr 2010;91(4):894-899. View abstract.

84418

Pittas, A. G., Chung, M., Trikalinos, T., Mitri, J., Brendel, M., Patel, K., Lichtenstein, A. H., Lau, J., and Balk, E. M. Systematic review: Vitamin D and cardiometabolic outcomes. Ann.Intern Med 3-2-2010;152(5):307-314. View abstract.

84419

Hosono, S., Matsuo, K., Kajiyama, H., Hirose, K., Suzuki, T., Kawase, T., Kidokoro, K., Nakanishi, T., Hamajima, N., Kikkawa, F., Tajima, K., and Tanaka, H. Association between dietary calcium and vitamin D intake and cervical carcinogenesis among Japanese women. Eur J Clin Nutr 2010;64(4):400-409. View abstract.

84420

Nishioka, T., Kurayama, H., Yasuda, T., Udagawa, J., Matsumura, C., and Niimi, H. Nasal administration of salmon calcitonin for prevention of glucocorticoid-induced osteoporosis in children with nephrosis. J Pediatr. 1991;118(5):703-707. View abstract.

84422

Salovaara, K., Tuppurainen, M., Karkkainen, M., Rikkonen, T., Sandini, L., Sirola, J., Honkanen, R., Alhava, E., and Kroger, H. Effect of vitamin D(3) and calcium on fracture risk in 65- to 71-year-old women: a population-based 3-year randomized, controlled trial–the OSTPRE-FPS. J Bone Miner.Res 2010;25(7):1487-1495. View abstract.

84423

Matias, P. J., Jorge, C., Ferreira, C., Borges, M., Aires, I., Amaral, T., Gil, C., Cortez, J., and Ferreira, A. Cholecalciferol supplementation in hemodialysis patients: effects on mineral metabolism, inflammation, and cardiac dimension parameters. Clin.J Am Soc.Nephrol. 2010;5(5):905-911. View abstract.

84424

Kositsawat, J., Freeman, V. L., Gerber, B. S., and Geraci, S. Association of A1C levels with vitamin D status in U.S. adults: data from the National Health and Nutrition Examination Survey. Diabetes Care 2010;33(6):1236-1238. View abstract.

84425

Rodriguez-Rodriguez, E., Navia-Lomban, B., Lopez-Sobaler, A. M., and Ortega, R. M. Associations between abdominal fat and body mass index on vitamin D status in a group of Spanish schoolchildren. Eur J Clin Nutr 2010;64(5):461-467. View abstract.

84426

Cook, L. S., Neilson, H. K., Lorenzetti, D. L., and Lee, R. C. A systematic literature review of vitamin D and ovarian cancer. Am J Obstet Gynecol 2010;203(1):70-78. View abstract.

84427

Casey, C. F., Slawson, D. C., and Neal, L. R. VItamin D supplementation in infants, children, and adolescents. Am Fam Physician 3-15-2010;81(6):745-748. View abstract.

84428

Ruiz-Irastorza, G., Gordo, S., Olivares, N., Egurbide, M. V., and Aguirre, C. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage. Arthritis Care Res (Hoboken.) 2010;62(8):1160-1165. View abstract.

84429

Freishtat, R. J., Iqbal, S. F., Pillai, D. K., Klein, C. J., Ryan, L. M., Benton, A. S., and Teach, S. J. High prevalence of vitamin D deficiency among inner-city African American youth with asthma in Washington, DC. J Pediatr 2010;156(6):948-952. View abstract.

84430

Yagmurdur, M. C., Atac, F. B., Uslu, N., Ekici, Y., Verdi, H., Ozdemir, B. H., Moray, G., and Haberal, M. Clinical importance of vitamin D receptor gene polymorphism in invasive ductal carcinoma. Int Surg. 2009;94(4):304-309. View abstract.

84431

Parekh, D., Sarathi, V., Shivane, V. K., Bandgar, T. R., Menon, P. S., and Shah, N. S. Pilot study to evaluate the effect of short-term improvement in vitamin D status on glucose tolerance in patients with type 2 diabetes mellitus. Endocr.Pract. 2010;16(4):600-608. View abstract.

84432

Terushkin, V., Bender, A., Psaty, E. L., Engelsen, O., Wang, S. Q., and Halpern, A. C. Estimated equivalency of vitamin D production from natural sun exposure versus oral vitamin D supplementation across seasons at two US latitudes. J Am Acad Dermatol 2010;62(6):929. View abstract.

84433

Carlton, S., Clopton, D., and Cappuzzo, K. A. Vitamin D deficiency: appropriate replenishment therapies and the effects of vitamin D toxicity. Consult Pharm 2010;25(3):171-177. View abstract.

84434

Marjamaki, L., Niinisto, S., Kenward, M. G., Uusitalo, L., Uusitalo, U., Ovaskainen, M. L., Kronberg-Kippila, C., Simell, O., Veijola, R., Ilonen, J., Knip, M., and Virtanen, S. M. Maternal intake of vitamin D during pregnancy and risk of advanced beta cell autoimmunity and type 1 diabetes in offspring. Diabetologia 2010;53(8):1599-1607. View abstract.

84435

Mak, J. C., Stuart-Harris, J., Cameron, I. D., and Mason, R. S. Oral vitamin D replacement after hip fracture: a comparative review. J Am Geriatr Soc 2010;58(2):382-383. View abstract.

84436

Wasserman, P. and Rubin, D. S. Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care. AIDS Patient.Care STDS. 2010;24(4):223-227. View abstract.

84437

Liu, E., Meigs, J. B., Pittas, A. G., Economos, C. D., McKeown, N. M., Booth, S. L., and Jacques, P. F. Predicted 25-hydroxyvitamin D score and incident type 2 diabetes in the Framingham Offspring Study. Am J Clin.Nutr 2010;91(6):1627-1633. View abstract.

84438

Ameri, P., Ronco, D., Casu, M., Denegri, A., Bovio, M., Menoni, S., Ferone, D., and Murialdo, G. High prevalence of vitamin D deficiency and its association with left ventricular dilation: an echocardiography study in elderly patients with chronic heart failure. Nutr Metab Cardiovasc.Dis. 2010;20(9):633-640. View abstract.

84439

Roudebush, P., Polzin, D. J., Adams, L. G., Towell, T. L., and Forrester, S. D. An evidence-based review of therapies for canine chronic kidney disease. J Small Anim Pract. 2010;51(5):244-252. View abstract.

84440

Tsugawa, N. [Vitamin D and osteoporosis: current topics from epidemiological studies]. Rinsho Byori 2010;58(3):244-253. View abstract.

84442

Ahn, J., Yu, K., Stolzenberg-Solomon, R., Simon, K. C., McCullough, M. L., Gallicchio, L., Jacobs, E. J., Ascherio, A., Helzlsouer, K., Jacobs, K. B., Li, Q., Weinstein, S. J., Purdue, M., Virtamo, J., Horst, R., Wheeler, W., Chanock, S., Hunter, D. J., Hayes, R. B., Kraft, P., and Albanes, D. Genome-wide association study of circulating vitamin D levels. Hum Mol.Genet 7-1-2010;19(13):2739-2745. View abstract.

84443

Grossmann, R. E. and Tangpricha, V. Evaluation of vehicle substances on vitamin D bioavailability: a systematic review. Mol.Nutr Food Res 2010;54(8):1055-1061. View abstract.

84444

Burton, J. M., Kimball, S., Vieth, R., Bar-Or, A., Dosch, H. M., Cheung, R., Gagne, D., D’Souza, C., Ursell, M., and O’Connor, P. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 6-8-2010;74(23):1852-1859. View abstract.

84445

Boldo, A., Campbell, P., Luthra, P., and White, W. B. Should the concentration of vitamin D be measured in all patients with hypertension? J Clin Hypertens.(Greenwich.) 2010;12(3):149-152. View abstract.

84446

Goodman, B. M., III, Artz, N., Radford, B., and Chen, I. A. Prevalence of vitamin D deficiency in adults with sickle cell disease. J Natl Med Assoc 2010;102(4):332-335. View abstract.

84447

Amital, H., Szekanecz, Z., Szucs, G., Danko, K., Nagy, E., Csepany, T., Kiss, E., Rovensky, J., Tuchynova, A., Kozakova, D., Doria, A., Corocher, N., Agmon-Levin, N., Barak, V., Orbach, H., Zandman-Goddard, G., and Shoenfeld, Y. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann.Rheum.Dis. 2010;69(6):1155-1157. View abstract.

84450

Taxel, P., Dowsett, R., Richter, L., Fall, P., Klepinger, A., and Albertsen, P. Risedronate prevents early bone loss and increased bone turnover in the first 6 months of luteinizing hormone-releasing hormone-agonist therapy for prostate cancer. BJU.Int 2010;106(10):1473-1476. View abstract.

84451

Yin, L., Grandi, N., Raum, E., Haug, U., Arndt, V., and Brenner, H. Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer 2010;46(12):2196-2205. View abstract.

84452

Bischoff-Ferrari, H. A., Dawson-Hughes, B., Platz, A., Orav, E. J., Stahelin, H. B., Willett, W. C., Can, U., Egli, A., Mueller, N. J., Looser, S., Bretscher, B., Minder, E., Vergopoulos, A., and Theiler, R. Effect of high-dosage cholecalciferol and extended physiotherapy on complications after hip fracture: a randomized controlled trial. Arch.Intern.Med. 5-10-2010;170(9):813-820. View abstract.

84453

Sanders, K. M., Stuart, A. L., Williamson, E. J., Simpson, J. A., Kotowicz, M. A., Young, D., and Nicholson, G. C. Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial. JAMA 5-12-2010;303(18):1815-1822. View abstract.

84454

Gandini, S., Boniol, M., Haukka, J., Byrnes, G., Cox, B., Sneyd, M. J., Mullie, P., and Autier, P. Meta-analysis of observational studies of serum 25-hydroxyvitamin D levels and colorectal, breast and prostate cancer and colorectal adenoma. Int J Cancer 3-15-2011;128(6):1414-1424. View abstract.

84456

Jorgensen, S. P., Agnholt, J., Glerup, H., Lyhne, S., Villadsen, G. E., Hvas, C. L., Bartels, L. E., Kelsen, J., Christensen, L. A., and Dahlerup, J. F. Clinical trial: vitamin D3 treatment in Crohn’s disease – a randomized double-blind placebo-controlled study. Aliment.Pharmacol Ther. 2010;32(3):377-383. View abstract.

84457

McBeth, J., Pye, S. R., O’Neill, T. W., Macfarlane, G. J., Tajar, A., Bartfai, G., Boonen, S., Bouillon, R., Casanueva, F., Finn, J. D., Forti, G., Giwercman, A., Han, T. S., Huhtaniemi, I. T., Kula, K., Lean, M. E., Pendleton, N., Punab, M., Silman, A. J., Vanderschueren, D., and Wu, F. C. Musculoskeletal pain is associated with very low levels of vitamin D in men: results from the European Male Ageing Study. Ann.Rheum.Dis. 2010;69(8):1448-1452. View abstract.

84458

Chung, M., Balk, E. M., Ip, S., Lee, J., Terasawa, T., Raman, G., Trikalinos, T., Lichtenstein, A. H., and Lau, J. Systematic review to support the development of nutrient reference intake values: challenges and solutions. Am J Clin Nutr 2010;92(2):273-276. View abstract.

84459

Gal-Moscovici, A. and Sprague, S. M. Use of vitamin D in chronic kidney disease patients. Kidney Int 2010;78(2):146-151. View abstract.

84460

Gutierrez, O. M. Fibroblast growth factor 23 and disordered vitamin D metabolism in chronic kidney disease: updating the “trade-off” hypothesis. Clin J Am Soc Nephrol. 2010;5(9):1710-1716. View abstract.

84461

Christakos, S., Ajibade, D. V., Dhawan, P., Fechner, A. J., and Mady, L. J. Vitamin D: metabolism. Endocrinol.Metab Clin North Am 2010;39(2):243-53, table. View abstract.

84462

Binkley, N., Ramamurthy, R., and Krueger, D. Low vitamin D status: definition, prevalence, consequences, and correction. Endocrinol.Metab Clin North Am 2010;39(2):287-301, table. View abstract.

84463

Hewison, M. Vitamin D and the immune system: new perspectives on an old theme. Endocrinol.Metab Clin North Am 2010;39(2):365-79, table. View abstract.

84464

Krishnan, A. V., Trump, D. L., Johnson, C. S., and Feldman, D. The role of vitamin D in cancer prevention and treatment. Endocrinol.Metab Clin North Am 2010;39(2):401-18, table. View abstract.

84466

Lagunova, Z., Porojnicu, A. C., Grant, W. B., Bruland, O., and Moan, J. E. Obesity and increased risk of cancer: does decrease of serum 25-hydroxyvitamin D level with increasing body mass index explain some of the association? Mol.Nutr Food Res 2010;54(8):1127-1133. View abstract.

84467

Ashwell, M., Stone, E. M., Stolte, H., Cashman, K. D., Macdonald, H., Lanham-New, S., Hiom, S., Webb, A., and Fraser, D. UK Food Standards Agency Workshop Report: an investigation of the relative contributions of diet and sunlight to vitamin D status. Br J Nutr 2010;104(4):603-611. View abstract.

84468

Handunnetthi, L., Ramagopalan, S. V., and Ebers, G. C. Multiple sclerosis, vitamin D, and HLA-DRB1*15. Neurology 6-8-2010;74(23):1905-1910. View abstract.

84469

Bartoszewska, M., Kamboj, M., and Patel, D. R. Vitamin D, muscle function, and exercise performance. Pediatr Clin North Am 2010;57(3):849-861. View abstract.

84470

Maxwell, D. R., Benjamin, D. M., Donahay, S. L., Allen, M. K., Hamburger, R. J., and Luft, F. C. Calcitriol in dialysis patients. Clin Pharmacol.Ther 1978;23(5):515-519. View abstract.

84471

Lai, J. K., Lucas, R. M., Clements, M. S., Roddam, A. W., and Banks, E. Hip fracture risk in relation to vitamin D supplementation and serum 25-hydroxyvitamin D levels: a systematic review and meta-analysis of randomised controlled trials and observational studies. BMC.Public Health 2010;10:331. View abstract.

84472

Wang, T. J., Zhang, F., Richards, J. B., Kestenbaum, B., van Meurs, J. B., Berry, D., Kiel, D. P., Streeten, E. A., Ohlsson, C., Koller, D. L., Peltonen, L., Cooper, J. D., O’Reilly, P. F., Houston, D. K., Glazer, N. L., Vandenput, L., Peacock, M., Shi, J., Rivadeneira, F., McCarthy, M. I., Anneli, P., de Boer, I. H., Mangino, M., Kato, B., Smyth, D. J., Booth, S. L., Jacques, P. F., Burke, G. L., Goodarzi, M., Cheung, C. L., Wolf, M., Rice, K., Goltzman, D., Hidiroglou, N., Ladouceur, M., Wareham, N. J., Hocking, L. J., Hart, D., Arden, N. K., Cooper, C., Malik, S., Fraser, W. D., Hartikainen, A. L., Zhai, G., Macdonald, H. M., Forouhi, N. G., Loos, R. J., Reid, D. M., Hakim, A., Dennison, E., Liu, Y., Power, C., Stevens, H. E., Jaana, L., Vasan, R. S., Soranzo, N., Bojunga, J., Psaty, B. M., Lorentzon, M., Foroud, T., Harris, T. B., Hofman, A., Jansson, J. O., Cauley, J. A., Uitterlinden, A. G., Gibson, Q., Jarvelin, M. R., Karasik, D., Siscovick, D. S., Econs, M. J., Kritchevsky, S. B., Florez, J. C., Todd, J. A., Dupuis, J., Hypponen, E., and Spector, T. D. Common genetic determinants of vitamin D insufficiency: a genome-wide association study. Lancet 7-17-2010;376(9736):180-188. View abstract.

84473

Nielsen, N. O., Skifte, T., Andersson, M., Wohlfahrt, J., Soborg, B., Koch, A., Melbye, M., and Ladefoged, K. Both high and low serum vitamin D concentrations are associated with tuberculosis: a case-control study in Greenland. Br J Nutr 2010;104(10):1487-1491. View abstract.

84474

Stolzenberg-Solomon, R. Z., Jacobs, E. J., Arslan, A. A., Qi, D., Patel, A. V., Helzlsouer, K. J., Weinstein, S. J., McCullough, M. L., Purdue, M. P., Shu, X. O., Snyder, K., Virtamo, J., Wilkins, L. R., Yu, K., Zeleniuch-Jacquotte, A., Zheng, W., Albanes, D., Cai, Q., Harvey, C., Hayes, R., Clipp, S., Horst, R. L., Irish, L., Koenig, K., Le, Marchand L., and Kolonel, L. N. Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol. 7-1-2010;172(1):81-93. View abstract.

84476

Meguid, N. A., Hashish, A. F., Anwar, M., and Sidhom, G. Reduced serum levels of 25-hydroxy and 1,25-dihydroxy vitamin D in Egyptian children with autism. J Altern Complement Med 2010;16(6):641-645. View abstract.

84477

May, H. T., Bair, T. L., Lappe, D. L., Anderson, J. L., Horne, B. D., Carlquist, J. F., and Muhlestein, J. B. Association of vitamin D levels with incident depression among a general cardiovascular population. Am Heart J 2010;159(6):1037-1043. View abstract.

84478

Grandi, N. C., Breitling, L. P., Vossen, C. Y., Hahmann, H., Wusten, B., Marz, W., Rothenbacher, D., and Brenner, H. Serum vitamin D and risk of secondary cardiovascular disease events in patients with stable coronary heart disease. Am Heart J 2010;159(6):1044-1051. View abstract.

84479

Grant, W. B. Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers. J Photochem.Photobiol.B 11-3-2010;101(2):130-136. View abstract.

84480

Wheless, L., Black, J., and Alberg, A. J. Nonmelanoma skin cancer and the risk of second primary cancers: a systematic review. Cancer Epidemiol.Biomarkers Prev. 2010;19(7):1686-1695. View abstract.

84481

Stewart, R. and Hirani, V. Relationship between vitamin D levels and depressive symptoms in older residents from a national survey population. Psychosom Med 2010;72(7):608-612. View abstract.

84482

Witham, M. D., Dove, F. J., Dryburgh, M., Sugden, J. A., Morris, A. D., and Struthers, A. D. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia 2010;53(10):2112-2119. View abstract.

84483

Grandi, N. C., Breitling, L. P., and Brenner, H. Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev.Med 2010;51(3-4):228-233. View abstract.

84484

Lepore, L., Pennesi, M., Barbi, E., and Pozzi, R. Treatment and prevention of osteoporosis in juvenile chronic arthritis with disodium clodronate. Clin Exp.Rheumatol 1991;9 Suppl 6:33-35. View abstract.

84485

Batchelor, F., Hill, K., Mackintosh, S., and Said, C. What works in falls prevention after stroke?: a systematic review and meta-analysis. Stroke 2010;41(8):1715-1722. View abstract.

84486

Wu, S. H., Ho, S. C., and Zhong, L. Effects of vitamin D supplementation on blood pressure. South Med J 2010;103(8):729-737. View abstract.

84487

Laaksi, I., Ruohola, J. P., Mattila, V., Auvinen, A., Ylikomi, T., and Pihlajamaki, H. Vitamin D supplementation for the prevention of acute respiratory tract infection: a randomized, double-blinded trial among young Finnish men. J Infect.Dis. 9-1-2010;202(5):809-814. View abstract.

84488

Sabherwal, S., Bravis, V., and Devendra, D. Effect of oral vitamin D and calcium replacement on glycaemic control in South Asian patients with type 2 diabetes. Int J Clin Pract. 2010;64(8):1084-1089. View abstract.

84489

Giusti, A., Barone, A., Pioli, G., Girasole, G., Razzano, M., Pizzonia, M., Pedrazzoni, M., Palummeri, E., and Bianchi, G. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency. J Am Geriatr Soc 2010;58(8):1489-1495. View abstract.

84490

Fedirko, V., Bostick, R. M., Goodman, M., Flanders, W. D., and Gross, M. D. Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study. Am J Epidemiol. 9-1-2010;172(5):489-500. View abstract.

84491

Javanbakht, M. H., Keshavarz, S. A., Djalali, M., Siassi, F., Eshraghian, M. R., Firooz, A., Seirafi, H., Ehsani, A. H., Chamari, M., and Mirshafiey, A. Randomized controlled trial using vitamins E and D supplementation in atopic dermatitis. J Dermatolog.Treat. 2011;22(3):144-150. View abstract.

84492

Aloia, J. F., Chen, D. G., Yeh, J. K., and Chen, H. Serum vitamin D metabolites and intestinal calcium absorption efficiency in women. Am J Clin Nutr 2010;92(4):835-840. View abstract.

84493

Heaney, R. P. Does inconclusive evidence for vitamin D supplementation to reduce risk for cardiovascular disease warrant pessimism? Ann.Intern Med 8-3-2010;153(3):208-209. View abstract.

84494

Plotnikoff, G. A. Does inconclusive evidence for vitamin D supplementation to reduce risk for cardiovascular disease warrant pessimism? Ann.Intern Med 8-3-2010;153(3):208-210. View abstract.

84497

Haseen, F., Murray, L. J., O’Neill, R. F., O’Sullivan, J. M., and Cantwell, M. M. A randomised controlled trial to evaluate the efficacy of a 6 month dietary and physical activity intervention for prostate cancer patients receiving androgen deprivation therapy. Trials 2010;11:86. View abstract.

84499

Michaelsson, K., Baron, J. A., Snellman, G., Gedeborg, R., Byberg, L., Sundstrom, J., Berglund, L., Arnlov, J., Hellman, P., Blomhoff, R., Wolk, A., Garmo, H., Holmberg, L., and Melhus, H. Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr 2010;92(4):841-848. View abstract.

84500

Manaseki-Holland, S., Qader, G., Isaq, Masher M., Bruce, J., Zulf, Mughal M., Chandramohan, D., and Walraven, G. Effects of vitamin D supplementation to children diagnosed with pneumonia in Kabul: a randomised controlled trial. Trop.Med.Int Health 2010;15(10):1148-1155. View abstract.

84503

Oleson, C. V., Patel, P. H., and Wuermser, L. A. Influence of season, ethnicity, and chronicity on vitamin D deficiency in traumatic spinal cord injury. J Spinal Cord.Med 2010;33(3):202-213. View abstract.

84504

Meems, L. M., van der Harst, P., van Gilst, W. H., and de Boer, R. A. Vitamin D biology in heart failure: molecular mechanisms and systematic review. Curr Drug Targets. 2011;12(1):29-41. View abstract.

84505

Sandhu, M. S. and Casale, T. B. The role of vitamin D in asthma. Ann.Allergy Asthma Immunol. 2010;105(3):191-199. View abstract.

84506

Pittas, A. G., Sun, Q., Manson, J. E., Dawson-Hughes, B., and Hu, F. B. Plasma 25-hydroxyvitamin D concentration and risk of incident type 2 diabetes in women. Diabetes Care 2010;33(9):2021-2023. View abstract.

84507

Shahar, D. R., Schwarzfuchs, D., Fraser, D., Vardi, H., Thiery, J., Fiedler, G. M., Bluher, M., Stumvoll, M., Stampfer, M. J., and Shai, I. Dairy calcium intake, serum vitamin D, and successful weight loss. Am J Clin Nutr 2010;92(5):1017-1022. View abstract.

84508

Doria, A., Zen, M., Canova, M., Bettio, S., Bassi, N., Nalotto, L., Rampudda, M., Ghirardello, A., and Iaccarino, L. SLE diagnosis and treatment: when early is early. Autoimmun.Rev. 2010;10(1):55-60. View abstract.

84509

Reddy, Vanga S., Good, M., Howard, P. A., and Vacek, J. L. Role of vitamin D in cardiovascular health. Am J Cardiol 9-15-2010;106(6):798-805. View abstract.

84510

Jorde, R., Figenschau, Y., Hutchinson, M., Emaus, N., and Grimnes, G. High serum 25-hydroxyvitamin D concentrations are associated with a favorable serum lipid profile. Eur.J Clin.Nutr 2010;64(12):1457-1464. View abstract.

84511

Shen, H., Bielak, L. F., Ferguson, J. F., Streeten, E. A., Yerges-Armstrong, L. M., Liu, J., Post, W., O’Connell, J. R., Hixson, J. E., Kardia, S. L., Sun, Y. V., Jhun, M. A., Wang, X., Mehta, N. N., Li, M., Koller, D. L., Hakonarson, H., Keating, B. J., Rader, D. J., Shuldiner, A. R., Peyser, P. A., Reilly, M. P., and Mitchell, B. D. Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler.Thromb.Vasc.Biol. 2010;30(12):2648-2654. View abstract.

84512

Anderson, J. L., May, H. T., Horne, B. D., Bair, T. L., Hall, N. L., Carlquist, J. F., Lappe, D. L., and Muhlestein, J. B. Relation of vitamin D deficiency to cardiovascular risk factors, disease status, and incident events in a general healthcare population. Am J Cardiol 10-1-2010;106(7):963-968. View abstract.

84513

Zold, E., Szodoray, P., Nakken, B., Barath, S., Kappelmayer, J., Csathy, L., Hajas, A., Sipka, S., Gyimesi, E., Gaal, J., Barta, Z., Hallay, J., Szegedi, G., and Bodolay, E. Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease. Autoimmun.Rev. 2011;10(3):155-162. View abstract.

84514

Toner, C. D., Davis, C. D., and Milner, J. A. The vitamin D and cancer conundrum: aiming at a moving target. J Am Diet Assoc 2010;110(10):1492-1500. View abstract.

84515

Hari, P., Gupta, N., Hari, S., Gulati, A., Mahajan, P., and Bagga, A. Vitamin D insufficiency and effect of cholecalciferol in children with chronic kidney disease. Pediatr.Nephrol. 2010;25(12):2483-2488. View abstract.

84516

Kandula, P., Dobre, M., Schold, J. D., Schreiber, M. J., Jr., Mehrotra, R., and Navaneethan, S. D. Vitamin D supplementation in chronic kidney disease: a systematic review and meta-analysis of observational studies and randomized controlled trials. Clin J Am Soc Nephrol. 2011;6(1):50-62. View abstract.

84518

Patel, P., Poretsky, L., and Liao, E. Lack of effect of subtherapeutic vitamin D treatment on glycemic and lipid parameters in Type 2 diabetes: A pilot prospective randomized trial. J Diabetes 2010;2(1):36-40. View abstract.

84519

Meeuwis, K. A., de Hullu, J. A., Massuger, L. F., van de Kerkhof, P. C., and van Rossum, M. M. Genital psoriasis: A systematic literature review on this hidden skin disease. Acta Derm.Venereol. 2011;91(1):5-11. View abstract.

84520

Winzenberg, T. M., Powell, S., Shaw, K. A., and Jones, G. Vitamin D supplementation for improving bone mineral density in children. Cochrane Database Syst Rev 2010;(10):CD006944. View abstract.

84522

Rendina, D., De, Filippo G., and Strazzullo, P. Should vitamin D status be assessed in patients with congestive heart failure? Nutr Metab Cardiovasc.Dis. 2010;20(9):627-632. View abstract.

84523

Jean, G., Vanel, T., Terrat, J. C., and Chazot, C. Prevention of secondary hyperparathyroidism in hemodialysis patients: the key role of native vitamin D supplementation. Hemodial.Int 2010;14(4):486-491. View abstract.

84524

Zeeb, H. and Greinert, R. The role of vitamin D in cancer prevention: does UV protection conflict with the need to raise low levels of vitamin D? Dtsch.Arztebl.Int 2010;107(37):638-643. View abstract.

84525

Tenforde, A. S., Sayres, L. C., Sainani, K. L., and Fredericson, M. Evaluating the relationship of calcium and vitamin D in the prevention of stress fracture injuries in the young athlete: a review of the literature. PM.R. 2010;2(10):945-949. View abstract.

84526

Boullata, J. I. Vitamin D supplementation: a pharmacologic perspective. Curr Opin.Clin Nutr Metab Care 2010;13(6):677-684. View abstract.

84527

Haggerty, L. L. Maternal supplementation for prevention and treatment of vitamin d deficiency in exclusively breastfed infants. Breastfeed.Med 2011;6:137-144. View abstract.

84529

Kriegel, M. A., Manson, J. E., and Costenbader, K. H. Does vitamin d affect risk of developing autoimmune disease?: a systematic review. Semin.Arthritis Rheum. 2011;40(6):512-531. View abstract.

84530

Zhu, K., Austin, N., Devine, A., Bruce, D., and Prince, R. L. A randomized controlled trial of the effects of vitamin D on muscle strength and mobility in older women with vitamin D insufficiency. J Am Geriatr.Soc. 2010;58(11):2063-2068. View abstract.

84531

de, Zeeuw D., Agarwal, R., Amdahl, M., Audhya, P., Coyne, D., Garimella, T., Parving, H. H., Pritchett, Y., Remuzzi, G., Ritz, E., and Andress, D. Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 11-6-2010;376(9752):1543-1551. View abstract.

84533

Rabenda, V., Bruyere, O., and Reginster, J. Y. Relationship between bone mineral density changes and risk of fractures among patients receiving calcium with or without vitamin D supplementation: a meta-regression. Osteoporos.Int 2011;22(3):893-901. View abstract.

84534

Annweiler, C., Schott, A. M., Rolland, Y., Blain, H., Herrmann, F. R., and Beauchet, O. Dietary intake of vitamin D and cognition in older women: a large population-based study. Neurology 11-16-2010;75(20):1810-1816. View abstract.

84535

Lebret, T., Coloby, P., Descotes, J. L., Droupy, S., Geraud, M., and Tombal, B. Educational tool-kit on diet and exercise: survey of prostate cancer patients about to receive androgen deprivation therapy. Urology 2010;76(6):1434-1439. View abstract.

84536

van de Kerkhof, P., de, Peuter R., Ryttov, J., and Jansen, J. P. Mixed treatment comparison of a two-compound formulation (TCF) product containing calcipotriol and betamethasone dipropionate with other topical treatments in psoriasis vulgaris. Curr.Med.Res Opin. 2011;27(1):225-238. View abstract.

84537

Vecchio, M., Navaneethan, S. D., Johnson, D. W., Lucisano, G., Graziano, G., Saglimbene, V., Ruospo, M., Querques, M., Jannini, E. A., and Strippoli, G. F. Interventions for treating sexual dysfunction in patients with chronic kidney disease. Cochrane Database Syst Rev 2010;(12):CD007747. View abstract.

84538

Jagannath, V. A., Fedorowicz, Z., Asokan, G. V., Robak, E. W., and Whamond, L. Vitamin D for the management of multiple sclerosis. Cochrane Database Syst Rev 2010;(12):CD008422. View abstract.

84539

Michael, Y. L., Whitlock, E. P., Lin, J. S., Fu, R., O’Connor, E. A., and Gold, R. Primary care-relevant interventions to prevent falling in older adults: a systematic evidence review for the U.S. Preventive Services Task Force. Ann.Intern Med 12-21-2010;153(12):815-825. View abstract.

84541

Burgaz, A., Orsini, N., Larsson, S. C., and Wolk, A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. J Hypertens. 2011;29(4):636-645. View abstract.

84543

Gilbert, R., Martin, R. M., Beynon, R., Harris, R., Savovic, J., Zuccolo, L., Bekkering, G. E., Fraser, W. D., Sterne, J. A., and Metcalfe, C. Associations of circulating and dietary vitamin D with prostate cancer risk: a systematic review and dose-response meta-analysis. Cancer Causes Control 2011;22(3):319-340. View abstract.

84544

Martineau, A. R., Timms, P. M., Bothamley, G. H., Hanifa, Y., Islam, K., Claxton, A. P., Packe, G. E., Moore-Gillon, J. C., Darmalingam, M., Davidson, R. N., Milburn, H. J., Baker, L. V., Barker, R. D., Woodward, N. J., Venton, T. R., Barnes, K. E., Mullett, C. J., Coussens, A. K., Rutterford, C. M., Mein, C. A., Davies, G. R., Wilkinson, R. J., Nikolayevskyy, V., Drobniewski, F. A., Eldridge, S. M., and Griffiths, C. J. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 1-15-2011;377(9761):242-250. View abstract.

84545

Annweiler, C., Fantino, B., Le, Gall D., Schott, A. M., Berrut, G., and Beauchet, O. Severe vitamin D deficiency is associated with advanced-stage dementia in geriatric inpatients. J Am Geriatr Soc 2011;59(1):169-171. View abstract.

84547

Maki, K. C., Rubin, M. R., Wong, L. G., McManus, J. F., Jensen, C. D., and Lawless, A. Effects of vitamin D supplementation on 25-hydroxyvitamin D, high-density lipoprotein cholesterol, and other cardiovascular disease risk markers in subjects with elevated waist circumference. Int J Food Sci Nutr 2011;62(4):318-327. View abstract.

84549

Winzenberg, T., Powell, S., Shaw, K. A., and Jones, G. Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta-analysis. BMJ 2011;342:c7254. View abstract.

84550

Shaw, N. Vitamin D and bone health in children. BMJ 2011;342:d192. View abstract.

84553

Arnson, Y., Amital, H., Agmon-Levin, N., Alon, D., Sanchez-Castanon, M., Lopez-Hoyos, M., Matucci-Cerinic, M., Szucs, G., Shapira, Y., Szekanecz, Z., and Shoenfeld, Y. Serum 25-OH vitamin D concentrations are linked with various clinical aspects in patients with systemic sclerosis: a retrospective cohort study and review of the literature. Autoimmun.Rev. 2011;10(8):490-494. View abstract.

84554

Petchey, W. G., Johnson, D. W., and Isbel, N. M. Shining D’ light on chronic kidney disease: mechanisms that may underpin the cardiovascular benefit of vitamin D. Nephrology.(Carlton.) 2011;16(4):351-367. View abstract.

84555

Yin, L., Grandi, N., Raum, E., Haug, U., Arndt, V., and Brenner, H. Meta-analysis: Circulating vitamin D and ovarian cancer risk. Gynecol Oncol. 5-1-2011;121(2):369-375. View abstract.

84556

Touvier, M., Chan, D. S., Lau, R., Aune, D., Vieira, R., Greenwood, D. C., Kampman, E., Riboli, E., Hercberg, S., and Norat, T. Meta-analyses of vitamin D intake, 25-hydroxyvitamin D status, vitamin D receptor polymorphisms, and colorectal cancer risk. Cancer Epidemiol.Biomarkers Prev. 2011;20(5):1003-1016. View abstract.

84558

Reid, I. R., Bolland, M. J., Avenell, A., and Grey, A. Cardiovascular effects of calcium supplementation. Osteoporos.Int 2011;22(6):1649-1658. View abstract.

84559

Zittermann, A., Gummert, J. F., and Borgermann, J. The role of vitamin D in dyslipidemia and cardiovascular disease. Curr.Pharm Des 2011;17(9):933-942. View abstract.

84560

Sudarsanam, T. D., John, J., Kang, G., Mahendri, V., Gerrior, J., Franciosa, M., Gopal, S., John, K. R., Wanke, C. A., and Muliyil, J. Pilot randomized trial of nutritional supplementation in patients with tuberculosis and HIV-tuberculosis coinfection receiving directly observed short-course chemotherapy for tuberculosis. Trop.Med.Int Health 2011;16(6):699-706. View abstract.

84561

Manson, J. E., Mayne, S. T., and Clinton, S. K. Vitamin D and prevention of cancer–ready for prime time? N.Engl.J Med. 4-14-2011;364(15):1385-1387. View abstract.

84562

Kaats, G. R., Preuss, H. G., Croft, H. A., Keith, S. C., and Keith, P. L. A comparative effectiveness study of bone density changes in women over 40 following three bone health plans containing variations of the same novel plant-sourced calcium. Int J Med Sci 2011;8(3):180-191. View abstract.

84563

Neyens, J. C., van Haastregt, J. C., Dijcks, B. P., Martens, M., van den Heuvel, W. J., de Witte, L. P., and Schols, J. M. Effectiveness and implementation aspects of interventions for preventing falls in elderly people in long-term care facilities: a systematic review of RCTs. J Am Med.Dir.Assoc. 2011;12(6):410-425. View abstract.

84565

Messenger, W., Nielson, C. M., Li, H., Beer, T., Barrett-Connor, E., Stone, K., and Shannon, J. Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr Metab Cardiovasc.Dis. 2012;22(10):856-863. View abstract.

84566

Torregrosa, J. V., Bover, J., Cannata, Andia J., Lorenzo, V., de Francisco, A. L., Martinez, I., Rodriguez, Portillo M., Arenas, L., Gonzalez, Parra E., Caravaca, F., Martin-Malo, A., Fernandez, Giraldez E., and Torres, A. Spanish Society of Nephrology recommendations for controlling mineral and bone disorder in chronic kidney disease patients (S.E.N.-M.B.D.). Nefrologia. 2011;31 Suppl 1:3-32. View abstract.

84567

Leytin, V. and Beaudoin, F. L. Reducing hip fractures in the elderly. Clin.Interv.Aging 2011;6:61-65. View abstract.

84568

Scher, H. I., Jia, X., Chi, K., de, Wit R., Berry, W. R., Albers, P., Henick, B., Waterhouse, D., Ruether, D. J., Rosen, P. J., Meluch, A. A., Nordquist, L. T., Venner, P. M., Heidenreich, A., Chu, L., and Heller, G. Randomized, open-label phase III trial of docetaxel plus high-dose calcitriol versus docetaxel plus prednisone for patients with castration-resistant prostate cancer. J Clin.Oncol. 6-1-2011;29(16):2191-2198. View abstract.

84569

Grozdev, I. S., Van Voorhees, A. S., Gottlieb, A. B., Hsu, S., Lebwohl, M. G., Bebo, B. F., Jr., and Korman, N. J. Psoriasis in the elderly: from the Medical Board of the National Psoriasis Foundation. J Am Acad.Dermatol. 2011;65(3):537-545. View abstract.

84572

Bolland, M. J., Grey, A., Avenell, A., Gamble, G. D., and Reid, I. R. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women’s Health Initiative limited access dataset and meta-analysis. BMJ 2011;342:d2040. View abstract.

84575

Motiwala, S. R. and Wang, T. J. Vitamin D and cardiovascular disease. Curr.Opin.Nephrol.Hypertens. 2011;20(4):345-353. View abstract.

84576

Block, G. A. Therapeutic interventions for chronic kidney disease-mineral and bone disorders: focus on mortality. Curr.Opin.Nephrol.Hypertens. 2011;20(4):376-381. View abstract.

84577

Martinez, C., Virgili, N., Cuerda, C., Chicharro, L., Gomez, P., Moreno, J. M., Alvarez, J., Marti, E., Matia, P., Penacho, M. A., Garde, C., De, Luis D., Gonzalo, M., and Lobo, G. [Transversal study on the prevalence of Metabolic Bone Disease (MBD) and Home Parenteral Nutrition (HPN) in Spain: data from NADYA group]. Nutr Hosp. 2010;25(6):920-924. View abstract.

84578

Salesi, M. and Farajzadegan, Z. Efficacy of Vitamin D in patients with active rheumatoid arthritis receiving methotrexate therapy. Rheumatol Int 4-27-2011; View abstract.

84579

Cesur, Y., Dogan, M., Ariyuca, S., Basaranoglu, M., Bektas, M. S., Peker, E., Akbayram, S., and Caksen, H. Evaluation of children with nutritional rickets. J Pediatr.Endocrinol.Metab 2011;24(1-2):35-43. View abstract.

84580

Vestergaard, P., Mosekilde, L., and Langdahl, B. Fracture prevention in postmenopausal women. Clin.Evid.(Online.) 2011;2011 View abstract.

84581

Yeh, Y., Slovik, D., Carter, D., Clapp, M., Churchill, W., and Reddy, P. Intravenous bisphosphonates for post-menopausal osteoporosis: adherence to a network guideline. J Clin.Pharm Ther. 2011;36(3):342-347. View abstract.

84583

Sticherling, M., Augustin, M., Boehncke, W. H., Christophers, E., Domm, S., Gollnick, H., Reich, K., and Mrowietz, U. Therapy of psoriasis in childhood and adolescence – a German expert consensus. J Dtsch.Dermatol.Ges. 2011;9(10):815-823. View abstract.

84585

Church, J., Goodall, S., Norman, R., and Haas, M. An economic evaluation of community and residential aged care falls prevention strategies in NSW. N.S.W.Public Health Bull. 2011;22(3-4):60-68. View abstract.

84587

Holick, M. F., Binkley, N. C., Bischoff-Ferrari, H. A., Gordon, C. M., Hanley, D. A., Heaney, R. P., Murad, M. H., and Weaver, C. M. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin.Endocrinol.Metab 2011;96(7):1911-1930. View abstract.

84588

Moorthi, R. N., Kandula, P., and Moe, S. M. Optimal vitamin D, calcitriol, and vitamin D analog replacement in chronic kidney disease: to D or not to D: that is the question. Curr.Opin.Nephrol.Hypertens. 2011;20(4):354-359. View abstract.

84589

Bischoff-Ferrari, H. A. The role of falls in fracture prediction. Curr.Osteoporos.Rep 2011;9(3):116-121. View abstract.

84590

Elamin, M. B., Abu Elnour, N. O., Elamin, K. B., Fatourechi, M. M., Alkatib, A. A., Almandoz, J. P., Liu, H., Lane, M. A., Mullan, R. J., Hazem, A., Erwin, P. J., Hensrud, D. D., Murad, M. H., and Montori, V. M. Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis. J Clin.Endocrinol.Metab 2011;96(7):1931-1942. View abstract.

84592

Hollis, B. W., Johnson, D., Hulsey, T. C., Ebeling, M., and Wagner, C. L. Vitamin D supplementation during pregnancy: double-blind, randomized clinical trial of safety and effectiveness. J Bone Miner.Res 2011;26(10):2341-2357. View abstract.

84593

Sai, A. J., Gallagher, J. C., and Fang, X. Effect of hormone therapy and calcitriol on serum lipid profile in postmenopausal older women: association with estrogen receptor-alpha genotypes. Menopause. 2011;18(10):1101-1112. View abstract.

84594

Mitri, J., Muraru, M. D., and Pittas, A. G. Vitamin D and type 2 diabetes: a systematic review. Eur.J Clin.Nutr 2011;65(9):1005-1015. View abstract.

84595

Bjelakovic, G., Gluud, L. L., Nikolova, D., Whitfield, K., Wetterslev, J., Simonetti, R. G., Bjelakovic, M., and Gluud, C. Vitamin D supplementation for prevention of mortality in adults. Cochrane.Database.Syst.Rev. 2011;(7):CD007470. View abstract.

84597

Vondracek, S. F. and Hoody, D. W. Combination vitamin D therapy in stage 5 chronic kidney disease. Ann.Pharmacother. 2011;45(7-8):1011-1015. View abstract.

84598

Shiraki, M. [Doctor initiated clinical trial for obtaining evidences in treatment of osteoporosis: JOINT (Japanese Osteoporosis Intervention Trial) protocol]. Nihon Rinsho 2011;69(7):1281-1286. View abstract.

84599

Brunner, R. L., Wactawski-Wende, J., Caan, B. J., Cochrane, B. B., Chlebowski, R. T., Gass, M. L., Jacobs, E. T., LaCroix, A. Z., Lane, D., Larson, J., Margolis, K. L., Millen, A. E., Sarto, G. E., Vitolins, M. Z., and Wallace, R. B. The effect of calcium plus vitamin D on risk for invasive cancer: results of the Women’s Health Initiative (WHI) calcium plus vitamin D randomized clinical trial. Nutr Cancer 2011;63(6):827-841. View abstract.

84600

Murad, M. H., Elamin, K. B., Abu Elnour, N. O., Elamin, M. B., Alkatib, A. A., Fatourechi, M. M., Almandoz, J. P., Mullan, R. J., Lane, M. A., Liu, H., Erwin, P. J., Hensrud, D. D., and Montori, V. M. Clinical review: The effect of vitamin D on falls: a systematic review and meta-analysis. J Clin.Endocrinol.Metab 2011;96(10):2997-3006. View abstract.

84601

Aloia, J. F. Clinical Review: The 2011 report on dietary reference intake for vitamin D: where do we go from here? J Clin.Endocrinol.Metab 2011;96(10):2987-2996. View abstract.

84602

Barnett, C. M. and Beer, T. M. Prostate cancer and vitamin D: what does the evidence really suggest? Urol.Clin.North Am 2011;38(3):333-342. View abstract.

84605

Vucinic, V., Skodric-Trifunovic, V., and Ignjatovic, S. How to diagnose and manage difficult problems of calcium metabolism in sarcoidosis: an evidence-based review. Curr.Opin.Pulm.Med. 2011;17(5):297-302. View abstract.

84606

Buttigliero, C., Monagheddu, C., Petroni, P., Saini, A., Dogliotti, L., Ciccone, G., and Berruti, A. Prognostic role of vitamin d status and efficacy of vitamin D supplementation in cancer patients: a systematic review. Oncologist. 2011;16(9):1215-1227. View abstract.

84607

Stein, E. M., Ortiz, D., Jin, Z., McMahon, D. J., and Shane, E. Prevention of fractures after solid organ transplantation: a meta-analysis. J Clin.Endocrinol.Metab 2011;96(11):3457-3465. View abstract.

84608

Ma, Y., Zhang, P., Wang, F., Yang, J., Liu, Z., and Qin, H. Association between vitamin D and risk of colorectal cancer: a systematic review of prospective studies. J Clin.Oncol. 10-1-2011;29(28):3775-3782. View abstract.

84609

Daniel, D. and Pirotta, M. V. Fibromyalgia–should we be testing and treating for vitamin D deficiency? Aust.Fam.Physician 2011;40(9):712-716. View abstract.

84610

Brophy, S., Davies, H., Mannan, S., Brunt, H., and Williams, R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane.Database.Syst.Rev. 2011;(9):CD006165. View abstract.

84613

Iqbal, S. F. and Freishtat, R. J. Mechanism of action of vitamin D in the asthmatic lung. J Investig.Med. 2011;59(8):1200-1202. View abstract.

84614

Mitchell, D. The relationship between vitamin D and cancer. Clin.J Oncol.Nurs. 2011;15(5):557-560. View abstract.

84616

Bollerslev, J., Marcocci, C., Sosa, M., Nordenstrom, J., Bouillon, R., and Mosekilde, L. Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism. Eur.J Endocrinol. 2011;165(6):851-864. View abstract.

84617

Schnatz, P. F. The 2010 North American Menopause Society position statement: Updates on screening, prevention and management of postmenopausal osteoporosis. Conn.Med. 2011;75(8):485-487. View abstract.

84618

Yaghjyan, L., Colditz, G. A., and Drake, B. Vitamin D and mammographic breast density: a systematic review. Cancer Causes Control 2012;23(1):1-13. View abstract.

84619

Cashman, K. D., Fitzgerald, A. P., Kiely, M., and Seamans, K. M. A systematic review and meta-regression analysis of the vitamin D intake-serum 25-hydroxyvitamin D relationship to inform European recommendations. Br.J Nutr 2011;106(11):1638-1648. View abstract.

84620

Paul, G., Brehm, J. M., Alcorn, J. F., Holguin, F., Aujla, S. J., and Celedon, J. C. Vitamin D and asthma. Am J Respir.Crit Care Med. 1-15-2012;185(2):124-132. View abstract.

84621

Fehlings, D., Switzer, L., Agarwal, P., Wong, C., Sochett, E., Stevenson, R., Sonnenberg, L., Smile, S., Young, E., Huber, J., Milo-Manson, G., Kuwaik, G. A., and Gaebler, D. Informing evidence-based clinical practice guidelines for children with cerebral palsy at risk of osteoporosis: a systematic review. Dev.Med.Child Neurol. 2012;54(2):106-116. View abstract.

84622

Chen, L. L., Li, H., Zhang, P. P., and Wang, S. M. Association between vitamin D receptor polymorphisms and periodontitis: a meta-analysis. J Periodontol. 2012;83(9):1095-1103. View abstract.

84623

Chung, M., Lee, J., Terasawa, T., Lau, J., and Trikalinos, T. A. Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann.Intern.Med. 12-20-2011;155(12):827-838. View abstract.

84624

Muir, S. W. and Montero-Odasso, M. Effect of vitamin D supplementation on muscle strength, gait and balance in older adults: a systematic review and meta-analysis. J Am Geriatr.Soc. 2011;59(12):2291-2300. View abstract.

84625

Melamed, M. L. and Thadhani, R. I. Vitamin D therapy in chronic kidney disease and end stage renal disease. Clin.J Am Soc.Nephrol. 2012;7(2):358-365. View abstract.

84626

Schoindre, Y., Terrier, B., Kahn, J. E., Saadoun, D., Souberbielle, J. C., Benveniste, O., Amoura, Z., Piette, J. C., Cacoub, P., and Costedoat-Chalumeau, N. [Vitamin D and autoimmunity. Second part: Clinical aspects]. Rev.Med.Interne 2012;33(2):87-93. View abstract.

84627

Kalra, P., Das, V., Agarwal, A., Kumar, M., Ramesh, V., Bhatia, E., Gupta, S., Singh, S., Saxena, P., and Bhatia, V. Effect of vitamin D supplementation during pregnancy on neonatal mineral homeostasis and anthropometry of the newborn and infant. Br.J Nutr 9-28-2012;108(6):1052-1058. View abstract.

84628

Cheng, J., Zhang, W., Zhang, X., Li, X., and Chen, J. Efficacy and safety of paricalcitol therapy for chronic kidney disease: a meta-analysis. Clin.J Am Soc.Nephrol. 2012;7(3):391-400. View abstract.

84629

Bischoff-Ferrari, H., Stahelin, H. B., and Walter, P. Vitamin D effects on bone and muscle. Int J Vitam.Nutr Res 2011;81(4):264-272. View abstract.

84630

Lerchbaum, E. and Obermayer-Pietsch, B. Vitamin D and fertility: a systematic review. Eur.J Endocrinol. 2012;166(5):765-778. View abstract.

84631

Body, J. J., Bergmann, P., Boonen, S., Devogelaer, J. P., Gielen, E., Goemaere, S., Kaufman, J. M., Rozenberg, S., and Reginster, J. Y. Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications. Osteoporos.Int 2012;23 Suppl 1:S1-23. View abstract.

84632

Reyes, Garcia R., Jodar, Gimeno E., Garcia, Martin A., Romero, Munoz M., Gomez Saez, J. M., Luque, Fernandez, I, Varsavsky, M., Guadalix, Iglesias S., Cano, Rodriguez, I, Ballesteros Pomar, M. D., Vidal, Casariego A., Rozas, Moreno P., Cortes, Berdonces M., Fernandez, Garcia D., Calleja, Canelas A., Palma, Moya M., Martinez Diaz-Guerra, G., Jimenez Moleon, J. J., and Munoz, Torres M. [Clinical practice guidelines for evaluation and treatment of osteoporosis associated to endocrine and nutritional conditions. Bone Metabolism Working Group of the Spanish Society of Endocrinology]. Endocrinol.Nutr 2012;59(3):174-196. View abstract.

84633

Urrutia, R. P. and Thorp, J. M. Vitamin D in pregnancy: current concepts. Curr.Opin.Obstet.Gynecol. 2012;24(2):57-64. View abstract.

84634

De-Regil, L. M., Palacios, C., Ansary, A., Kulier, R., and Pena-Rosas, J. P. Vitamin D supplementation for women during pregnancy. Cochrane.Database.Syst.Rev. 2012;2:CD008873. View abstract.

84635

Martinez Suarez, V, Moreno Villares, J. M., and Dalmau, Serra J. [Recommended intake of calcium and vitamin D: positioning of the Nutrition Committee of the AEP]. An.Pediatr.(Barc.) 2012;77(1):57-58. View abstract.

84636

Thomas, G. N., Scragg, R., Jiang, C. Q., Chan, W., Marz, W., Pilz, S., Kim, H. C., Tomlinson, B., Bosch, J., Lam, T. H., Cheung, B. M., and Cheng, K. K. Hyperglycaemia and vitamin D: a systematic overview. Curr.Diabetes Rev. 2012;8(1):18-31. View abstract.

84637

Nicholson, I., Dalzell, A. M., and El-Matary, W. Vitamin D as a therapy for colitis: a systematic review. J Crohns.Colitis. 2012;6(4):405-411. View abstract.

84638

Tangpricha, V., Kelly, A., Stephenson, A., Maguiness, K., Enders, J., Robinson, K. A., Marshall, B. C., and Borowitz, D. An update on the screening, diagnosis, management, and treatment of vitamin D deficiency in individuals with cystic fibrosis: evidence-based recommendations from the Cystic Fibrosis Foundation. J Clin.Endocrinol.Metab 2012;97(4):1082-1093. View abstract.

84639

Glade, M. J. A 21st century evaluation of the safety of oral vitamin D. Nutrition 2012;28(4):344-356. View abstract.

84640

Huckins, D., Felson, D. T., and Holick, M. Treatment of psoriatic arthritis with oral 1,25-dihydroxyvitamin D3: a pilot study. Arthritis Rheum. 1990;33(11):1723-1727. View abstract.

84641

Bacigalupi, R. M., Postolova, A., and Davis, R. S. Evidence-based, non-surgical treatments for vitiligo: a review. Am J Clin.Dermatol. 8-1-2012;13(4):217-237. View abstract.

84642

Wang, H., Xia, N., Yang, Y., and Peng, D. Q. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids Health Dis. 2012;11:42. View abstract.

84643

Haines, S. T. and Park, S. K. Vitamin D supplementation: what’s known, what to do, and what’s needed. Pharmacotherapy 2012;32(4):354-382. View abstract.

84644

Murad, M. H., Drake, M. T., Mullan, R. J., Mauck, K. F., Stuart, L. M., Lane, M. A., Abu Elnour, N. O., Erwin, P. J., Hazem, A., Puhan, M. A., Li, T., and Montori, V. M. Clinical review. Comparative effectiveness of drug treatments to prevent fragility fractures: a systematic review and network meta-analysis. J Clin.Endocrinol.Metab 2012;97(6):1871-1880. View abstract.

84645

George, P. S., Pearson, E. R., and Witham, M. D. Effect of vitamin D supplementation on glycaemic control and insulin resistance: a systematic review and meta-analysis. Diabet.Med. 2012;29(8):e142-e150. View abstract.

84646

Cao, S., Luo, P. F., Li, W., Tang, W. Q., Cong, X. N., and Wei, P. M. Vitamin D receptor genetic polymorphisms and tuberculosis among Chinese Han ethnic group. Chin Med.J (Engl.) 2012;125(5):920-925. View abstract.

84647

Devaux, S., Castela, A., Archier, E., Gallini, A., Joly, P., Misery, L., Aractingi, S., Aubin, F., Bachelez, H., Cribier, B., Jullien, D., Le, Maitre M., Richard, M. A., Ortonne, J. P., and Paul, C. Topical vitamin D analogues alone or in association with topical steroids for psoriasis: a systematic review. J Eur.Acad.Dermatol.Venereol. 2012;26 Suppl 3:52-60. View abstract.

84648

Ferguson, J. H. and Chang, A. B. Vitamin D supplementation for cystic fibrosis. Cochrane.Database.Syst.Rev. 2012;4:CD007298. View abstract.

84649

Black, L. J., Seamans, K. M., Cashman, K. D., and Kiely, M. An updated systematic review and meta-analysis of the efficacy of vitamin D food fortification. J Nutr 2012;142(6):1102-1108. View abstract.

84650

Pun, K. K., Wong, F. H., Wang, C., Lau, P., Ho, P. W., Pun, W. K., Chow, S. P., Cheng, C. L., Leong, J. C., and Young, R. T. Vitamin D status among patients with fractured neck of femur in Hong Kong. Bone 1990;11(5):365-368. View abstract.

84651

Kobold, U. Approaches to measurement of vitamin D concentrations – mass spectrometry. Scand.J Clin.Lab Invest Suppl 2012;243:54-59. View abstract.

84652

Tripkovic, L., Lambert, H., Hart, K., Smith, C. P., Bucca, G., Penson, S., Chope, G., Hypponen, E., Berry, J., Vieth, R., and Lanham-New, S. Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis. Am J Clin.Nutr 2012;95(6):1357-1364. View abstract.

84653

Crandall, C. J., Newberry, S. J., Diamant, A., Lim, Y. W., Gellad, W. F., Suttorp, M. J., Motala, A., Ewing, B., Roth, B., Shanman, R., Timmer, M., and Shekelle, P. G. 2012; View abstract.

84654

Rejnmark, L., Avenell, A., Masud, T., Anderson, F., Meyer, H. E., Sanders, K. M., Salovaara, K., Cooper, C., Smith, H. E., Jacobs, E. T., Torgerson, D., Jackson, R. D., Manson, J. E., Brixen, K., Mosekilde, L., Robbins, J. A., Francis, R. M., and Abrahamsen, B. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin.Endocrinol.Metab 2012;97(8):2670-2681. View abstract.

84655

Sanabria, A., Dominguez, L. C., Vega, V., Osorio, C., and Duarte, D. Cost-effectiveness analysis regarding postoperative administration of vitamin-D and calcium after thyroidectomy to prevent hypocalcaemia. Rev.Salud Publica (Bogota.) 2011;13(5):804-813. View abstract.

84657

Autier, P., Gandini, S., and Mullie, P. A systematic review: influence of vitamin D supplementation on serum 25-hydroxyvitamin D concentration. J Clin.Endocrinol.Metab 2012;97(8):2606-2613. View abstract.

84658

Levis, S. and Theodore, G. Summary of AHRQ’s comparative effectiveness review of treatment to prevent fractures in men and women with low bone density or osteoporosis: update of the 2007 report. J Manag.Care Pharm 2012;18(4 Suppl B):S1-15. View abstract.

84659

Thorne-Lyman, A. and Fawzi, W. W. Vitamin D during pregnancy and maternal, neonatal and infant health outcomes: a systematic review and meta-analysis. Paediatr.Perinat.Epidemiol 2012;26 Suppl 1:75-90. View abstract.

84660

Bischoff-Ferrari, H. A., Willett, W. C., Orav, E. J., Lips, P., Meunier, P. J., Lyons, R. A., Flicker, L., Wark, J., Jackson, R. D., Cauley, J. A., Meyer, H. E., Pfeifer, M., Sanders, K. M., Stahelin, H. B., Theiler, R., and Dawson-Hughes, B. A pooled analysis of vitamin D dose requirements for fracture prevention. N.Engl.J Med. 7-5-2012;367(1):40-49. View abstract.

84661

Antico, A., Tampoia, M., Tozzoli, R., and Bizzaro, N. Can supplementation with vitamin D reduce the risk or modify the course of autoimmune diseases? A systematic review of the literature. Autoimmun.Rev. 2012;12(2):127-136. View abstract.

84662

Datta, M. and Schwartz, G. G. Calcium and vitamin D supplementation during androgen deprivation therapy for prostate cancer: a critical review. Oncologist. 2012;17(9):1171-1179. View abstract.

84663

Moyer, V. A. Prevention of falls in community-dwelling older adults: U.S. Preventive Services Task Force recommendation statement. Ann.Intern.Med. 8-7-2012;157(3):197-204. View abstract.

84664

Liu, Y. T., Cai, Y. F., and Shi, J. P. [Meta-analysis on the relationship between 25-hydroxyvitamin D level and hypertension]. Zhonghua Yi Xue Za Zhi 5-15-2012;92(18):1268-1271. View abstract.

84665

Pereira, I. A., Mota, L. M., Cruz, B. A., Brenol, C. V., Fronza, L. S., Bertolo, M. B., Freitas, M. V., Silva, N. A., Louzada-Junior, P., Giorgi, R. D., Lima, R. A., and Pinheiro, Gda R. 2012 Brazilian Society of Rheumatology Consensus on the management of comorbidities in patients with rheumatoid arthritis. Rev.Bras.Reumatol. 2012;52(4):474-495. View abstract.

84666

Pereira, R. M., Carvalho, J. F., Paula, A. P., Zerbini, C., Domiciano, D. S., Goncalves, H., Danowski, J. S., Marques Neto, J. F., Mendonca, L. M., Bezerra, M. C., Terreri, M. T., Imamura, M., Weingrill, P., Plapler, P. G., Radominski, S., Tourinho, T., Szejnfeld, V. L., and Andrada, N. C. Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis. Rev.Bras.Reumatol. 2012;52(4):580-593. View abstract.

84667

Camargo, C. A., Jr., Ganmaa, D., Frazier, A. L., Kirchberg, F. F., Stuart, J. J., Kleinman, K., Sumberzul, N., and Rich-Edwards, J. W. Randomized trial of vitamin D supplementation and risk of acute respiratory infection in Mongolia. Pediatrics 2012;130(3):e561-e567. View abstract.

84668

Brondum-Jacobsen, P., Benn, M., Jensen, G. B., and Nordestgaard, B. G. 25-hydroxyvitamin d levels and risk of ischemic heart disease, myocardial infarction, and early death: population-based study and meta-analyses of 18 and 17 studies. Arterioscler.Thromb.Vasc.Biol. 2012;32(11):2794-2802. View abstract.

84669

Chowdhury, R., Stevens, S., Ward, H., Chowdhury, S., Sajjad, A., and Franco, O. H. Circulating vitamin D, calcium and risk of cerebrovascular disease: a systematic review and meta-analysis. Eur.J Epidemiol 2012;27(8):581-591. View abstract.

84670

Gillespie, L. D., Robertson, M. C., Gillespie, W. J., Sherrington, C., Gates, S., Clemson, L. M., and Lamb, S. E. Interventions for preventing falls in older people living in the community. Cochrane.Database.Syst.Rev. 2012;9:CD007146. View abstract.

84671

Christesen, H. T., Falkenberg, T., Lamont, R. F., and Jorgensen, J. S. The impact of vitamin D on pregnancy: a systematic review. Acta Obstet.Gynecol.Scand. 2012;91(12):1357-1367. View abstract.

84672

Balion, C., Griffith, L. E., Strifler, L., Henderson, M., Patterson, C., Heckman, G., Llewellyn, D. J., and Raina, P. Vitamin D, cognition, and dementia: a systematic review and meta-analysis. Neurology 9-25-2012;79(13):1397-1405. View abstract.

84673

Millar, H. and Davison, J. Nutrition education for osteoporosis prevention in men with prostate cancer initiating androgen deprivation therapy. Clin J Oncol.Nurs. 2012;16(5):497-503. View abstract.

84674

Murdoch, D. R., Slow, S., Chambers, S. T., Jennings, L. C., Stewart, A. W., Priest, P. C., Florkowski, C. M., Livesey, J. H., Camargo, C. A., and Scragg, R. Effect of vitamin D3 supplementation on upper respiratory tract infections in healthy adults: the VIDARIS randomized controlled trial. JAMA 10-3-2012;308(13):1333-1339. View abstract.

84675

Holmoy, T., Kampman, M. T., and Smolders, J. Vitamin D in multiple sclerosis: implications for assessment and treatment. Expert.Rev.Neurother. 2012;12(9):1101-1112. View abstract.

84676

Paik, J. M., Curhan, G. C., and Taylor, E. N. Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study. BMJ 2012;345:e6390. View abstract.

84677

Cortet, B., Lartigau, E., Caty, A., Moulinier, F., Staerman, F., Villamizar-Vesga, J., and Villers, A. [Androgen deprivation therapy for prostate cancer and osteoporotic risk]. Prog.Urol. 2012;22 Suppl 2:S31-S38. View abstract.

84678

de Gruijl, F. R. and Pavel, S. The effects of a mid-winter 8-week course of sub-sunburn sunbed exposures on tanning, vitamin D status and colds. Photochem.Photobiol.Sci 2012;11(12):1848-1854. View abstract.

84679

Wang, L., Song, Y., Manson, J. E., Pilz, S., Marz, W., Michaelsson, K., Lundqvist, A., Jassal, S. K., Barrett-Connor, E., Zhang, C., Eaton, C. B., May, H. T., Anderson, J. L., and Sesso, H. D. Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ.Cardiovasc.Qual.Outcomes. 2012;5(6):819-829. View abstract.

84680

Girolomoni, G., Vena, G. A., Ayala, F., Cannavo, S. P., De, Pita O., Chimenti, S., and Peserico, A. Consensus on the use of the fixed combination calcipotriol/betamethasone dipropionate in the treatment of plaque psoriasis. G.Ital.Dermatol.Venereol. 2012;147(6):609-624. View abstract.

84681

Witteveen, J. E., van, Thiel S., Romijn, J. A., and Hamdy, N. A. Hungry bone syndrome: still a challenge in the post-operative management of primary hyperparathyroidism: a systematic review of the literature. Eur J Endocrinol 2013;168(3):R45-R53. View abstract.

84682

Christesen, H. T., Elvander, C., Lamont, R. F., and Jorgensen, J. S. The impact of vitamin D in pregnancy on extraskeletal health in children: a systematic review. Acta Obstet.Gynecol.Scand. 2012;91(12):1368-1380. View abstract.

84683

Brondum-Jacobsen, P., Nordestgaard, B. G., Schnohr, P., and Benn, M. 25-hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis. Ann.Neurol. 2013;73(1):38-47. View abstract.

84684

Cameron, I. D., Gillespie, L. D., Robertson, M. C., Murray, G. R., Hill, K. D., Cumming, R. G., and Kerse, N. Interventions for preventing falls in older people in care facilities and hospitals. Cochrane.Database.Syst.Rev. 2012;12:CD005465. View abstract.

84685

Bergman, P., Norlin, A. C., Hansen, S., Rekha, R. S., Agerberth, B., Bjorkhem-Bergman, L., Ekstrom, L., Lindh, J. D., and Andersson, J. Vitamin D3 supplementation in patients with frequent respiratory tract infections: a randomised and double-blind intervention study. BMJ Open. 2012;2(6) View abstract.

84686

Roth, D. E., Al, Mahmud A., Raqib, R., Black, R. E., and Baqui, A. H. Pharmacokinetics of a single oral dose of vitamin D3 (70,000 IU) in pregnant and non-pregnant women. Nutr J 2012;11:114. View abstract.

84687

Fluss, J., Kern, I., de, Coulon G., Gonzalez, E., and Chehade, H. Vitamin D deficiency: A forgotten treatable cause of motor delay and proximal myopathy. Brain Dev. 12-26-2012; View abstract.

84688

McAlindon, T., LaValley, M., Schneider, E., Nuite, M., Lee, J. Y., Price, L. L., Lo, G., and Dawson-Hughes, B. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial. JAMA 1-9-2013;309(2):155-162. View abstract.

84689

Charan, J., Goyal, J. P., Saxena, D., and Yadav, P. Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis. J Pharmacol Pharmacother. 2012;3(4):300-303. View abstract.

84690

Hujoel, P. P. Vitamin D and dental caries in controlled clinical trials: systematic review and meta-analysis. Nutr Rev. 2013;71(2):88-97. View abstract.

84691

Paxton, G. A., Teale, G. R., Nowson, C. A., Mason, R. S., McGrath, J. J., Thompson, M. J., Siafarikas, A., Rodda, C. P., and Munns, C. F. Vitamin D and health in pregnancy, infants, children and adolescents in Australia and New Zealand: a position statement. Med.J Aust. 2-18-2013;198(3):142-143. View abstract.

84692

Witham, M. D., Price, R. J., Struthers, A. D., Donnan, P. T., Messow, C. M., Ford, I., and McMurdo, M. E. Cholecalciferol Treatment to Reduce Blood Pressure in Older Patients With Isolated Systolic Hypertension: The VitDISH Randomized Controlled Trial. JAMA Intern.Med. 8-12-2013; View abstract.

84694

Staberg, B., Roed-Petersen, J., and Menne, T. Efficacy of topical treatment in psoriasis with MC903, a new vitamin D analogue. Acta Derm.Venereol. 1989;69(2):147-150. View abstract.

84695

Garland, C. F., Comstock, G. W., Garland, F. C., Helsing, K. J., Shaw, E. K., and Gorham, E. D. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 11-18-1989;2(8673):1176-1178. View abstract.

84696

Lau, E. M., Woo, J., Swaminathan, R., MacDonald, D., and Donnan, S. P. Plasma 25-hydroxyvitamin D concentration in patients with hip fracture in Hong Kong. Gerontology 1989;35(4):198-204. View abstract.

84697

Lind, L., Wengle, B., Wide, L., and Ljunghall, S. Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am J Hypertens. 1989;2(1):20-25. View abstract.

84698

Baker, L. R., Abrams, L., Roe, C. J., Faugere, M. C., Fanti, P., Subayti, Y., and Malluche, H. H. 1,25(OH)2D3 administration in moderate renal failure: a prospective double-blind trial. Kidney Int 1989;35(2):661-669. View abstract.

84699

Yamauchi, Y., Tsunematsu, T., Konda, S., Hoshino, T., Itokawa, Y., and Hoshizaki, H. [A double blind trial of alfacalcidol on patients with rheumatoid arthritis (RA)]. Ryumachi 1989;29(1):11-24. View abstract.

84700

van de Kerkhof, P. C., van, Bokhoven M., Zultak, M., and Czarnetzki, B. M. A double-blind study of topical 1 alpha,25-dihydroxyvitamin D3 in psoriasis. Br J Dermatol 1989;120(5):661-664. View abstract.

84701

Lind, L., Pollare, T., Hvarfner, A., Lithell, H., Sorensen, O. H., and Ljunghall, S. Long-term treatment with active vitamin D (alphacalcidol) in middle-aged men with impaired glucose tolerance. Effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res 1989;11(3):141-147. View abstract.

84702

Hargreaves, J. A. and Thompson, G. W. Ultraviolet light and dental caries in children. Caries Res 1989;23(5):389-392. View abstract.

84704

Yamada, H. [Long-term effect of 1 alpha-hydroxyvitamin D, calcium and thiazide administration on glucocorticoid-induced osteoporosis]. Nippon Naibunpi Gakkai Zasshi 6-20-1989;65(6):603-614. View abstract.

84709

Lind, L., Wengle, B., Wide, L., Sorensen, O. H., and Ljunghall, S. Hypertension in primary hyperparathyroidism–reduction of blood pressure by long-term treatment with vitamin D (alphacalcidol). A double-blind, placebo-controlled study. Am J Hypertens. 1988;1(4 Pt 1):397-402. View abstract.

84710

Nordal, K. P. and Dahl, E. Low dose calcitriol versus placebo in patients with predialysis chronic renal failure. J Clin Endocrinol.Metab 1988;67(5):929-936. View abstract.

84711

Marya, R. K., Rathee, S., Dua, V., and Sangwan, K. Effect of vitamin D supplementation during pregnancy on foetal growth. Indian J Med Res 1988;88:488-492. View abstract.

84713

Lind, L., Lithell, H., Skarfors, E., Wide, L., and Ljunghall, S. Reduction of blood pressure by treatment with alphacalcidol. A double-blind, placebo-controlled study in subjects with impaired glucose tolerance. Acta Med Scand 1988;223(3):211-217. View abstract.

84716

Ljunghall, S., Lind, L., Lithell, H., Skarfors, E., Selinus, I., Sorensen, O. H., and Wide, L. Treatment with one-alpha-hydroxycholecalciferol in middle-aged men with impaired glucose tolerance–a prospective randomized double-blind study. Acta Med Scand 1987;222(4):361-367. View abstract.

84717

Lind, L., Wengle, B., and Ljunghall, S. Blood pressure is lowered by vitamin D (alphacalcidol) during long-term treatment of patients with intermittent hypercalcaemia. A double-blind, placebo-controlled study. Acta Med Scand 1987;222(5):423-427. View abstract.

84719

Delvin, E. E., Salle, B. L., Glorieux, F. H., Adeleine, P., and David, L. S. Vitamin D supplementation during pregnancy: effect on neonatal calcium homeostasis. J Pediatr 1986;109(2):328-334. View abstract.

84721

Buckley, D. B. A double-blind comparison of 0.1% dithranol in a 17% urea base (“Psoradrate”) and base alone in the treatment of active chronic psoriasis. Curr Med Res Opin. 1978;5(6):489-494. View abstract.

84722

Baker, L. R., Muir, J. W., Sharman, V. L., Abrams, S. M., Greenwood, R. N., Cattell, W. R., Goodwin, F. J., Marsh, F. P., Adami, S., Hately, W., and . Controlled trial of calcitriol in hemodialysis patients. Clin Nephrol. 1986;26(4):185-191. View abstract.

84723

Goldberg, P., Fleming, M. C., and Picard, E. H. Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med Hypotheses 1986;21(2):193-200. View abstract.

84724

Lips, P., van Ginkel, F. C., Jongen, M. J., Rubertus, F., van der Vijgh, W. J., and Netelenbos, J. C. Determinants of vitamin D status in patients with hip fracture and in elderly control subjects. Am J Clin Nutr 1987;46(6):1005-1010. View abstract.

84727

Mallet, E., Gugi, B., Brunelle, P., Henocq, A., Basuyau, J. P., and Lemeur, H. Vitamin D supplementation in pregnancy: a controlled trial of two methods. Obstet Gynecol 1986;68(3):300-304. View abstract.

84731

Moriniere, P., Fournier, A., Leflon, A., Herve, M., Sebert, J. L., Gregoire, I., Bataille, P., and Gueris, J. Comparison of 1 alpha-OH-vitamin D3 and high doses of calcium carbonate for the control of hyperparathyroidism and hyperaluminemia in patients on maintenance dialysis. Nephron 1985;39(4):309-315. View abstract.

84735

Aloia, J. F., Vaswani, A., Ellis, K., Yuen, K., and Cohn, S. H. A model for involutional bone loss. J Lab Clin.Med. 1985;106(6):630-637. View abstract.

84737

Brohult, J. and Jonson, B. Effects of large doses of calciferol on patients with rheumatoid arthritis. A double-blind clinical trial. Scand J Rheumatol 1973;2(4):173-176. View abstract.

84738

Baker, M. R., McDonnell, H., Peacock, M., and Nordin, B. E. Plasma 25-hydroxy vitamin D concentrations in patients with fractures of the femoral neck. Br Med J 3-3-1979;1(6163):589. View abstract.

84739

Christiansen, C., Rodbro, P., and Lund, M. Effect of vitamin D on bone mineral mass in normal subjects and in epileptic patients on anticonvulsants: a controlled therapeutic trial. Br Med J 4-28-1973;2(5860):208-209. View abstract.

84741

Lund, B., Sorensen, O. H., and Christensen, A. B. 25-Hydroxycholecaliferol and fractures of the proximal. Lancet 8-16-1975;2(7929):300-302. View abstract.

84742

Carlson, L. A., Derblom, H., and Lanner, A. Effect of different doses of vitamin D on serum cholesterol and triglyceride levels in healthy men. Atherosclerosis 1970;12(2):313-317. View abstract.

84743

Tougaard, L., Sorensen, E., Brochner-Mortensen, J., Christensen, M. S., Rodbro, P., and Sorensen, A. W. Controlled trial of 1apha-hydroxycholecalciferol in chronic renal failure. Lancet 5-15-1976;1(7968):1044-1047. View abstract.

84746

Berl, T., Berns, A. S., Huffer, W. E., Alfrey, A. C., Arnaud, C. D., and Schrier, R. R. Controlled trial of the effects of 1,25-dihydroxycholecalciferol in patients treated with regular dialysis. Contrib.Nephrol. 1980;18:72-81. View abstract.

84748

Grove, O. and Halver, B. Relief of osteoporotic backache with fluoride, calcium, and calciferol. Acta Med.Scand. 1981;209(6):469-471. View abstract.

84749

Nilas, L. and Christiansen, C. Treatment with vitamin D or its analogues does not change body weight or blood glucose level in postmenopausal women. Int J Obes. 1984;8(5):407-411. View abstract.

84750

Greer, F. R., Hollis, B. W., and Napoli, J. L. High concentrations of vitamin D2 in human milk associated with pharmacologic doses of vitamin D2. J Pediatr 1984;105(1):61-64. View abstract.

84752

Blumberg, A., Wildbolz, A., Descoeudres, C., Hennes, U., Dambacher, M. A., Fischer, J. A., and Weidmann, P. Influence of 1,25 dihydroxycholecalciferol on sexual dysfunction and related endocrine parameters in patiens on maintenance hemodialysis. Clin Nephrol. 1980;13(5):208-214. View abstract.

84753

Memmos, D. E., Eastwood, J. B., Talner, L. B., Gower, P. E., Curtis, J. R., Phillips, M. E., Carter, G. D., Alaghband-Zadeh, J., Roberts, A. P., and de Wardener, H. E. Double-blind trial of oral 1,25-dihydroxy vitamin D3 versus placebo in asymptomatic hyperparathyroidism in patients receiving maintenance haemodialysis. Br Med J (Clin Res Ed) 6-13-1981;282(6280):1919-1924. View abstract.

84754

Maxwell, J. D., Ang, L., Brooke, O. G., and Brown, I. R. Vitamin D supplements enhance weight gain and nutritional status in pregnant Asians. Br J Obstet Gynaecol 1981;88(10):987-991. View abstract.

84757

von, Knorring J., Slatis, P., Weber, T. H., and Helenius, T. Serum levels of 25-hydroxyvitamin D, 24,25-dihydroxyvitamin D and parathyroid hormone in patients with femoral neck fracture in southern Finland. Clin Endocrinol.(Oxf) 1982;17(2):189-194. View abstract.

84759

Brooke, O. G., Brown, I. R., Bone, C. D., Carter, N. D., Cleeve, H. J., Maxwell, J. D., Robinson, V. P., and Winder, S. M. Vitamin D supplements in pregnant Asian women: effects on calcium status and fetal growth. Br Med J 3-15-1980;280(6216):751-754. View abstract.

84763

Hoikka, V., Alhava, E. M., Savolainen, K., and Parviainen, M. Osteomalacia in fractures of the proximal femur. Acta Orthop.Scand 1982;53(2):255-260. View abstract.

84764

Marya, R. K., Rathee, S., Lata, V., and Mudgil, S. Effects of vitamin D supplementation in pregnancy. Gynecol Obstet Invest 1981;12(3):155-161. View abstract.

84765

Johnson, K. R., Jobber, J., and Stonawski, B. J. Prophylactic vitamin D in the elderly. Age Ageing 1980;9(2):121-127. View abstract.

84766

Cockburn, F., Belton, N. R., Purvis, R. J., Giles, M. M., Brown, J. K., Turner, T. L., Wilkinson, E. M., Forfar, J. O., Barrie, W. J., McKay, G. S., and Pocock, S. J. Maternal vitamin D intake and mineral metabolism in mothers and their newborn infants. Br.Med.J 7-5-1980;281(6232):11-14. View abstract.

84768

Scragg, R., Khaw, K. T., and Murphy, S. Effect of winter oral vitamin D3 supplementation on cardiovascular risk factors in elderly adults. Eur J Clin Nutr 1995;49(9):640-646. View abstract.

84772

Gloth, F. M., III, Smith, C. E., Hollis, B. W., and Tobin, J. D. Functional improvement with vitamin D replenishment in a cohort of frail, vitamin D-deficient older people. J Am Geriatr Soc 1995;43(11):1269-1271. View abstract.

84773

Benhamou, C. L., Tourliere, D., Gauvain, J. B., Picaper, G., Audran, M., and Jallet, P. Calciotropic hormones in elderly people with and without hip fracture. Osteoporos Int 1995;5(2):103-107. View abstract.

84777

Lucker, G. P., van de Kerkhof, P. C., Cruysberg, J. R., der Kinderen, D. J., and Steijlen, P. M. Topical treatment of Sjogren-Larsson syndrome with calcipotriol. Dermatology 1995;190(4):292-294. View abstract.

84778

Tuppurainen, M., Heikkinen, A. M., Penttila, I., and Saarikoski, S. Does vitamin D3 have negative effects on serum levels of lipids? A follow-up study with a sequential combination of estradiol valerate and cyproterone acetate and/or vitamin D3. Maturitas 1995;22(1):55-61. View abstract.

84780

Hamdy, N. A., Kanis, J. A., Beneton, M. N., Brown, C. B., Juttmann, J. R., Jordans, J. G., Josse, S., Meyrier, A., Lins, R. L., and Fairey, I. T. Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 2-11-1995;310(6976):358-363. View abstract.

84783

Kragballe, K., Steijlen, P. M., Ibsen, H. H., van de Kerkhof, P. C., Esmann, J., Sorensen, L. H., and Axelsen, M. B. Efficacy, tolerability, and safety of calcipotriol ointment in disorders of keratinization. Results of a randomized, double-blind, vehicle-controlled, right/left comparative study. Arch Dermatol 1995;131(5):556-560. View abstract.

84784

Birkenhager-Frenkel, D. H., Pols, H. A., Zeelenberg, J., Eijgelsheim, J. J., Schot, R., Nigg, A. L., Weimar, W., Mulder, P. G., and Birkenhager, J. C. Effects of 24R,25-dihydroxyvitamin D3 in combination with 1 alpha-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous bone. J Bone Miner.Res 1995;10(2):197-204. View abstract.

84785

Przedlacki, J., Manelius, J., and Huttunen, K. Bone mineral density evaluated by dual-energy X-ray absorptiometry after one-year treatment with calcitriol started in the predialysis phase of chronic renal failure. Nephron 1995;69(4):433-437. View abstract.

84787

Highton, A. and Quell, J. Calcipotriene ointment 0.005% for psoriasis: a safety and efficacy study. Calcipotriene Study Group. J Am Acad Dermatol 1995;32(1):67-72. View abstract.

84788

Lin, S. H., Lin, Y. F., Lu, K. C., Diang, L. K., Chyr, S. H., Liao, W. K., and Shieh, S. D. Effects of intravenous calcitriol on lipid profiles and glucose tolerance in uraemic patients with secondary hyperparathyroidism. Clin.Sci (Lond) 1994;87(5):533-538. View abstract.

84791

Djukanovic, L., Pejanovic, S., Dragojlovic, Z., and Stosovic, M. Treatment of secondary hyperparathyroidism with intermittent oral high doses of 1-alpha-OHD3 plus pharmacological dose of 24,25(OH)2D3. Ren Fail. 1994;16(6):715-723. View abstract.

84792

Mortensen, L., Kragballe, K., Wegmann, E., Schifter, S., Risteli, J., and Charles, P. Treatment of psoriasis vulgaris with topical calcipotriol has no short-term effect on calcium or bone metabolism. A randomized, double-blind, placebo-controlled study. Acta Derm.Venereol. 1993;73(4):300-304. View abstract.

84793

Humbert, P., Dupond, J. L., Agache, P., Laurent, R., Rochefort, A., Drobacheff, C., de, Wazieres B., and Aubin, F. Treatment of scleroderma with oral 1,25-dihydroxyvitamin D3: evaluation of skin involvement using non-invasive techniques. Results of an open prospective trial. Acta Derm.Venereol. 1993;73(6):449-451. View abstract.

84796

Hulshof, M. M., Pavel, S., Breedveld, F. C., Dijkmans, B. A., and Vermeer, B. J. Oral calcitriol as a new therapeutic modality for generalized morphea. Arch Dermatol 1994;130(10):1290-1293. View abstract.

84797

Lucker, G. P., van de Kerkhof, P. C., van Dijk, M. R., and Steijlen, P. M. Effect of topical calcipotriol on congenital ichthyoses. Br J Dermatol 1994;131(4):546-550. View abstract.

84799

Reid, I. R., Wattie, D. J., Evans, M. C., Gamble, G. D., Stapleton, J. P., and Cornish, J. Continuous therapy with pamidronate, a potent bisphosphonate, in postmenopausal osteoporosis. J Clin Endocrinol.Metab 1994;79(6):1595-1599. View abstract.

84800

Tham, S. N., Lun, K. C., and Cheong, W. K. A comparative study of calcipotriol ointment and tar in chronic plaque psoriasis. Br J Dermatol 1994;131(5):673-677. View abstract.

84802

Lowenthal, M. N. and Shany, S. Osteomalacia in Bedouin women of the Negev. Isr.J Med.Sci 1994;30(7):520-523. View abstract.

84804

Christiansen, C., Rodbro, P., Christensen, M. S., Hartnack, B., and Transbol, I. Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol. Lancet 9-30-1978;2(8092 Pt 1):700-703. View abstract.

84806

Rosen, C. J., Morrison, A., Zhou, H., Storm, D., Hunter, S. J., Musgrave, K., Chen, T., Wei, W., and Holick, M. F. Elderly women in northern New England exhibit seasonal changes in bone mineral density and calciotropic hormones. Bone Miner. 1994;25(2):83-92. View abstract.

84808

Orwoll, E., Riddle, M., and Prince, M. Effects of vitamin D on insulin and glucagon secretion in non-insulin-dependent diabetes mellitus. Am J Clin Nutr 1994;59(5):1083-1087. View abstract.

84809

Rehman, P. K. Sub-clinical rickets and recurrent infection. J Trop.Pediatr 1994;40(1):58. View abstract.

84810

Green, C., Ganpule, M., Harris, D., Kavanagh, G., Kennedy, C., Mallett, R., Rustin, M., and Downes, N. Comparative effects of calcipotriol (MC903) solution and placebo (vehicle of MC903) in the treatment of psoriasis of the scalp. Br J Dermatol 1994;130(4):483-487. View abstract.

84814

Bourke, J. F., Berth-Jones, J., and Hutchinson, P. E. Occlusion enhances the efficacy of topical calcipotriol in the treatment of psoriasis vulgaris. Clin Exp.Dermatol 1993;18(6):504-506. View abstract.

84815

Fischer, E. R. and Harris, D. C. Comparison of intermittent oral and intravenous calcitriol in hemodialysis patients with secondary hyperparathyroidism. Clin Nephrol. 1993;40(4):216-220. View abstract.

84820

Nellen, J. F., Smulders, Y. M., Jos Frissen, P. H., Slaats, E. H., and Silberbusch, J. Hypovitaminosis D in immigrant women: slow to be diagnosed. BMJ 3-2-1996;312(7030):570-572. View abstract.

84822

Van Cleemput, J., Daenen, W., Geusens, P., Dequeker, P., Van De Werf, F., and VanHaecke, J. Prevention of bone loss in cardiac transplant recipients. A comparison of biphosphonates and vitamin D. Transplantation 5-27-1996;61(10):1495-1499. View abstract.

84825

Boucher, B. J., Mannan, N., Noonan, K., Hales, C. N., and Evans, S. J. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in east London Asians. Diabetologia 1995;38(10):1239-1245. View abstract.

84827

Perez, A., Chen, T. C., Turner, A., Raab, R., Bhawan, J., Poche, P., and Holick, M. F. Efficacy and safety of topical calcitriol (1,25-dihydroxyvitamin d3) for the treatment of psoriasis. Br J Dermatol 1996;134(2):238-246. View abstract.

84828

Ritz, E., Kuster, S., Schmidt-Gayk, H., Stein, G., Scholz, C., Kraatz, G., and Heidland, A. Low-dose calcitriol prevents the rise in 1,84-iPTH without affecting serum calcium and phosphate in patients with moderate renal failure (prospective placebo-controlled multicentre trial). Nephrol.Dial.Transplant. 1995;10(12):2228-2234. View abstract.

84830

Falcini, F., Trapani, S., Ermini, M., and Brandi, M. L. Intravenous administration of alendronate counteracts the in vivo effects of glucocorticoids on bone remodeling. Calcif.Tissue Int 1996;58(3):166-169. View abstract.

84831

Ravn, P., Clemmesen, B., Riis, B. J., and Christiansen, C. The effect on bone mass and bone markers of different doses of ibandronate: a new bisphosphonate for prevention and treatment of postmenopausal osteoporosis: a 1-year, randomized, double-blind, placebo-controlled dose-finding study. Bone 1996;19(5):527-533. View abstract.

84833

Oliveri, M. B., Palermo, R., Mautalen, C., and Hubscher, O. Regression of calcinosis during diltiazem treatment in juvenile dermatomyositis. J Rheumatol 1996;23(12):2152-2155. View abstract.

84834

van de Kerkhof, P. C., Werfel, T., Haustein, U. F., Luger, T., Czarnetzki, B. M., Niemann, R., and Planitz-Stenzel, V. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety. Br J Dermatol 1996;135(5):758-765. View abstract.

84835

Oranje, A. P., Marcoux, D., Svensson, A., Prendiville, J., Krafchik, B., Toole, J., Rosenthal, D., de Waard-van der Spek FB, Molin, L., and Axelsen, M. Topical calcipotriol in childhood psoriasis. J Am Acad Dermatol 1997;36(2 Pt 1):203-208. View abstract.

84836

Molin, L., Cutler, T. P., Helander, I., Nyfors, B., and Downes, N. Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study. Calcipotriol Study Group. Br J Dermatol 1997;136(1):89-93. View abstract.

84838

Kinyamu, H. K., Gallagher, J. C., Balhorn, K. E., Petranick, K. M., and Rafferty, K. A. Serum vitamin D metabolites and calcium absorption in normal young and elderly free-living women and in women living in nursing homes. Am J Clin Nutr 1997;65(3):790-797. View abstract.

84840

Karpf, D. B., Shapiro, D. R., Seeman, E., Ensrud, K. E., Johnston, C. C., Jr., Adami, S., Harris, S. T., Santora, A. C., Hirsch, L. J., Oppenheimer, L., and Thompson, D. Prevention of nonvertebral fractures by alendronate. A meta-analysis. Alendronate Osteoporosis Treatment Study Groups. JAMA 4-9-1997;277(14):1159-1164. View abstract.

84845

Snyman, J. R., de, Sommers K., Steinmann, M. A., and Lizamore, D. J. Effects of calcitriol on eosinophil activity and antibody responses in patients with schistosomiasis. Eur J Clin Pharmacol. 1997;52(4):277-280. View abstract.

84846

Fliser, D., Stefanski, A., Franek, E., Fode, P., Gudarzi, A., and Ritz, E. No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 1997;27(7):629-633. View abstract.

84848

Brumsen, C., Hamdy, N. A., and Papapoulos, S. E. Long-term effects of bisphosphonates on the growing skeleton. Studies of young patients with severe osteoporosis. Medicine (Baltimore) 1997;76(4):266-283. View abstract.

84849

Boonen, S., Broos, P., Verbeke, G., Aerssens, J., Van, Herck E., Jans, I., Dequeker, J., and Bouillon, R. Calciotropic hormones and markers of bone remodeling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperparathyroidism-induced bone resorption. J Gerontol.A Biol.Sci Med Sci 1997;52(5):M286-M293. View abstract.

84853

Veien, N. K., Bjerke, J. R., Rossmann-Ringdahl, I., and Jakobsen, H. B. Once daily treatment of psoriasis with tacalcitol compared with twice daily treatment with calcipotriol. A double-blind trial. Br J Dermatol 1997;137(4):581-586. View abstract.

84855

Heikkinen, A. M., Tuppurainen, M. T., Niskanen, L., Komulainen, M., Penttila, I., and Saarikoski, S. Long-term vitamin D3 supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapy. Eur J Endocrinol. 1997;137(5):495-502. View abstract.

84857

Thiebaud, D., Burckhardt, P., Costanza, M., Sloutskis, D., Gilliard, D., Quinodoz, F., Jacquet, A. F., and Burnand, B. Importance of albumin, 25(OH)-vitamin D and IGFBP-3 as risk factors in elderly women and men with hip fracture. Osteoporos Int 1997;7(5):457-462. View abstract.

84858

el-Reshaid, K., el-Reshaid, W., Sugathan, T., al-Mohannadi, S., and Sivanandan, R. Comparison of the efficacy of two injectable forms of vitamin D3 and oral one-alpha in treatment of secondary hyperparathyroidism in patients on maintenance hemodialysis. Am J Nephrol. 1997;17(6):505-510. View abstract.

84859

Hosking, D., Chilvers, C. E., Christiansen, C., Ravn, P., Wasnich, R., Ross, P., McClung, M., Balske, A., Thompson, D., Daley, M., and Yates, A. J. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group. N.Engl.J Med 2-19-1998;338(8):485-492. View abstract.

84861

Lansdowne, A. T. and Provost, S. C. Vitamin D3 enhances mood in healthy subjects during winter. Psychopharmacology (Berl) 1998;135(4):319-323. View abstract.

84863

Wimalawansa, S. J. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis. Am J Med 1998;104(3):219-226. View abstract.

84865

Panichi, V., Andreini, B., De, Pietro S., Migliori, M., Taccola, D., Giovannini, L., Ferdeghini, M., and Palla, R. Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialytic renal failure. Clin Nephrol. 1998;49(4):245-250. View abstract.

84867

Ruzicka, T. and Lorenz, B. Comparison of calcipotriol monotherapy and a combination of calcipotriol and betamethasone valerate after 2 weeks’ treatment with calcipotriol in the topical therapy of psoriasis vulgaris: a multicentre, double-blind, randomized study. Br J Dermatol 1998;138(2):254-258. View abstract.

84870

Evans, S. R., Nolla, J., Hanfelt, J., Shabahang, M., Nauta, R. J., and Shchepotin, I. B. Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer. Clin.Cancer Res 1998;4(7):1591-1595. View abstract.

84871

Martin, K. J., Gonzalez, E. A., Gellens, M., Hamm, L. L., Abboud, H., and Lindberg, J. 19-Nor-1-alpha-25-dihydroxyvitamin D2 (Paricalcitol) safely and effectively reduces the levels of intact parathyroid hormone in patients on hemodialysis. J Am Soc Nephrol. 1998;9(8):1427-1432. View abstract.

84872

Cunningham, B. B., Landells, I. D., Langman, C., Sailer, D. E., and Paller, A. S. Topical calcipotriene for morphea/linear scleroderma. J Am Acad Dermatol 1998;39(2 Pt 1):211-215. View abstract.

84877

Parsad, D., Saini, R., and Verma, N. Combination of PUVAsol and topical calcipotriol in vitiligo. Dermatology 1998;197(2):167-170. View abstract.

84879

Marchetti, A., LaPensee, K., and An, P. A pharmacoeconomic analysis of topical therapies for patients with mild-to-moderate stable plaque psoriasis: a US study. Clin Ther 1998;20(4):851-869. View abstract.

84881

Fisher, B., Costantino, J. P., Wickerham, D. L., Redmond, C. K., Kavanah, M., Cronin, W. M., Vogel, V., Robidoux, A., Dimitrov, N., Atkins, J., Daly, M., Wieand, S., Tan-Chiu, E., Ford, L., and Wolmark, N. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. J Natl Cancer Inst. 9-16-1998;90(18):1371-1388. View abstract.

84884

Lufkin, E. G., Whitaker, M. D., Nickelsen, T., Argueta, R., Caplan, R. H., Knickerbocker, R. K., and Riggs, B. L. Treatment of established postmenopausal osteoporosis with raloxifene: a randomized trial. J Bone Miner.Res 1998;13(11):1747-1754. View abstract.

84885

Llach, F., Keshav, G., Goldblat, M. V., Lindberg, J. S., Sadler, R., Delmez, J., Arruda, J., Lau, A., and Slatopolsky, E. Suppression of parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2. Am J Kidney Dis. 1998;32(2 Suppl 2):S48-S54. View abstract.

84886

Sato, Y., Manabe, S., Kuno, H., and Oizumi, K. Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson’s disease. J Neurol.Neurosurg.Psychiatry 1999;66(1):64-68. View abstract.

84887

Kragballe, K., Barnes, L., Hamberg, K. J., Hutchinson, P., Murphy, F., Moller, S., Ruzicka, T., and van de Kerkhof, P. C. Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br.J Dermatol. 1998;139(4):649-654. View abstract.

84890

Thacher TD, Ighogboja SI, and Fischer PR. Rickets without vitamin D deficiency in Nigerian children. AMBULATORY CHILD HEALTH 1997;3(1):56-64.

84891

Petitpain D, Budak A, DesMarteau J, Durkalski V, and Byrne TK. Preoperative vitamin D status in potential bariatric surgery patients. BARIATRIC NURS SURG PATIENT CARE 2010;5(3):255-260.

84892

Musculoskeletal citations. Vitamin D results in more — not fewer — falls and fractures in older women. J MUSCULOSKELETAL MED 2010;27(2):245.

84893

Hashemipur S, Sarokhani MR, Asefzadeh S, Mehrtash B, Sheikholeslami H, and Ghoddosi A. PrFont34Bin0BinSub0Frac0Def1Margin0Margin0Jc1Indent1440Lim0Lim1Effect of different dosagse [sic] of intramuscular vitamin D3 on serum 25(OH)D. IRANIAN J ENDOCRINOL METAB 2008;10(2):182.

84894

Reginster JY, Kaufman JM, and Gangjii V. Preference for and acceptability of two formulations of a dietary supplement containing calcium plus vitamin D3: a randomized, open-label, crossover trial in adult patients with calcium and vitamin D deficiencies. CURR THER RES 2005;66(1):23-34.

84895

Yanuskiewicz A. The role of vitamin D in the prevention of breast cancer. INTERNET J NUTR WELLNESS 2010;8(2):15.

84896

Smedshaug GB, Pedersen JI, and Meyer HE. Can vitamin D supplementation improve grip strength in elderly nursing home residents? A double-blinded controlled trial. Scand J Food Nutr 2007;51:74-78.

84897

Thierfelder W, Roth HJ, Laussmann D, Pientka L, Schumacher J, and Schulz. Vitamin D and parathyroid hormone: a tool to determine assay-specific cutoff values for vitamin D. LABORATORIUMSMEDIZIN 2008;32(6):456-463.

84898

Vokk R, Liebert T, Pitsi T, and Annunziata AI. Consumption of milk products, calcium and vitamin D by Estonian children in 1996 and 2002. SCAND J NUTR 2005;49(4):159-164.

84901

Monastirli A, Zografakis C Braun H et al. Calcipotriol vs. Anthralin in the treatment of chronic plaque psoriasis. Z Hautk 2000;75:626-629.

84902

Kiss I, McCreary HL, Siskin SB, and Epinette WW. A Randomized, Double- Blind, Parallel Group, Dose-Ranging Comparison of the Efficacy and Safety of Calcipotriene Solution in the Treatment of Scalp Psoriasis. American Academy of Dermatology, 54th annual Meeting. 1996;

84903

Kragballe K, Beck HI, and Søgaard H. Improvement of Psoriasis by a Topical Vitamin D3 Analogue (Mc 903) in a Double-Blind Study. British Journal Of Dermatology 1988;119(2):223-230.

84904

Langner A, Verjans H, Stapor V, Mol M, and Fraczykowska M. 1 Alpha,25-Dihydroxyvitamin D-3 (Calcitriol) Ointment in Psoriasis. Journal Of Dermatological Treatment 1992;3(4):177-180.

84905

Lister RK, Woodrow Sl, Hughes JH, Cerio R, Norris PG, and Griffiths CEM. Can dithranol have a lasting effect and bemore acceptable to patients? Micanol Cream – a trial of 171 patients with psoriasis. British Journal Of Dermatology 1997;137(Suppl50):17.

84906

Scarpa C. Tacalcitol Ointment Is an Efficacious and Well Tolerated Treatment for Psoriasis. Journal of the European Academy of Dermatology & Venereology 1996;6(2):142-146.

84907

Scarpa C, Kokelj F, Plozzer C, Lavaroni G, and Torsello P. Efficacy and Tolerability of Tacalcitol Administered Once Daily in the Treatment of Psoriasis Vulgaris (Double-Blind, Randomized, Placebo Controlled Italian Multicenter Study). Giornale Italiano di Dermatologiae Venereologia 1997;132(5):335-338.

84908

Christensen OB, Mork NJ, and Ashton R. Comparison of a treatment phase and a follow-up phase of short contact dithranol and calcipotriol in outpatients with chronic plaque psoriasis. J Dermatol Treat 1999;10:261-265.

84922

van Dijk F, Thio HB Neumann HAM. Non-oncological and non-infectious diseases of the penis (penile lesions). EAU- EBU Update Series 2006;4:13-19.

84923

Camilleri MJ, Calobrisi SD. Skin eruptions in the diaper area. Curr Problems Dermatol 1999;11:214-243.

84924

Mellanby M, Pattison CL Proud JW. The effect of diet on the development and extension of caries in the teeth of children. Br Med J. 1924;2:354-355.

84925

Mellanby M, Pattison CL. Some factors of diet influencing the spread of caries in children. Br Dent J. 1926;47:1045-1057.

84926

Medical Research Council. The Influence of Diet on Caries in Children’s Teeth (Final Report). London: H.M.Stationery Off. 1936;

84927

McKeag RH. Report on a practical test of the effects of “ostelin”and parathyroid on the teeth of children. Br Dent J. 1930;51:281-286.

84928

Schoenthal L, Brodsky RH. Dietary control and etiology of dental caries. Am J Dis Child. 1933;46:91-104.

84929

Brodsky RH. Factors in the etiology and arrest of dental caries. J AmDent Assoc. 1933;20:1440-1458.

84930

Hubbell RB, Bunting RW. Calcium and phosphorus of saliva in relation to dental caries. J Nutr. 1932;5:599-605.

84931

McBeath EC. Experiments on the dietary control of dental caries in children. J Dent Res. 1932;12(723):747.

84932

The School of Dental and Oral Surgery of Columbia University. Report to Commonwealth Fund. New York: Commonwealth Fund 1934;

84933

Hollander F. Coordinated report of the Columbia University Dental Caries Research Group. J Dent Res. 1934;14:303-313.

84934

McBeath EC, Zucker TF. The role of vitamin D in the control of dental caries in children. J Nutr. 1938;15:547-564.

84935

Anderson PG, Williams CHM Halderson H et al. The influence of vitamin D in the prevention of dental caries. J Am Dent Assoc. 1934;21:1349-1366.

84936

Agnew MC, Agnew RG Tisdall FF. The production and prevention of dental caries. J Am Dent Assoc. 1933;20:193-212.

84937

Tisdall FF. The effect of nutrition on the primary teeth. Child Dev 1937;8:102-104.

84938

Jameson AB, Cox H. Clinical note on vitamin D and dental caries. N Z Med J. 1933;32:41-42.

84939

Day MCD, Sedwick HJ. The fat-soluble vitamins and dental caries in children. J Nutr. 1934;8:309-328.

84940

Jundell I, Hanson R Sandberg T. Stoffwechsel im Zahnschmelz und Prophylaxe gegen Zahncaries [in German]. Acta Paediatr. 1938;23:141.

84941

Goll H. Ist die Karies derMilchzähne durchVerabreichung der Lebertran gunstig zu beeinflussen? [in German]. Wien Klin Wochenschr. 1939;52:35.

84942

Brodsky RH, Schick B Vollmer H. Prevention of dental caries by massive doses of vitamin D. Am J Dis Child. 1941;62:1183-1187.

84943

McBeath EC, Verlin WA. Further studies on the role of vitamin D in the nutritional control of dental caries in children. J AmDent Assoc. 1942;29:1393-1397.

84944

Strean LP, Beaudet JP. Inhibition of dental caries by ingestion of fluoridevitamin tablets. N Y State J Med. 1945;45:2183.

84945

Ott JN. Light; photosynthesis, the oculoendocrine system and dental caries. J Am Soc Prev Dent. 1975;5:10-15.

84946

Mayron L, Ott JN Amontree E et al. Light, radiation and dental caries. Incidence of dental caries in school children as a function of light quality and radiation shielding. Acad Ther. 2013;1975(10):441-448.

84947

Larsen ER, Mosekilde L, and Foldspang A. Vitamin D and calcium treatment and environmental adjustment in the prevention of falls and osteoporotic fractures among elderly Danish community residents. J Bone Miner Res 2002;17:1137.

84948

Bischoff HA, Staehelin HB, and Dick W. Fall prevention by vitamin D. A randomized controlled trial. J Bone Miner Res 2001;16:163.

84949

Binder EF. Implementing a structured exercise program for frail nursing home residents with dementia. Issues and challenges. J Aging Phys Activity 1995;3:383-395.

84952

Hayashi Y, Fujita T, and Inoue T. Decrease of vertebral fracture in osteoporosis by administration of 1a-hydroxy-vita- min D3. JBMM 1992;10:184-188.

84953

Holick MF. Vitamin D: the underappreciated D-lightful hormone that is important for skeletal and cellular health. Curr Opin Endocrinol Diabetes 2002;9:87-98.

84954

National Osteoporosis Foundation. Clinician’s Guide to Prevention and Treatment of Osteoporosis. 2008;

84955

Food and Nutrition Board Institute of Medicine. Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. Dietary Reference Intakes: Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride. 1997;

84961

Brazier M, Kamel S, Lorget F, Maamer M, Tavera C, Heurtebize N, Grados F, Mathieu M, Garabedian M, Sebert JL, and Fardellone P. Biological effects of supplementation with vitamin D and calcium in postmenopausal women with low bone mass receiving alendronate. Clinical Drug Investigation 2002;22:849-857.

84963

Fuleihan GEH, Nabulsi M, and Tamim H. Effect of vitamin D replacement on musculoskeletal parameters in school children: A randomized controlled trial. J Clin Endocrinol Metab 2006;91(2):406-412.

84964

Gattinara M, Pontikaki I, Gerloni V, and Fantini F. Use of cyclic etidronate in patients with juvenile chronic rheumatic diseases receiving long term treatment with steroids. Ann Rheum Dis 2000;59:743-744.

84965

Bardare M, Grassi A, Dell’Era L, Corona F, and Bianchi M. Alendronate in the treatment of osteoporosis in rheumatic diseases of childhood. Ann Rheum Dis 2000;59:742.

84966

Bayer M, Stepan J, and Kutilek S. Alendronate in treatment of osteoporosis in childhood. Osteologicky Bull 2002;7:23-24.

84967

Klaus G, Hinderer J, Lingens B, Keuth B, Querfield U, and Mehls O. Comparison of intermittent and continuous (daily) oral calcitriol for treatment of renal hyperparathyroidism in children on dialysis Vitamin D compounds for people with chronic kidney disease requiring dialysis. Pediatric Nephrology 1995;9(6):C75.

84968

Buccianti G, Valenti G, and Miradoli R. Treatment of uremic osteodystrophy. A clinical trial with calcitonin, 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol. Dialysis and Transplantation 1981;10(6):523-528.

84969

Coen G, Gallucci MT, and Bonucci E. Treatment of renal osteodystrophy (ROD) with 25-OHD3 and 1,25 (OH)2D3: Synergic effect unrelated to 24,25 (OH)2D3 synthesis. Kidney International 1982;22(1):96.

84970

Fournier A, Moriniere P, Boudaillez B, Maurouard C, Westeel PF, and Achard JM. Prevention of radiologically obvious hyperparathyroidism in dialysis patients by i.v. 1aOH vitamin D3 (Etalpha) in association with Mg(OH)2 as sole phosphate binder. Nieren-und Hochdruckkrankheiten 1993;22:S39-44.

84980

Eid P, Scuderi G, Aroldi A, Ciammella M, and Nencioni T. Bone loss after renal transplantation: HRT versus calcitriol in postmenopausal recipients. Osteoporosis International 1996;6(Suppl1):294.

84981

Nordal KP, Halse J, and Dahl E. The effect of nasal calcitonin on bone mineral density in renal transplant recipients. Nephrology Dialysis Transplantation 1996;11(6):1212.

84982

Psimenou E, Konstantinidou E, Giapraka N, Marinaki S, Kostakis A, and Stathakis CP. Randomized controlled study of calcitonin and etidronate in the treatment of osteoporosis in renal transplant patients. XIXth International Congress of the Transplantation Society 2002;

84983

Sharma RK, Jeloka T, Gupta A, Gupta S, Gulati S, and Sharma AP. Role of alendronate in post renal transplant osteoporosis: a randomised study. Indian Journal of Nephrology 2002;12(4):236-237.

84984

Coen G, Mazzaferro S, Manni M, Napoletano I, Fondi G, and Sardella D. Treatment with small doses of 1, 25-dihydroxyvitamin D3 in predialysis chronic renal failure may lower the rate of decline of renal function. Ital J Mineral Electrolyte Metab 1994;8:117-121.

84985

Juttmann JR and Birkenhager JC. Treatment of predialysis renal bone disease (RBD) with 1alpha (OH) vitamin D3 and 1,25-(OH) 2 vitamin D3. Netherlands Journal of Medicine 1979;22(5):172.

84986

Corless D, Ellis M Dawson E Fraser F. Using activities of daily living assessments to measure the effectiveness of vitamin D supplements in elderly long-stay patients. Br J Occup Ther 1987;50:60-62.

84987

Schaadt OP and Bohr HH. Alfacalcidol in prednisone treatment -a controlled study of effect on bone mineral content in lumbar spine, femoral neck and shaft. Calcif Tissue Int 1986;39(Suppl):A58.

84988

Diamond T, McGuigan L, Schonell M, Levy S, and Rae D. A 2 year open randomized controlled trial comparing calcitriol to cyclic etidronate for the treatment of glucocorticoid-induced osteoporosis. J Bone Miner Res 1997;12(Suppl1):S511.

84989

Lakatos P, Kiss L, Horvath C, Takacs I, Foldes J, Bossanyi A, and Major T. Prevention of corticosteroidinduced osteoporosis with alphacalcidol. Lege Artis Med 1996;6:624-629.

84990

Emkey R, Procaccini R, and Gaich G. The effect of calcitonin on bone mass in steroid-induced osteoporosis. Arthritis Rheum 1994;37(Suppl9):S183.

84991

Christensen RS, Alex NH, Perloff JJ, Georgitis WJ, and McDermott MT. Coherence therapy for steroid-induced osteoporosis, one year report. 77th Annual Meeting of the Endocrine Society, Washington, DC. 6-14-1995;

84994

Sambrook PN. Which treatments are effective in preventing and treating glucocorticoid-induced bone loss: comment on the American College of Rheumatology recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheum 1997;40:1550-1551.

84995

Henderson NK, Marshall G, Sambrook PN, Keogh A, and Eisman JA. Prevention of bone loss after heart or lung transplantation. J Bone Miner Res 2011;12(Suppl):S400.

84996

Lems WF, Jacobs JWG, Bijlsma JWJ, Croone A, Houben HHML, and Haanen HCM. Corticosteroids and bone [thesis]. Utrecht (The Netherlands): Univ. of Utrecht. 1996;

84999

Saadati N, Rajabian R. The effect of bisphosphonate on prevention of glucocorticoid-induced osteoporosis. Iranian Red Crescent Medical Journal 2008;10:8-11.

85000

Schachter HM, Clifford TJ, Cranney A, Barrowman NJ, and Moher D. Raloxifene for primary and secondary prevention of osteoporotic fractures in postmenopausal women: a systematic review of efficacy and safety evidence Ottawa, Ontario, Canada: Canadian Coordinating Office for Health Technology Assessment. 2005;

85002

Kawaura A. Inhibitory effect of long term 1alpha-hydroxyvitamin D3 administration on Helicobacter pylori infection. J Clin Biochem Nutr 2006;38:103-106.

85003

Brown SA, Aris RM, Leigh MW, Retsch-Bogart GZ, Caminiti MJ, Jennings-Grant T, Lester GE, and Ontjes DA. Baseline BMD status in children and young adults with CF: calcitriol intervention study. Pediatric Pulmonology 2005;40(Suppl):354.

85004

Popescu M, Morris J, and Hillman L. Calcium and vitamin D supplementation in CF children. Pediatric Pulmonology 1998;26(Suppl17):359.

85005

Smith, M. R. Osteoporosis during androgen deprivation therapy for prostate cancer. Urology 2002;60(3):79-85.

85008

Delfino M, Fabbrocini G, and Sammarco E. Efficacy of calcipotriol versus lactic acid cream in the treatment of lamellar and X-linked ichthyoses. J Dermatol Treat 1994;5:151-152.

85010

Wesa KM, Cronin A Segal NH et al. Serum 25-hydroxy vitamin D (vit D) and survival in colorectal cancer (CRC): A retrospective analysis [abstract3615]. J Clin Oncol 2010;28:289.

85011

Piura E, Chapman JW Lipton A et al. Serum 1-OH vitamin D and prognosis of postmenopausal breast cancer patients: NCIC-CTG MA 14 trial[abstract 534]. J Clin Oncol 2013;27:15.